cid	atc	pert_iname	pert_id	pert_count	cell_id_count	inst_id	rna_plate	rna_well	pert_type	pert_dose	pert_dose_unit	pert_time	pert_time_unit	cell_id	cell_type	base_cell_id	precursor_cell_id	modification	sample_type	primary_site	subtype	original_growth_pattern	provider_catalog_id	original_source_vendor	donor_age	donor_sex	donor_ethnicity
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:J08	CPC004_A375_6H_X1	J08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:J08	CPC004_A375_6H_X2	J08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:J08	CPC004_A375_6H_X3	J08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_A375_6H_X1_B4_DUO52HI53LO:L09	CPC015_A375_6H_X1	L09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_A375_6H_X2_B4_DUO52HI53LO:L09	CPC015_A375_6H_X2	L09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_A375_6H_X3_B4_DUO52HI53LO:L09	CPC015_A375_6H_X3	L09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A375_6H_X1_B3_DUO52HI53LO:G10	CPC011_A375_6H_X1	G10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A375_6H_X2_B3_DUO52HI53LO:G10	CPC011_A375_6H_X2	G10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A375_6H_X3_B3_DUO52HI53LO:G10	CPC011_A375_6H_X3	G10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A375_6H_X1_B3_DUO52HI53LO:B03	CPC011_A375_6H_X1	B03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A375_6H_X2_B3_DUO52HI53LO:B03	CPC011_A375_6H_X2	B03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A375_6H_X3_B3_DUO52HI53LO:B03	CPC011_A375_6H_X3	B03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_A375_6H_X1_B4_DUO52HI53LO:J10	CPC015_A375_6H_X1	J10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_A375_6H_X2_B4_DUO52HI53LO:J10	CPC015_A375_6H_X2	J10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_A375_6H_X3_B4_DUO52HI53LO:J10	CPC015_A375_6H_X3	J10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X1_B10:O07	BRAF001_A375_6H_X1	O07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X1_B10:O08	BRAF001_A375_6H_X1	O08	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X1_B10:O15	BRAF001_A375_6H_X1	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X1_B10:O16	BRAF001_A375_6H_X1	O16	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X1_B10:O23	BRAF001_A375_6H_X1	O23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X1_B10:O24	BRAF001_A375_6H_X1	O24	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X1_B10:P07	BRAF001_A375_6H_X1	P07	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X1_B10:P08	BRAF001_A375_6H_X1	P08	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X1_B10:P15	BRAF001_A375_6H_X1	P15	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X1_B10:P16	BRAF001_A375_6H_X1	P16	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X1_B10:P23	BRAF001_A375_6H_X1	P23	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X2_B10:O07	BRAF001_A375_6H_X2	O07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X2_B10:O08	BRAF001_A375_6H_X2	O08	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X2_B10:O15	BRAF001_A375_6H_X2	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X2_B10:O16	BRAF001_A375_6H_X2	O16	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X2_B10:O23	BRAF001_A375_6H_X2	O23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X2_B10:O24	BRAF001_A375_6H_X2	O24	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X2_B10:P07	BRAF001_A375_6H_X2	P07	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X2_B10:P08	BRAF001_A375_6H_X2	P08	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X2_B10:P15	BRAF001_A375_6H_X2	P15	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X2_B10:P16	BRAF001_A375_6H_X2	P16	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X2_B10:P23	BRAF001_A375_6H_X2	P23	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:O07	BRAF001_A375_6H_X3	O07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:O08	BRAF001_A375_6H_X3	O08	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:O15	BRAF001_A375_6H_X3	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:O16	BRAF001_A375_6H_X3	O16	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:O23	BRAF001_A375_6H_X3	O23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:O24	BRAF001_A375_6H_X3	O24	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:P07	BRAF001_A375_6H_X3	P07	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:P08	BRAF001_A375_6H_X3	P08	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:P15	BRAF001_A375_6H_X3	P15	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:P16	BRAF001_A375_6H_X3	P16	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:P23	BRAF001_A375_6H_X3	P23	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_6H_X3_B10:P24	BRAF001_A375_6H_X3	P24	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:O07	BRAF001_A375_24H_X1	O07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:O08	BRAF001_A375_24H_X1	O08	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:O15	BRAF001_A375_24H_X1	O15	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:O16	BRAF001_A375_24H_X1	O16	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:O23	BRAF001_A375_24H_X1	O23	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:O24	BRAF001_A375_24H_X1	O24	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:P07	BRAF001_A375_24H_X1	P07	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:P08	BRAF001_A375_24H_X1	P08	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:P15	BRAF001_A375_24H_X1	P15	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:P16	BRAF001_A375_24H_X1	P16	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:P23	BRAF001_A375_24H_X1	P23	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X1_B10:P24	BRAF001_A375_24H_X1	P24	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X2_B10:O07	BRAF001_A375_24H_X2	O07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X2_B10:O08	BRAF001_A375_24H_X2	O08	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X2_B10:O15	BRAF001_A375_24H_X2	O15	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X2_B10:O16	BRAF001_A375_24H_X2	O16	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X2_B10:O23	BRAF001_A375_24H_X2	O23	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X2_B10:O24	BRAF001_A375_24H_X2	O24	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X2_B10:P08	BRAF001_A375_24H_X2	P08	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X2_B10:P15	BRAF001_A375_24H_X2	P15	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X2_B10:P16	BRAF001_A375_24H_X2	P16	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X2_B10:P23	BRAF001_A375_24H_X2	P23	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:O07	BRAF001_A375_24H_X4	O07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:O08	BRAF001_A375_24H_X4	O08	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:O15	BRAF001_A375_24H_X4	O15	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:O16	BRAF001_A375_24H_X4	O16	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:O23	BRAF001_A375_24H_X4	O23	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:O24	BRAF001_A375_24H_X4	O24	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:P07	BRAF001_A375_24H_X4	P07	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:P08	BRAF001_A375_24H_X4	P08	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:P15	BRAF001_A375_24H_X4	P15	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:P16	BRAF001_A375_24H_X4	P16	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:P23	BRAF001_A375_24H_X4	P23	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_A375_24H_X4_B11:P24	BRAF001_A375_24H_X4	P24	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:E01	CPC004_A375_6H_X1	E01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:E01	CPC004_A375_6H_X2	E01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:E01	CPC004_A375_6H_X3	E01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:K18	CPC017_A375_6H_X4	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A375_6H_X1_B4_DUO52HI53LO:F24	CPC020_A375_6H_X1	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A375_6H_X1_B4_DUO52HI53LO:H08	CPC020_A375_6H_X1	H08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A375_6H_X2_B4_DUO52HI53LO:F24	CPC020_A375_6H_X2	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A375_6H_X2_B4_DUO52HI53LO:H08	CPC020_A375_6H_X2	H08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A375_6H_X3_B4_DUO52HI53LO:F24	CPC020_A375_6H_X3	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A375_6H_X3_B4_DUO52HI53LO:H08	CPC020_A375_6H_X3	H08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A375_6H_X4_B5_DUO52HI53LO:F24	CPC020_A375_6H_X4	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A375_6H_X4_B5_DUO52HI53LO:H08	CPC020_A375_6H_X4	H08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:F24	CPC020_A375_6H_X5	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:H08	CPC020_A375_6H_X5	H08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_A375_6H_X2_B4_DUO52HI53LO:K18	CPC017_A375_6H_X2	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_A375_6H_X3_B4_DUO52HI53LO:K18	CPC017_A375_6H_X3	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A375_24H_X1_B3_DUO52HI53LO:F24	CPC005_A375_24H_X1	F24	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A375_24H_X2_B3_DUO52HI53LO:F24	CPC005_A375_24H_X2	F24	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A375_24H_X3_B3_DUO52HI53LO:F24	CPC005_A375_24H_X3	F24	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A375_6H_X1_B3_DUO52HI53LO:F24	CPC005_A375_6H_X1	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A375_6H_X2_B3_DUO52HI53LO:F24	CPC005_A375_6H_X2	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A375_6H_X3_B3_DUO52HI53LO:F24	CPC005_A375_6H_X3	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_A375_6H_X1_B3_DUO52HI53LO:B24	CPC009_A375_6H_X1	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_A375_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_A375_6H_X2	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_A375_6H_X4_B5_DUO52HI53LO:B24	CPC009_A375_6H_X4	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_A375_6H_X5_F1B5_DUO52HI53LO:B24	CPC009_A375_6H_X5	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_A375_6H_X1_B3_DUO52HI53LO:P10	CPC011_A375_6H_X1	P10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_A375_6H_X2_B3_DUO52HI53LO:P10	CPC011_A375_6H_X2	P10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_A375_6H_X3_B3_DUO52HI53LO:P10	CPC011_A375_6H_X3	P10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A375_24H_X1_B3_DUO52HI53LO:F24	CPC005_A375_24H_X1	F24	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A375_24H_X2_B3_DUO52HI53LO:F24	CPC005_A375_24H_X2	F24	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A375_24H_X3_B3_DUO52HI53LO:F24	CPC005_A375_24H_X3	F24	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A375_6H_X1_B3_DUO52HI53LO:F24	CPC005_A375_6H_X1	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A375_6H_X2_B3_DUO52HI53LO:F24	CPC005_A375_6H_X2	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A375_6H_X3_B3_DUO52HI53LO:F24	CPC005_A375_6H_X3	F24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_A375_6H_X1_B3_DUO52HI53LO:B24	CPC009_A375_6H_X1	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_A375_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_A375_6H_X2	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_A375_6H_X4_B5_DUO52HI53LO:B24	CPC009_A375_6H_X4	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_A375_6H_X5_F1B5_DUO52HI53LO:B24	CPC009_A375_6H_X5	B24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_A375_6H_X1_B3_DUO52HI53LO:P10	CPC011_A375_6H_X1	P10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_A375_6H_X2_B3_DUO52HI53LO:P10	CPC011_A375_6H_X2	P10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_A375_6H_X3_B3_DUO52HI53LO:P10	CPC011_A375_6H_X3	P10	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_A375_6H_X4_F1B5_DUO52HI53LO:F20	CPC018_A375_6H_X4	F20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_A375_6H_X5_F1B5_DUO52HI53LO:F20	CPC018_A375_6H_X5	F20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_A375_6H_X1_B4_DUO52HI53LO:P19	CPC020_A375_6H_X1	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_A375_6H_X2_B4_DUO52HI53LO:P19	CPC020_A375_6H_X2	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_A375_6H_X3_B4_DUO52HI53LO:P19	CPC020_A375_6H_X3	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_A375_6H_X4_B5_DUO52HI53LO:P19	CPC020_A375_6H_X4	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_A375_6H_X1_B4_DUO52HI53LO:F20	CPC018_A375_6H_X1	F20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_A375_6H_X2_B4_DUO52HI53LO:F20	CPC018_A375_6H_X2	F20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_A375_6H_X3_B4_DUO52HI53LO:F20	CPC018_A375_6H_X3	F20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:E11	CPC004_A375_6H_X1	E11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:E11	CPC004_A375_6H_X2	E11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:E11	CPC004_A375_6H_X3	E11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:M02	CPC017_A375_6H_X4	M02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_A375_6H_X1_B4_DUO52HI53LO:F21	CPC020_A375_6H_X1	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_A375_6H_X2_B4_DUO52HI53LO:F21	CPC020_A375_6H_X2	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_A375_6H_X3_B4_DUO52HI53LO:F21	CPC020_A375_6H_X3	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_A375_6H_X4_B5_DUO52HI53LO:F21	CPC020_A375_6H_X4	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:F21	CPC020_A375_6H_X5	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_A375_6H_X2_B4_DUO52HI53LO:M02	CPC017_A375_6H_X2	M02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_A375_6H_X3_B4_DUO52HI53LO:M02	CPC017_A375_6H_X3	M02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:K17	CPC004_A375_6H_X1	K17	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:K17	CPC004_A375_6H_X2	K17	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:K17	CPC004_A375_6H_X3	K17	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_A375_6H_X4_F1B5_DUO52HI53LO:A20	CPC018_A375_6H_X4	A20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_A375_6H_X5_F1B5_DUO52HI53LO:A20	CPC018_A375_6H_X5	A20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_A375_6H_X1_B4_DUO52HI53LO:A20	CPC018_A375_6H_X1	A20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_A375_6H_X2_B4_DUO52HI53LO:A20	CPC018_A375_6H_X2	A20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_A375_6H_X3_B4_DUO52HI53LO:A20	CPC018_A375_6H_X3	A20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:G23	CPC004_A375_6H_X1	G23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:G23	CPC004_A375_6H_X2	G23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:G23	CPC004_A375_6H_X3	G23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:O16	CPC017_A375_6H_X4	O16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_A375_6H_X1_B3_DUO52HI53LO:G15	CPC011_A375_6H_X1	G15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_A375_6H_X2_B3_DUO52HI53LO:G15	CPC011_A375_6H_X2	G15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_A375_6H_X3_B3_DUO52HI53LO:G15	CPC011_A375_6H_X3	G15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_A375_6H_X2_B4_DUO52HI53LO:O16	CPC017_A375_6H_X2	O16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_A375_6H_X3_B4_DUO52HI53LO:O16	CPC017_A375_6H_X3	O16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:I07	CPC017_A375_6H_X4	I07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_A375_6H_X1_B4_DUO52HI53LO:O02	CPC020_A375_6H_X1	O02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_A375_6H_X3_B4_DUO52HI53LO:O02	CPC020_A375_6H_X3	O02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_A375_6H_X4_B5_DUO52HI53LO:O02	CPC020_A375_6H_X4	O02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:O02	CPC020_A375_6H_X5	O02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_A375_6H_X2_B4_DUO52HI53LO:I07	CPC017_A375_6H_X2	I07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_A375_6H_X3_B4_DUO52HI53LO:I07	CPC017_A375_6H_X3	I07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A375_24H_X1_B3_DUO52HI53LO:P19	CPC005_A375_24H_X1	P19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A375_24H_X2_B3_DUO52HI53LO:P19	CPC005_A375_24H_X2	P19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A375_24H_X3_B3_DUO52HI53LO:P19	CPC005_A375_24H_X3	P19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A375_6H_X1_B3_DUO52HI53LO:P19	CPC005_A375_6H_X1	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A375_6H_X2_B3_DUO52HI53LO:P19	CPC005_A375_6H_X2	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A375_6H_X3_B3_DUO52HI53LO:P19	CPC005_A375_6H_X3	P19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_A375_6H_X2_F1B3_DUO52HI53LO:J24	CPC009_A375_6H_X2	J24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_A375_6H_X5_F1B5_DUO52HI53LO:J24	CPC009_A375_6H_X5	J24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_A375_6H_X1_B3_DUO52HI53LO:J24	CPC009_A375_6H_X1	J24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_A375_6H_X4_B5_DUO52HI53LO:J24	CPC009_A375_6H_X4	J24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_A375_6H_X1_B3_DUO52HI53LO:E15	CPC011_A375_6H_X1	E15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_A375_6H_X2_B3_DUO52HI53LO:E15	CPC011_A375_6H_X2	E15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_A375_6H_X3_B3_DUO52HI53LO:E15	CPC011_A375_6H_X3	E15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_A375_6H_X1_B4_DUO52HI53LO:M15	CPC016_A375_6H_X1	M15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_A375_6H_X2_B4_DUO52HI53LO:M15	CPC016_A375_6H_X2	M15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_A375_6H_X3_B4_DUO52HI53LO:M15	CPC016_A375_6H_X3	M15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_A375_6H_X4_B5_DUO52HI53LO:M15	CPC016_A375_6H_X4	M15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_A375_6H_X5_B5_DUO52HI53LO:M15	CPC016_A375_6H_X5	M15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_A375_6H_X1_B3_DUO52HI53LO:K23	CPC009_A375_6H_X1	K23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_A375_6H_X2_F1B3_DUO52HI53LO:K23	CPC009_A375_6H_X2	K23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_A375_6H_X4_B5_DUO52HI53LO:K23	CPC009_A375_6H_X4	K23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_A375_6H_X5_F1B5_DUO52HI53LO:K23	CPC009_A375_6H_X5	K23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_A375_6H_X1_B3_DUO52HI53LO:I11	CPC011_A375_6H_X1	I11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_A375_6H_X2_B3_DUO52HI53LO:I11	CPC011_A375_6H_X2	I11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_A375_6H_X3_B3_DUO52HI53LO:I11	CPC011_A375_6H_X3	I11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A375_24H_X1_B3_DUO52HI53LO:C12	CPC005_A375_24H_X1	C12	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A375_24H_X2_B3_DUO52HI53LO:C12	CPC005_A375_24H_X2	C12	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A375_24H_X3_B3_DUO52HI53LO:C12	CPC005_A375_24H_X3	C12	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A375_6H_X1_B3_DUO52HI53LO:C12	CPC005_A375_6H_X1	C12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A375_6H_X2_B3_DUO52HI53LO:C12	CPC005_A375_6H_X2	C12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A375_6H_X3_B3_DUO52HI53LO:C12	CPC005_A375_6H_X3	C12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A375_6H_X1_B4_DUO52HI53LO:H14	CPC020_A375_6H_X1	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A375_6H_X1_B4_DUO52HI53LO:L24	CPC020_A375_6H_X1	L24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A375_6H_X2_B4_DUO52HI53LO:H14	CPC020_A375_6H_X2	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A375_6H_X2_B4_DUO52HI53LO:L24	CPC020_A375_6H_X2	L24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A375_6H_X3_B4_DUO52HI53LO:H14	CPC020_A375_6H_X3	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A375_6H_X3_B4_DUO52HI53LO:L24	CPC020_A375_6H_X3	L24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A375_6H_X4_B5_DUO52HI53LO:H14	CPC020_A375_6H_X4	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A375_6H_X4_B5_DUO52HI53LO:L24	CPC020_A375_6H_X4	L24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:H14	CPC020_A375_6H_X5	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:L24	CPC020_A375_6H_X5	L24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:O03	BRAF001_A375_6H_X1	O03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:O04	BRAF001_A375_6H_X1	O04	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:O11	BRAF001_A375_6H_X1	O11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:O12	BRAF001_A375_6H_X1	O12	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:O19	BRAF001_A375_6H_X1	O19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:O20	BRAF001_A375_6H_X1	O20	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:P03	BRAF001_A375_6H_X1	P03	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:P04	BRAF001_A375_6H_X1	P04	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:P11	BRAF001_A375_6H_X1	P11	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:P12	BRAF001_A375_6H_X1	P12	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:P19	BRAF001_A375_6H_X1	P19	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X1_B10:P20	BRAF001_A375_6H_X1	P20	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X2_B10:O03	BRAF001_A375_6H_X2	O03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X2_B10:O04	BRAF001_A375_6H_X2	O04	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X2_B10:O11	BRAF001_A375_6H_X2	O11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X2_B10:O19	BRAF001_A375_6H_X2	O19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X2_B10:O20	BRAF001_A375_6H_X2	O20	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X2_B10:P03	BRAF001_A375_6H_X2	P03	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X2_B10:P04	BRAF001_A375_6H_X2	P04	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X2_B10:P11	BRAF001_A375_6H_X2	P11	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X2_B10:P12	BRAF001_A375_6H_X2	P12	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X2_B10:P19	BRAF001_A375_6H_X2	P19	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X2_B10:P20	BRAF001_A375_6H_X2	P20	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:O03	BRAF001_A375_6H_X3	O03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:O04	BRAF001_A375_6H_X3	O04	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:O11	BRAF001_A375_6H_X3	O11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:O12	BRAF001_A375_6H_X3	O12	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:O19	BRAF001_A375_6H_X3	O19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:O20	BRAF001_A375_6H_X3	O20	trt_cp	2.5	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:P03	BRAF001_A375_6H_X3	P03	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:P04	BRAF001_A375_6H_X3	P04	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:P11	BRAF001_A375_6H_X3	P11	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:P12	BRAF001_A375_6H_X3	P12	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:P19	BRAF001_A375_6H_X3	P19	trt_cp	0.625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_6H_X3_B10:P20	BRAF001_A375_6H_X3	P20	trt_cp	0.15625	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:O03	BRAF001_A375_24H_X1	O03	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:O04	BRAF001_A375_24H_X1	O04	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:O11	BRAF001_A375_24H_X1	O11	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:O12	BRAF001_A375_24H_X1	O12	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:O19	BRAF001_A375_24H_X1	O19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:O20	BRAF001_A375_24H_X1	O20	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:P03	BRAF001_A375_24H_X1	P03	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:P04	BRAF001_A375_24H_X1	P04	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:P11	BRAF001_A375_24H_X1	P11	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:P12	BRAF001_A375_24H_X1	P12	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:P19	BRAF001_A375_24H_X1	P19	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X1_B10:P20	BRAF001_A375_24H_X1	P20	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:O03	BRAF001_A375_24H_X2	O03	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:O04	BRAF001_A375_24H_X2	O04	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:O11	BRAF001_A375_24H_X2	O11	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:O12	BRAF001_A375_24H_X2	O12	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:O19	BRAF001_A375_24H_X2	O19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:O20	BRAF001_A375_24H_X2	O20	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:P03	BRAF001_A375_24H_X2	P03	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:P04	BRAF001_A375_24H_X2	P04	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:P11	BRAF001_A375_24H_X2	P11	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:P12	BRAF001_A375_24H_X2	P12	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:P19	BRAF001_A375_24H_X2	P19	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X2_B10:P20	BRAF001_A375_24H_X2	P20	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:O03	BRAF001_A375_24H_X4	O03	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:O04	BRAF001_A375_24H_X4	O04	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:O11	BRAF001_A375_24H_X4	O11	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:O12	BRAF001_A375_24H_X4	O12	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:O19	BRAF001_A375_24H_X4	O19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:O20	BRAF001_A375_24H_X4	O20	trt_cp	2.5	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:P03	BRAF001_A375_24H_X4	P03	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:P04	BRAF001_A375_24H_X4	P04	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:P11	BRAF001_A375_24H_X4	P11	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:P12	BRAF001_A375_24H_X4	P12	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:P19	BRAF001_A375_24H_X4	P19	trt_cp	0.625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_A375_24H_X4_B11:P20	BRAF001_A375_24H_X4	P20	trt_cp	0.15625	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_A375_6H_X1_B4_DUO52HI53LO:M20	CPC016_A375_6H_X1	M20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_A375_6H_X2_B4_DUO52HI53LO:M20	CPC016_A375_6H_X2	M20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_A375_6H_X3_B4_DUO52HI53LO:M20	CPC016_A375_6H_X3	M20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_A375_6H_X4_B5_DUO52HI53LO:M20	CPC016_A375_6H_X4	M20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_A375_6H_X5_B5_DUO52HI53LO:M20	CPC016_A375_6H_X5	M20	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A375_24H_X1_B3_DUO52HI53LO:N07	CPC005_A375_24H_X1	N07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A375_24H_X2_B3_DUO52HI53LO:N07	CPC005_A375_24H_X2	N07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A375_24H_X3_B3_DUO52HI53LO:N07	CPC005_A375_24H_X3	N07	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A375_6H_X1_B3_DUO52HI53LO:N07	CPC005_A375_6H_X1	N07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A375_6H_X2_B3_DUO52HI53LO:N07	CPC005_A375_6H_X2	N07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A375_6H_X3_B3_DUO52HI53LO:N07	CPC005_A375_6H_X3	N07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_A375_6H_X4_F1B5_DUO52HI53LO:H09	CPC018_A375_6H_X4	H09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_A375_6H_X5_F1B5_DUO52HI53LO:H09	CPC018_A375_6H_X5	H09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_A375_6H_X1_B3_DUO52HI53LO:O15	CPC011_A375_6H_X1	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_A375_6H_X2_B3_DUO52HI53LO:O15	CPC011_A375_6H_X2	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_A375_6H_X3_B3_DUO52HI53LO:O15	CPC011_A375_6H_X3	O15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_A375_6H_X1_B4_DUO52HI53LO:H09	CPC018_A375_6H_X1	H09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_A375_6H_X2_B4_DUO52HI53LO:H09	CPC018_A375_6H_X2	H09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_A375_6H_X3_B4_DUO52HI53LO:H09	CPC018_A375_6H_X3	H09	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_A375_6H_X1_B4_DUO52HI53LO:O06	CPC016_A375_6H_X1	O06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_A375_6H_X2_B4_DUO52HI53LO:O06	CPC016_A375_6H_X2	O06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_A375_6H_X3_B4_DUO52HI53LO:O06	CPC016_A375_6H_X3	O06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_A375_6H_X4_B5_DUO52HI53LO:O06	CPC016_A375_6H_X4	O06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_A375_6H_X5_B5_DUO52HI53LO:O06	CPC016_A375_6H_X5	O06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:A16	CPC004_A375_6H_X1	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:A16	CPC004_A375_6H_X2	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:A16	CPC004_A375_6H_X3	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_A375_6H_X2_B3_DUO52HI53LO:G23	CPC011_A375_6H_X2	G23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_A375_6H_X3_B3_DUO52HI53LO:G23	CPC011_A375_6H_X3	G23	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_A375_6H_X1_B4_DUO52HI53LO:H06	CPC016_A375_6H_X1	H06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_A375_6H_X2_B4_DUO52HI53LO:H06	CPC016_A375_6H_X2	H06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_A375_6H_X3_B4_DUO52HI53LO:H06	CPC016_A375_6H_X3	H06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_A375_6H_X4_B5_DUO52HI53LO:H06	CPC016_A375_6H_X4	H06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_A375_6H_X5_B5_DUO52HI53LO:H06	CPC016_A375_6H_X5	H06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_A375_6H_X1_B4_DUO52HI53LO:D15	CPC020_A375_6H_X1	D15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_A375_6H_X2_B4_DUO52HI53LO:D15	CPC020_A375_6H_X2	D15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_A375_6H_X4_B5_DUO52HI53LO:D15	CPC020_A375_6H_X4	D15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:D15	CPC020_A375_6H_X5	D15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_A375_6H_X1_B3_DUO52HI53LO:A16	CPC011_A375_6H_X1	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_A375_6H_X2_B3_DUO52HI53LO:A16	CPC011_A375_6H_X2	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_A375_6H_X3_B3_DUO52HI53LO:A16	CPC011_A375_6H_X3	A16	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_A375_6H_X1_B3_DUO52HI53LO:J05	CPC011_A375_6H_X1	J05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_A375_6H_X2_B3_DUO52HI53LO:J05	CPC011_A375_6H_X2	J05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_A375_6H_X3_B3_DUO52HI53LO:J05	CPC011_A375_6H_X3	J05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_A375_6H_X1_B4_DUO52HI53LO:K22	CPC016_A375_6H_X1	K22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_A375_6H_X2_B4_DUO52HI53LO:K22	CPC016_A375_6H_X2	K22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_A375_6H_X3_B4_DUO52HI53LO:K22	CPC016_A375_6H_X3	K22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_A375_6H_X4_B5_DUO52HI53LO:K22	CPC016_A375_6H_X4	K22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_A375_6H_X5_B5_DUO52HI53LO:K22	CPC016_A375_6H_X5	K22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_A375_6H_X4_F1B5_DUO52HI53LO:J19	CPC018_A375_6H_X4	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_A375_6H_X5_F1B5_DUO52HI53LO:J19	CPC018_A375_6H_X5	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_A375_6H_X1_B4_DUO52HI53LO:J19	CPC018_A375_6H_X1	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_A375_6H_X2_B4_DUO52HI53LO:J19	CPC018_A375_6H_X2	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_A375_6H_X3_B4_DUO52HI53LO:J19	CPC018_A375_6H_X3	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_A375_6H_X1_B4_DUO52HI53LO:B15	CPC020_A375_6H_X1	B15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_A375_6H_X2_B4_DUO52HI53LO:B15	CPC020_A375_6H_X2	B15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_A375_6H_X3_B4_DUO52HI53LO:B15	CPC020_A375_6H_X3	B15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_A375_6H_X4_B5_DUO52HI53LO:B15	CPC020_A375_6H_X4	B15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_A375_6H_X5_F1B5_DUO52HI53LO:B15	CPC020_A375_6H_X5	B15	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_A375_6H_X1_B3_DUO52HI53LO:I12	CPC011_A375_6H_X1	I12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_A375_6H_X2_B3_DUO52HI53LO:I12	CPC011_A375_6H_X2	I12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_A375_6H_X3_B3_DUO52HI53LO:I12	CPC011_A375_6H_X3	I12	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:H24	CPC004_A375_6H_X1	H24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:H24	CPC004_A375_6H_X2	H24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:H24	CPC004_A375_6H_X3	H24	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_A375_6H_X1_B3_DUO52HI53LO:I21	CPC011_A375_6H_X1	I21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_A375_6H_X2_B3_DUO52HI53LO:I21	CPC011_A375_6H_X2	I21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_A375_6H_X3_B3_DUO52HI53LO:I21	CPC011_A375_6H_X3	I21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_A375_6H_X1_B4_DUO52HI53LO:L01	CPC015_A375_6H_X1	L01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_A375_6H_X2_B4_DUO52HI53LO:L01	CPC015_A375_6H_X2	L01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_A375_6H_X3_B4_DUO52HI53LO:L01	CPC015_A375_6H_X3	L01	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:J02	CPC004_A375_6H_X1	J02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:J02	CPC004_A375_6H_X2	J02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:J02	CPC004_A375_6H_X3	J02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_A375_6H_X1_B4_DUO52HI53LO:L03	CPC015_A375_6H_X1	L03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_A375_6H_X2_B4_DUO52HI53LO:L03	CPC015_A375_6H_X2	L03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_A375_6H_X3_B4_DUO52HI53LO:L03	CPC015_A375_6H_X3	L03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:H13	CPC004_A375_6H_X1	H13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:H13	CPC004_A375_6H_X2	H13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:H13	CPC004_A375_6H_X3	H13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_A375_6H_X1_B3_DUO52HI53LO:L11	CPC011_A375_6H_X1	L11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_A375_6H_X2_B3_DUO52HI53LO:L11	CPC011_A375_6H_X2	L11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_A375_6H_X3_B3_DUO52HI53LO:L11	CPC011_A375_6H_X3	L11	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_A375_6H_X1_B4_DUO52HI53LO:K04	CPC015_A375_6H_X1	K04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_A375_6H_X2_B4_DUO52HI53LO:K04	CPC015_A375_6H_X2	K04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_A375_6H_X3_B4_DUO52HI53LO:K04	CPC015_A375_6H_X3	K04	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A375_24H_X1_B3_DUO52HI53LO:E19	CPC005_A375_24H_X1	E19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A375_24H_X2_B3_DUO52HI53LO:E19	CPC005_A375_24H_X2	E19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A375_24H_X3_B3_DUO52HI53LO:E19	CPC005_A375_24H_X3	E19	trt_cp	10.0	um	24	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A375_6H_X1_B3_DUO52HI53LO:E19	CPC005_A375_6H_X1	E19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A375_6H_X2_B3_DUO52HI53LO:E19	CPC005_A375_6H_X2	E19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A375_6H_X3_B3_DUO52HI53LO:E19	CPC005_A375_6H_X3	E19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:I06	CPC004_A375_6H_X1	I06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:I06	CPC004_A375_6H_X2	I06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:I06	CPC004_A375_6H_X3	I06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_A375_6H_X1_B3_DUO52HI53LO:K13	CPC011_A375_6H_X1	K13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_A375_6H_X2_B3_DUO52HI53LO:K13	CPC011_A375_6H_X2	K13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_A375_6H_X3_B3_DUO52HI53LO:K13	CPC011_A375_6H_X3	K13	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_A375_6H_X1_B4_DUO52HI53LO:N14	CPC016_A375_6H_X1	N14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_A375_6H_X2_B4_DUO52HI53LO:N14	CPC016_A375_6H_X2	N14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_A375_6H_X3_B4_DUO52HI53LO:N14	CPC016_A375_6H_X3	N14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_A375_6H_X4_B5_DUO52HI53LO:N14	CPC016_A375_6H_X4	N14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_A375_6H_X5_B5_DUO52HI53LO:N14	CPC016_A375_6H_X5	N14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:I02	CPC004_A375_6H_X1	I02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:I02	CPC004_A375_6H_X2	I02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:I02	CPC004_A375_6H_X3	I02	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_A375_6H_X1_B4_DUO52HI53LO:N08	CPC016_A375_6H_X1	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_A375_6H_X2_B4_DUO52HI53LO:N08	CPC016_A375_6H_X2	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_A375_6H_X3_B4_DUO52HI53LO:N08	CPC016_A375_6H_X3	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_A375_6H_X4_B5_DUO52HI53LO:N08	CPC016_A375_6H_X4	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_A375_6H_X5_B5_DUO52HI53LO:N08	CPC016_A375_6H_X5	N08	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:J06	CPC004_A375_6H_X1	J06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:J06	CPC004_A375_6H_X2	J06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:J06	CPC004_A375_6H_X3	J06	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_A375_6H_X1_B3_DUO52HI53LO:J19	CPC011_A375_6H_X1	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_A375_6H_X2_B3_DUO52HI53LO:J19	CPC011_A375_6H_X2	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_A375_6H_X3_B3_DUO52HI53LO:J19	CPC011_A375_6H_X3	J19	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_A375_6H_X1_B4_DUO52HI53LO:L07	CPC015_A375_6H_X1	L07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_A375_6H_X2_B4_DUO52HI53LO:L07	CPC015_A375_6H_X2	L07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_A375_6H_X3_B4_DUO52HI53LO:L07	CPC015_A375_6H_X3	L07	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_A375_6H_X1_B3_DUO52HI53LO:H14	CPC011_A375_6H_X1	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_A375_6H_X2_B3_DUO52HI53LO:H14	CPC011_A375_6H_X2	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_A375_6H_X3_B3_DUO52HI53LO:H14	CPC011_A375_6H_X3	H14	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_A375_6H_X1_B3_DUO52HI53LO:J03	CPC004_A375_6H_X1	J03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_A375_6H_X2_B3_DUO52HI53LO:J03	CPC004_A375_6H_X2	J03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_A375_6H_X3_B3_DUO52HI53LO:J03	CPC004_A375_6H_X3	J03	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_A375_6H_X2_F1B3_DUO52HI53LO:G22	CPC010_A375_6H_X2	G22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_A375_6H_X3_B3_DUO52HI53LO:G22	CPC010_A375_6H_X3	G22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_A375_6H_X4_B5_DUO52HI53LO:G22	CPC010_A375_6H_X4	G22	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_A375_6H_X1_B3_DUO52HI53LO:I05	CPC011_A375_6H_X1	I05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_A375_6H_X2_B3_DUO52HI53LO:I05	CPC011_A375_6H_X2	I05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_A375_6H_X3_B3_DUO52HI53LO:I05	CPC011_A375_6H_X3	I05	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_A375_6H_X1_B4_DUO52HI53LO:K18	CPC015_A375_6H_X1	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_A375_6H_X2_B4_DUO52HI53LO:K18	CPC015_A375_6H_X2	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_A375_6H_X3_B4_DUO52HI53LO:K18	CPC015_A375_6H_X3	K18	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_A375_6H_X4_F1B5_DUO52HI53LO:F21	CPC017_A375_6H_X4	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_A375_6H_X2_B4_DUO52HI53LO:F21	CPC017_A375_6H_X2	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_A375_6H_X3_B4_DUO52HI53LO:F21	CPC017_A375_6H_X3	F21	trt_cp	10.0	um	6	h	A375	cell line	A375	-666	-666	tumor	skin	malignant melanoma	adherent	CRL-1619	ATCC	54	F	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:J08	CPC004_HA1E_24H_X1	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:J08	CPC004_HA1E_24H_X2	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:J08	CPC004_HA1E_24H_X3	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:J08	CPC004_HA1E_6H_X1	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:J08	CPC004_HA1E_6H_X2	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:J08	CPC004_HA1E_6H_X3	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:G10	CPC011_HA1E_6H_X1	G10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:G10	CPC011_HA1E_6H_X3	G10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:B03	CPC011_HA1E_6H_X1	B03	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:B03	CPC011_HA1E_6H_X3	B03	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_HA1E_24H_X1_B3_DUO52HI53LO:I02	CPC003_HA1E_24H_X1	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_HA1E_24H_X2_B3_DUO52HI53LO:I02	CPC003_HA1E_24H_X2	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_HA1E_24H_X3_B3_DUO52HI53LO:I02	CPC003_HA1E_24H_X3	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_HA1E_6H_X2_B3_DUO52HI53LO:I02	CPC003_HA1E_6H_X2	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_HA1E_6H_X3_B3_DUO52HI53LO:I02	CPC003_HA1E_6H_X3	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:E01	CPC004_HA1E_24H_X1	E01	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:E01	CPC004_HA1E_24H_X3	E01	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:E01	CPC004_HA1E_6H_X2	E01	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:E01	CPC004_HA1E_6H_X3	E01	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:F24	CPC020_HA1E_6H_X1	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:H08	CPC020_HA1E_6H_X1	H08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:F24	CPC020_HA1E_6H_X2	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:H08	CPC020_HA1E_6H_X2	H08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:F24	CPC020_HA1E_6H_X3	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:H08	CPC020_HA1E_6H_X3	H08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HA1E_24H_X1_B3_DUO52HI53LO:F24	CPC005_HA1E_24H_X1	F24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:F24	CPC005_HA1E_24H_X2	F24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:F24	CPC005_HA1E_24H_X3	F24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:F24	CPC005_HA1E_6H_X1	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:F24	CPC005_HA1E_6H_X3	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HA1E_6H_X1_B4_DUO52HI53LO:B24	CPC009_HA1E_6H_X1	B24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HA1E_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_HA1E_6H_X2	B24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HA1E_6H_X3_B4_DUO52HI53LO:B24	CPC009_HA1E_6H_X3	B24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:P10	CPC011_HA1E_6H_X1	P10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:P10	CPC011_HA1E_6H_X3	P10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HA1E_24H_X1_B3_DUO52HI53LO:F24	CPC005_HA1E_24H_X1	F24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:F24	CPC005_HA1E_24H_X2	F24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:F24	CPC005_HA1E_24H_X3	F24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:F24	CPC005_HA1E_6H_X1	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:F24	CPC005_HA1E_6H_X3	F24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HA1E_6H_X1_B4_DUO52HI53LO:B24	CPC009_HA1E_6H_X1	B24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HA1E_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_HA1E_6H_X2	B24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HA1E_6H_X3_B4_DUO52HI53LO:B24	CPC009_HA1E_6H_X3	B24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:P10	CPC011_HA1E_6H_X1	P10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:P10	CPC011_HA1E_6H_X3	P10	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:G20	CPC002_HA1E_24H_X1	G20	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:G20	CPC002_HA1E_24H_X2	G20	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:G20	CPC002_HA1E_24H_X3	G20	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:G20	CPC002_HA1E_6H_X1	G20	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:G20	CPC002_HA1E_6H_X2	G20	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HA1E_6H_X3_B3_DUO52HI53LO:G20	CPC002_HA1E_6H_X3	G20	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:P19	CPC020_HA1E_6H_X1	P19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:P19	CPC020_HA1E_6H_X2	P19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:E11	CPC004_HA1E_24H_X1	E11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:E11	CPC004_HA1E_24H_X2	E11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:E11	CPC004_HA1E_24H_X3	E11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:E11	CPC004_HA1E_6H_X1	E11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:E11	CPC004_HA1E_6H_X2	E11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:E11	CPC004_HA1E_6H_X3	E11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:F21	CPC020_HA1E_6H_X1	F21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:F21	CPC020_HA1E_6H_X2	F21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:F21	CPC020_HA1E_6H_X3	F21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:K17	CPC004_HA1E_24H_X1	K17	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:K17	CPC004_HA1E_24H_X2	K17	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:K17	CPC004_HA1E_24H_X3	K17	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:K17	CPC004_HA1E_6H_X1	K17	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:K17	CPC004_HA1E_6H_X2	K17	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:G23	CPC004_HA1E_24H_X1	G23	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:G23	CPC004_HA1E_24H_X2	G23	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:G23	CPC004_HA1E_24H_X3	G23	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:G23	CPC004_HA1E_6H_X1	G23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:G23	CPC004_HA1E_6H_X2	G23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:G23	CPC004_HA1E_6H_X3	G23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:G15	CPC011_HA1E_6H_X1	G15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:G15	CPC011_HA1E_6H_X3	G15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:F11	CPC002_HA1E_24H_X1	F11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:F11	CPC002_HA1E_24H_X2	F11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:F11	CPC002_HA1E_24H_X3	F11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:F11	CPC002_HA1E_6H_X1	F11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:F11	CPC002_HA1E_6H_X2	F11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_HA1E_6H_X3_B3_DUO52HI53LO:F11	CPC002_HA1E_6H_X3	F11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:O02	CPC020_HA1E_6H_X1	O02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:O02	CPC020_HA1E_6H_X2	O02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:O02	CPC020_HA1E_6H_X3	O02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HA1E_24H_X1_B3_DUO52HI53LO:P19	CPC005_HA1E_24H_X1	P19	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:P19	CPC005_HA1E_24H_X2	P19	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:P19	CPC005_HA1E_24H_X3	P19	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:P19	CPC005_HA1E_6H_X1	P19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:P19	CPC005_HA1E_6H_X3	P19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HA1E_6H_X2_F1B3_DUO52HI53LO:J24	CPC009_HA1E_6H_X2	J24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HA1E_6H_X1_B4_DUO52HI53LO:J24	CPC009_HA1E_6H_X1	J24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HA1E_6H_X3_B4_DUO52HI53LO:J24	CPC009_HA1E_6H_X3	J24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:E15	CPC011_HA1E_6H_X1	E15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:E15	CPC011_HA1E_6H_X3	E15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_HA1E_24H_X1_B3_DUO52HI53LO:P05	CPC003_HA1E_24H_X1	P05	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_HA1E_24H_X2_B3_DUO52HI53LO:P05	CPC003_HA1E_24H_X2	P05	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_HA1E_24H_X3_B3_DUO52HI53LO:P05	CPC003_HA1E_24H_X3	P05	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_HA1E_6H_X2_B3_DUO52HI53LO:P05	CPC003_HA1E_6H_X2	P05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_HA1E_6H_X3_B3_DUO52HI53LO:P05	CPC003_HA1E_6H_X3	P05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HA1E_6H_X1_B4_DUO52HI53LO:K23	CPC009_HA1E_6H_X1	K23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HA1E_6H_X2_F1B3_DUO52HI53LO:K23	CPC009_HA1E_6H_X2	K23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HA1E_6H_X3_B4_DUO52HI53LO:K23	CPC009_HA1E_6H_X3	K23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:I11	CPC011_HA1E_6H_X1	I11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:I11	CPC011_HA1E_6H_X3	I11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HA1E_24H_X1_B3_DUO52HI53LO:C12	CPC005_HA1E_24H_X1	C12	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:C12	CPC005_HA1E_24H_X2	C12	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:C12	CPC005_HA1E_24H_X3	C12	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:C12	CPC005_HA1E_6H_X1	C12	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:C12	CPC005_HA1E_6H_X3	C12	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:H14	CPC020_HA1E_6H_X1	H14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:L24	CPC020_HA1E_6H_X1	L24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:H14	CPC020_HA1E_6H_X2	H14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:L24	CPC020_HA1E_6H_X2	L24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:H14	CPC020_HA1E_6H_X3	H14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:L24	CPC020_HA1E_6H_X3	L24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:H22	CPC002_HA1E_24H_X1	H22	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:H22	CPC002_HA1E_24H_X2	H22	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:H22	CPC002_HA1E_24H_X3	H22	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:H22	CPC002_HA1E_6H_X1	H22	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:H22	CPC002_HA1E_6H_X2	H22	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HA1E_24H_X1_B3_DUO52HI53LO:N07	CPC005_HA1E_24H_X1	N07	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:N07	CPC005_HA1E_24H_X2	N07	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:N07	CPC005_HA1E_24H_X3	N07	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:N07	CPC005_HA1E_6H_X1	N07	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:N07	CPC005_HA1E_6H_X3	N07	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:K21	CPC002_HA1E_24H_X1	K21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:K21	CPC002_HA1E_24H_X2	K21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:K21	CPC002_HA1E_24H_X3	K21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:K21	CPC002_HA1E_6H_X1	K21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:K21	CPC002_HA1E_6H_X2	K21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HA1E_6H_X3_B3_DUO52HI53LO:K21	CPC002_HA1E_6H_X3	K21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:O15	CPC011_HA1E_6H_X1	O15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:O15	CPC011_HA1E_6H_X3	O15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:J08	CPC002_HA1E_24H_X1	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:J08	CPC002_HA1E_24H_X2	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:J08	CPC002_HA1E_24H_X3	J08	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:J08	CPC002_HA1E_6H_X1	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:J08	CPC002_HA1E_6H_X2	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HA1E_6H_X3_B3_DUO52HI53LO:J08	CPC002_HA1E_6H_X3	J08	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:A16	CPC004_HA1E_24H_X1	A16	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:A16	CPC004_HA1E_24H_X2	A16	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:A16	CPC004_HA1E_24H_X3	A16	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:A16	CPC004_HA1E_6H_X1	A16	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:A16	CPC004_HA1E_6H_X2	A16	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:A16	CPC004_HA1E_6H_X3	A16	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:G23	CPC011_HA1E_6H_X1	G23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:G23	CPC011_HA1E_6H_X3	G23	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:D15	CPC020_HA1E_6H_X1	D15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:D15	CPC020_HA1E_6H_X2	D15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:D15	CPC020_HA1E_6H_X3	D15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:A16	CPC011_HA1E_6H_X1	A16	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:A16	CPC011_HA1E_6H_X3	A16	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:H02	CPC002_HA1E_24H_X1	H02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:H02	CPC002_HA1E_24H_X2	H02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:H02	CPC002_HA1E_24H_X3	H02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:H02	CPC002_HA1E_6H_X1	H02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:H02	CPC002_HA1E_6H_X2	H02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HA1E_6H_X3_B3_DUO52HI53LO:H02	CPC002_HA1E_6H_X3	H02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:J05	CPC011_HA1E_6H_X1	J05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:J05	CPC011_HA1E_6H_X3	J05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_HA1E_24H_X1_B3_DUO52HI53LO:O11	CPC002_HA1E_24H_X1	O11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_HA1E_24H_X2_B3_DUO52HI53LO:O11	CPC002_HA1E_24H_X2	O11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_HA1E_24H_X3_B3_DUO52HI53LO:O11	CPC002_HA1E_24H_X3	O11	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_HA1E_6H_X1_B3_DUO52HI53LO:O11	CPC002_HA1E_6H_X1	O11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_HA1E_6H_X2_B3_DUO52HI53LO:O11	CPC002_HA1E_6H_X2	O11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_HA1E_6H_X1_F1B3_DUO52HI53LO:B15	CPC020_HA1E_6H_X1	B15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_HA1E_6H_X2_F1B3_DUO52HI53LO:B15	CPC020_HA1E_6H_X2	B15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_HA1E_6H_X3_F1B3_DUO52HI53LO:B15	CPC020_HA1E_6H_X3	B15	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:I12	CPC011_HA1E_6H_X1	I12	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:I12	CPC011_HA1E_6H_X3	I12	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:H24	CPC004_HA1E_24H_X1	H24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:H24	CPC004_HA1E_24H_X2	H24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:H24	CPC004_HA1E_24H_X3	H24	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:H24	CPC004_HA1E_6H_X1	H24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:H24	CPC004_HA1E_6H_X2	H24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:H24	CPC004_HA1E_6H_X3	H24	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:I21	CPC011_HA1E_6H_X1	I21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:I21	CPC011_HA1E_6H_X3	I21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:J02	CPC004_HA1E_24H_X1	J02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:J02	CPC004_HA1E_24H_X2	J02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:J02	CPC004_HA1E_24H_X3	J02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:J02	CPC004_HA1E_6H_X1	J02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:J02	CPC004_HA1E_6H_X2	J02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:J02	CPC004_HA1E_6H_X3	J02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:H13	CPC004_HA1E_24H_X1	H13	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:H13	CPC004_HA1E_24H_X2	H13	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:H13	CPC004_HA1E_24H_X3	H13	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:H13	CPC004_HA1E_6H_X1	H13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:H13	CPC004_HA1E_6H_X2	H13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:H13	CPC004_HA1E_6H_X3	H13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:L11	CPC011_HA1E_6H_X1	L11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:L11	CPC011_HA1E_6H_X3	L11	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HA1E_24H_X2_B3_DUO52HI53LO:E19	CPC005_HA1E_24H_X2	E19	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HA1E_24H_X3_B3_DUO52HI53LO:E19	CPC005_HA1E_24H_X3	E19	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HA1E_6H_X1_B3_DUO52HI53LO:E19	CPC005_HA1E_6H_X1	E19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HA1E_6H_X3_B3_DUO52HI53LO:E19	CPC005_HA1E_6H_X3	E19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:I06	CPC004_HA1E_24H_X1	I06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:I06	CPC004_HA1E_24H_X2	I06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:I06	CPC004_HA1E_24H_X3	I06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:I06	CPC004_HA1E_6H_X1	I06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:I06	CPC004_HA1E_6H_X2	I06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:I06	CPC004_HA1E_6H_X3	I06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:K13	CPC011_HA1E_6H_X1	K13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:K13	CPC011_HA1E_6H_X3	K13	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:I02	CPC004_HA1E_24H_X1	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:I02	CPC004_HA1E_24H_X2	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:I02	CPC004_HA1E_24H_X3	I02	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:I02	CPC004_HA1E_6H_X1	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:I02	CPC004_HA1E_6H_X2	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:I02	CPC004_HA1E_6H_X3	I02	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:J06	CPC004_HA1E_24H_X1	J06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:J06	CPC004_HA1E_24H_X2	J06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:J06	CPC004_HA1E_24H_X3	J06	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:J06	CPC004_HA1E_6H_X1	J06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:J06	CPC004_HA1E_6H_X2	J06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:J06	CPC004_HA1E_6H_X3	J06	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:J19	CPC011_HA1E_6H_X1	J19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:J19	CPC011_HA1E_6H_X3	J19	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:H14	CPC011_HA1E_6H_X1	H14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:H14	CPC011_HA1E_6H_X3	H14	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HA1E_24H_X1_B3_DUO52HI53LO:J03	CPC004_HA1E_24H_X1	J03	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HA1E_24H_X2_B3_DUO52HI53LO:J03	CPC004_HA1E_24H_X2	J03	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HA1E_24H_X3_B3_DUO52HI53LO:J03	CPC004_HA1E_24H_X3	J03	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HA1E_6H_X1_B3_DUO52HI53LO:J03	CPC004_HA1E_6H_X1	J03	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HA1E_6H_X2_B3_DUO52HI53LO:J03	CPC004_HA1E_6H_X2	J03	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HA1E_6H_X3_B3_DUO52HI53LO:J03	CPC004_HA1E_6H_X3	J03	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HA1E_6H_X1_B4_DUO52HI53LO:G22	CPC010_HA1E_6H_X1	G22	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HA1E_6H_X2_B4_DUO52HI53LO:G22	CPC010_HA1E_6H_X2	G22	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HA1E_6H_X3_F1B3_DUO52HI53LO:G22	CPC010_HA1E_6H_X3	G22	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_HA1E_6H_X1_F1B3_DUO52HI53LO:I05	CPC011_HA1E_6H_X1	I05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_HA1E_6H_X3_F1B3_DUO52HI53LO:I05	CPC011_HA1E_6H_X3	I05	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_HA1E_24H_X1_B3_DUO52HI53LO:L21	CPC001_HA1E_24H_X1	L21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_HA1E_24H_X2_B3_DUO52HI53LO:L21	CPC001_HA1E_24H_X2	L21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_HA1E_24H_X3_B3_DUO52HI53LO:L21	CPC001_HA1E_24H_X3	L21	trt_cp	10.0	um	24	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_HA1E_6H_X1_B3_DUO52HI53LO:L21	CPC001_HA1E_6H_X1	L21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_HA1E_6H_X2_B3_DUO52HI53LO:L21	CPC001_HA1E_6H_X2	L21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_HA1E_6H_X3_B3_DUO52HI53LO:L21	CPC001_HA1E_6H_X3	L21	trt_cp	10.0	um	6	h	HA1E	cell line	HA1E	-666	immortalized normal	normal	kidney	normal kidney	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:J08	CPC004_HCC515_24H_X1	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:J08	CPC004_HCC515_24H_X2	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:J08	CPC004_HCC515_24H_X3	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:J08	CPC004_HCC515_6H_X1	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:J08	CPC004_HCC515_6H_X2	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:J08	CPC004_HCC515_6H_X3	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_HCC515_24H_X1_B3_DUO52HI53LO:I02	CPC003_HCC515_24H_X1	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_HCC515_24H_X2_B3_DUO52HI53LO:I02	CPC003_HCC515_24H_X2	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_HCC515_24H_X3_B3_DUO52HI53LO:I02	CPC003_HCC515_24H_X3	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_HCC515_6H_X1_B3_DUO52HI53LO:I02	CPC003_HCC515_6H_X1	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_HCC515_6H_X2_B3_DUO52HI53LO:I02	CPC003_HCC515_6H_X2	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_HCC515_6H_X3_B3_DUO52HI53LO:I02	CPC003_HCC515_6H_X3	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:E01	CPC004_HCC515_24H_X1	E01	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:E01	CPC004_HCC515_24H_X2	E01	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:E01	CPC004_HCC515_24H_X3	E01	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:E01	CPC004_HCC515_6H_X1	E01	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:E01	CPC004_HCC515_6H_X2	E01	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:E01	CPC004_HCC515_6H_X3	E01	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:F24	CPC020_HCC515_6H_X2	F24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:H08	CPC020_HCC515_6H_X2	H08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:F24	CPC020_HCC515_6H_X3	F24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:H08	CPC020_HCC515_6H_X3	H08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HCC515_6H_X1_F1B3_DUO52HI53LO:B24	CPC009_HCC515_6H_X1	B24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HCC515_6H_X2_B4_DUO52HI53LO:B24	CPC009_HCC515_6H_X2	B24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HCC515_6H_X3_B4_DUO52HI53LO:B24	CPC009_HCC515_6H_X3	B24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:F24	CPC005_HCC515_6H_X2	F24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:F24	CPC005_HCC515_6H_X3	F24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HCC515_6H_X1_F1B3_DUO52HI53LO:B24	CPC009_HCC515_6H_X1	B24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HCC515_6H_X2_B4_DUO52HI53LO:B24	CPC009_HCC515_6H_X2	B24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HCC515_6H_X3_B4_DUO52HI53LO:B24	CPC009_HCC515_6H_X3	B24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:F24	CPC005_HCC515_6H_X2	F24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:F24	CPC005_HCC515_6H_X3	F24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:P19	CPC020_HCC515_6H_X2	P19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:P19	CPC020_HCC515_6H_X3	P19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:G20	CPC002_HCC515_24H_X1	G20	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:G20	CPC002_HCC515_24H_X2	G20	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:G20	CPC002_HCC515_24H_X3	G20	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:G20	CPC002_HCC515_6H_X1	G20	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:G20	CPC002_HCC515_6H_X2	G20	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:G20	CPC002_HCC515_6H_X3	G20	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:F21	CPC020_HCC515_6H_X2	F21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:F21	CPC020_HCC515_6H_X3	F21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:E11	CPC004_HCC515_24H_X1	E11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:E11	CPC004_HCC515_24H_X2	E11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:E11	CPC004_HCC515_24H_X3	E11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:E11	CPC004_HCC515_6H_X1	E11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:E11	CPC004_HCC515_6H_X2	E11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:E11	CPC004_HCC515_6H_X3	E11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:K17	CPC004_HCC515_6H_X1	K17	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:K17	CPC004_HCC515_6H_X2	K17	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:K17	CPC004_HCC515_6H_X3	K17	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:K17	CPC004_HCC515_24H_X1	K17	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:K17	CPC004_HCC515_24H_X2	K17	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:K17	CPC004_HCC515_24H_X3	K17	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:G23	CPC004_HCC515_6H_X1	G23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:G23	CPC004_HCC515_6H_X2	G23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:G23	CPC004_HCC515_6H_X3	G23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:G23	CPC004_HCC515_24H_X1	G23	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:G23	CPC004_HCC515_24H_X2	G23	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:G23	CPC004_HCC515_24H_X3	G23	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:F11	CPC002_HCC515_6H_X1	F11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:F11	CPC002_HCC515_6H_X3	F11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:O02	CPC020_HCC515_6H_X2	O02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:O02	CPC020_HCC515_6H_X3	O02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:F11	CPC002_HCC515_24H_X1	F11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:F11	CPC002_HCC515_24H_X2	F11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:F11	CPC002_HCC515_24H_X3	F11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HCC515_6H_X1_F1B3_DUO52HI53LO:J24	CPC009_HCC515_6H_X1	J24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HCC515_6H_X2_B4_DUO52HI53LO:J24	CPC009_HCC515_6H_X2	J24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HCC515_6H_X3_B4_DUO52HI53LO:J24	CPC009_HCC515_6H_X3	J24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:P19	CPC005_HCC515_6H_X2	P19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:P19	CPC005_HCC515_6H_X3	P19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_HCC515_24H_X1_B3_DUO52HI53LO:P05	CPC003_HCC515_24H_X1	P05	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_HCC515_24H_X2_B3_DUO52HI53LO:P05	CPC003_HCC515_24H_X2	P05	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_HCC515_24H_X3_B3_DUO52HI53LO:P05	CPC003_HCC515_24H_X3	P05	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_HCC515_6H_X1_B3_DUO52HI53LO:P05	CPC003_HCC515_6H_X1	P05	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_HCC515_6H_X3_B3_DUO52HI53LO:P05	CPC003_HCC515_6H_X3	P05	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HCC515_6H_X1_F1B3_DUO52HI53LO:K23	CPC009_HCC515_6H_X1	K23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HCC515_6H_X2_B4_DUO52HI53LO:K23	CPC009_HCC515_6H_X2	K23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HCC515_6H_X3_B4_DUO52HI53LO:K23	CPC009_HCC515_6H_X3	K23	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:H14	CPC020_HCC515_6H_X2	H14	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:L24	CPC020_HCC515_6H_X2	L24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:H14	CPC020_HCC515_6H_X3	H14	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:L24	CPC020_HCC515_6H_X3	L24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:C12	CPC005_HCC515_6H_X2	C12	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:C12	CPC005_HCC515_6H_X3	C12	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:H22	CPC002_HCC515_24H_X1	H22	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:H22	CPC002_HCC515_24H_X2	H22	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:H22	CPC002_HCC515_24H_X3	H22	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:H22	CPC002_HCC515_6H_X1	H22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:H22	CPC002_HCC515_6H_X2	H22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:H22	CPC002_HCC515_6H_X3	H22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:N07	CPC005_HCC515_6H_X2	N07	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:N07	CPC005_HCC515_6H_X3	N07	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:K21	CPC002_HCC515_24H_X1	K21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:K21	CPC002_HCC515_24H_X2	K21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:K21	CPC002_HCC515_24H_X3	K21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:K21	CPC002_HCC515_6H_X1	K21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:K21	CPC002_HCC515_6H_X2	K21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:K21	CPC002_HCC515_6H_X3	K21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:J08	CPC002_HCC515_24H_X1	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:J08	CPC002_HCC515_24H_X2	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:J08	CPC002_HCC515_24H_X3	J08	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:J08	CPC002_HCC515_6H_X1	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:J08	CPC002_HCC515_6H_X2	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:J08	CPC002_HCC515_6H_X3	J08	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:A16	CPC004_HCC515_24H_X1	A16	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:A16	CPC004_HCC515_24H_X2	A16	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:A16	CPC004_HCC515_24H_X3	A16	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:A16	CPC004_HCC515_6H_X1	A16	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:A16	CPC004_HCC515_6H_X2	A16	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:A16	CPC004_HCC515_6H_X3	A16	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:D15	CPC020_HCC515_6H_X2	D15	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:D15	CPC020_HCC515_6H_X3	D15	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:H02	CPC002_HCC515_24H_X1	H02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:H02	CPC002_HCC515_24H_X2	H02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:H02	CPC002_HCC515_24H_X3	H02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:H02	CPC002_HCC515_6H_X1	H02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:H02	CPC002_HCC515_6H_X2	H02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:H02	CPC002_HCC515_6H_X3	H02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_HCC515_24H_X1_B3_DUO52HI53LO:O11	CPC002_HCC515_24H_X1	O11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_HCC515_24H_X2_B3_DUO52HI53LO:O11	CPC002_HCC515_24H_X2	O11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_HCC515_24H_X3_B3_DUO52HI53LO:O11	CPC002_HCC515_24H_X3	O11	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_HCC515_6H_X1_B3_DUO52HI53LO:O11	CPC002_HCC515_6H_X1	O11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_HCC515_6H_X2_B3_DUO52HI53LO:O11	CPC002_HCC515_6H_X2	O11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_HCC515_6H_X3_B3_DUO52HI53LO:O11	CPC002_HCC515_6H_X3	O11	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_HCC515_6H_X2_F1B3_DUO52HI53LO:B15	CPC020_HCC515_6H_X2	B15	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_HCC515_6H_X3_B4_DUO52HI53LO:B15	CPC020_HCC515_6H_X3	B15	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:H24	CPC004_HCC515_24H_X1	H24	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:H24	CPC004_HCC515_24H_X2	H24	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:H24	CPC004_HCC515_24H_X3	H24	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:H24	CPC004_HCC515_6H_X1	H24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:H24	CPC004_HCC515_6H_X2	H24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:H24	CPC004_HCC515_6H_X3	H24	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:J02	CPC004_HCC515_24H_X1	J02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:J02	CPC004_HCC515_24H_X2	J02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:J02	CPC004_HCC515_24H_X3	J02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:J02	CPC004_HCC515_6H_X1	J02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:J02	CPC004_HCC515_6H_X2	J02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:H13	CPC004_HCC515_24H_X1	H13	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:H13	CPC004_HCC515_24H_X2	H13	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:H13	CPC004_HCC515_24H_X3	H13	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:H13	CPC004_HCC515_6H_X1	H13	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:H13	CPC004_HCC515_6H_X2	H13	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:H13	CPC004_HCC515_6H_X3	H13	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HCC515_6H_X2_F1B4_DUO52HI53LO:E19	CPC005_HCC515_6H_X2	E19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HCC515_6H_X3_F1B3_DUO52HI53LO:E19	CPC005_HCC515_6H_X3	E19	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:I06	CPC004_HCC515_24H_X1	I06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:I06	CPC004_HCC515_24H_X2	I06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:I06	CPC004_HCC515_24H_X3	I06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:I06	CPC004_HCC515_6H_X1	I06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:I06	CPC004_HCC515_6H_X2	I06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:I06	CPC004_HCC515_6H_X3	I06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:I02	CPC004_HCC515_6H_X1	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:I02	CPC004_HCC515_6H_X2	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:I02	CPC004_HCC515_6H_X3	I02	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:I02	CPC004_HCC515_24H_X1	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:I02	CPC004_HCC515_24H_X2	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:I02	CPC004_HCC515_24H_X3	I02	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:J06	CPC004_HCC515_24H_X1	J06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:J06	CPC004_HCC515_24H_X2	J06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:J06	CPC004_HCC515_24H_X3	J06	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:J06	CPC004_HCC515_6H_X1	J06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:J06	CPC004_HCC515_6H_X2	J06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:J06	CPC004_HCC515_6H_X3	J06	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HCC515_6H_X1_B4_DUO52HI53LO:G22	CPC010_HCC515_6H_X1	G22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HCC515_6H_X2_B4_DUO52HI53LO:G22	CPC010_HCC515_6H_X2	G22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HCC515_6H_X3_B4_DUO52HI53LO:G22	CPC010_HCC515_6H_X3	G22	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HCC515_24H_X1_B3_DUO52HI53LO:J03	CPC004_HCC515_24H_X1	J03	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HCC515_24H_X2_B3_DUO52HI53LO:J03	CPC004_HCC515_24H_X2	J03	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HCC515_24H_X3_B3_DUO52HI53LO:J03	CPC004_HCC515_24H_X3	J03	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HCC515_6H_X1_B3_DUO52HI53LO:J03	CPC004_HCC515_6H_X1	J03	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HCC515_6H_X2_B3_DUO52HI53LO:J03	CPC004_HCC515_6H_X2	J03	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HCC515_6H_X3_B3_DUO52HI53LO:J03	CPC004_HCC515_6H_X3	J03	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_HCC515_24H_X1_B3_DUO52HI53LO:L21	CPC001_HCC515_24H_X1	L21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_HCC515_24H_X2_B3_DUO52HI53LO:L21	CPC001_HCC515_24H_X2	L21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_HCC515_24H_X3_B3_DUO52HI53LO:L21	CPC001_HCC515_24H_X3	L21	trt_cp	10.0	um	24	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_HCC515_6H_X1_B3_DUO52HI53LO:L21	CPC001_HCC515_6H_X1	L21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_HCC515_6H_X2_B3_DUO52HI53LO:L21	CPC001_HCC515_6H_X2	L21	trt_cp	10.0	um	6	h	HCC515	cell line	HCC515	-666	-666	normal	lung	carcinoma	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:J08	CPC004_HEPG2_6H_X1	J08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:J08	CPC004_HEPG2_6H_X2	J08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:J08	CPC004_HEPG2_6H_X3.L2	J08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:L09	CPC015_HEPG2_6H_X2.L2	L09	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:L09	CPC015_HEPG2_6H_X3.L2	L09	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:J10	CPC015_HEPG2_6H_X2.L2	J10	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:J10	CPC015_HEPG2_6H_X3.L2	J10	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:E01	CPC004_HEPG2_6H_X1	E01	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:E01	CPC004_HEPG2_6H_X2	E01	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:E01	CPC004_HEPG2_6H_X3.L2	E01	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:K18	CPC017_HEPG2_6H_X1	K18	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:K18	CPC017_HEPG2_6H_X3	K18	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:K18	CPC017_HEPG2_6H_X4	K18	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HEPG2_6H_X1_B4_DUO52HI53LO:B24	CPC009_HEPG2_6H_X1	B24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HEPG2_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_HEPG2_6H_X2	B24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HEPG2_6H_X3_F1B3_DUO52HI53LO:B24	CPC009_HEPG2_6H_X3	B24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HEPG2_6H_X1_B4_DUO52HI53LO:B24	CPC009_HEPG2_6H_X1	B24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HEPG2_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_HEPG2_6H_X2	B24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HEPG2_6H_X3_F1B3_DUO52HI53LO:B24	CPC009_HEPG2_6H_X3	B24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_HEPG2_6H_X1_F1B3_DUO52HI53LO:F20	CPC018_HEPG2_6H_X1	F20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_HEPG2_6H_X2_F1B4_DUO52HI53LO:F20	CPC018_HEPG2_6H_X2	F20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_HEPG2_6H_X3_F1B3_DUO52HI53LO:F20	CPC018_HEPG2_6H_X3	F20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:E11	CPC004_HEPG2_6H_X1	E11	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:M02	CPC017_HEPG2_6H_X1	M02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:M02	CPC017_HEPG2_6H_X3	M02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:M02	CPC017_HEPG2_6H_X4	M02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:E11	CPC004_HEPG2_6H_X2	E11	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:E11	CPC004_HEPG2_6H_X3.L2	E11	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:K17	CPC004_HEPG2_6H_X1	K17	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_HEPG2_6H_X1_F1B3_DUO52HI53LO:A20	CPC018_HEPG2_6H_X1	A20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_HEPG2_6H_X2_F1B4_DUO52HI53LO:A20	CPC018_HEPG2_6H_X2	A20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_HEPG2_6H_X3_F1B3_DUO52HI53LO:A20	CPC018_HEPG2_6H_X3	A20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:K17	CPC004_HEPG2_6H_X2	K17	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:K17	CPC004_HEPG2_6H_X3.L2	K17	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:G23	CPC004_HEPG2_6H_X1	G23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:O16	CPC017_HEPG2_6H_X1	O16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:O16	CPC017_HEPG2_6H_X3	O16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:O16	CPC017_HEPG2_6H_X4	O16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:G23	CPC004_HEPG2_6H_X2	G23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:G23	CPC004_HEPG2_6H_X3.L2	G23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:I07	CPC017_HEPG2_6H_X1	I07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:I07	CPC017_HEPG2_6H_X3	I07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:I07	CPC017_HEPG2_6H_X4	I07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HEPG2_6H_X1_B4_DUO52HI53LO:J24	CPC009_HEPG2_6H_X1	J24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HEPG2_6H_X2_F1B3_DUO52HI53LO:J24	CPC009_HEPG2_6H_X2	J24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HEPG2_6H_X3_F1B3_DUO52HI53LO:J24	CPC009_HEPG2_6H_X3	J24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:M15	CPC016_HEPG2_6H_X1	M15	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:M15	CPC016_HEPG2_6H_X3	M15	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:M15	CPC016_HEPG2_6H_X4	M15	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HEPG2_6H_X1_B4_DUO52HI53LO:K23	CPC009_HEPG2_6H_X1	K23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HEPG2_6H_X2_F1B3_DUO52HI53LO:K23	CPC009_HEPG2_6H_X2	K23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HEPG2_6H_X3_F1B3_DUO52HI53LO:K23	CPC009_HEPG2_6H_X3	K23	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:M20	CPC016_HEPG2_6H_X1	M20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:M20	CPC016_HEPG2_6H_X3	M20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:M20	CPC016_HEPG2_6H_X4	M20	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_HEPG2_6H_X1_F1B3_DUO52HI53LO:H09	CPC018_HEPG2_6H_X1	H09	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_HEPG2_6H_X2_F1B4_DUO52HI53LO:H09	CPC018_HEPG2_6H_X2	H09	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_HEPG2_6H_X3_F1B3_DUO52HI53LO:H09	CPC018_HEPG2_6H_X3	H09	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:O06	CPC016_HEPG2_6H_X3	O06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:A16	CPC004_HEPG2_6H_X1	A16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:A16	CPC004_HEPG2_6H_X2	A16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:A16	CPC004_HEPG2_6H_X3.L2	A16	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:H06	CPC016_HEPG2_6H_X1	H06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:H06	CPC016_HEPG2_6H_X3	H06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:H06	CPC016_HEPG2_6H_X4	H06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:K22	CPC016_HEPG2_6H_X3	K22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:K22	CPC016_HEPG2_6H_X4	K22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_HEPG2_6H_X1_F1B3_DUO52HI53LO:J19	CPC018_HEPG2_6H_X1	J19	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_HEPG2_6H_X2_F1B4_DUO52HI53LO:J19	CPC018_HEPG2_6H_X2	J19	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_HEPG2_6H_X3_F1B3_DUO52HI53LO:J19	CPC018_HEPG2_6H_X3	J19	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:H24	CPC004_HEPG2_6H_X1	H24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:L01	CPC015_HEPG2_6H_X2.L2	L01	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:L01	CPC015_HEPG2_6H_X3.L2	L01	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:H24	CPC004_HEPG2_6H_X2	H24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:H24	CPC004_HEPG2_6H_X3.L2	H24	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:L03	CPC015_HEPG2_6H_X2.L2	L03	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:L03	CPC015_HEPG2_6H_X3.L2	L03	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:J02	CPC004_HEPG2_6H_X1	J02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:J02	CPC004_HEPG2_6H_X2	J02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:J02	CPC004_HEPG2_6H_X3.L2	J02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:H13	CPC004_HEPG2_6H_X1	H13	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:K04	CPC015_HEPG2_6H_X2.L2	K04	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:K04	CPC015_HEPG2_6H_X3.L2	K04	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:H13	CPC004_HEPG2_6H_X2	H13	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:H13	CPC004_HEPG2_6H_X3.L2	H13	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:I06	CPC004_HEPG2_6H_X1	I06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:N14	CPC016_HEPG2_6H_X1	N14	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:N14	CPC016_HEPG2_6H_X3	N14	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:N14	CPC016_HEPG2_6H_X4	N14	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:I06	CPC004_HEPG2_6H_X2	I06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:I06	CPC004_HEPG2_6H_X3.L2	I06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:I02	CPC004_HEPG2_6H_X1	I02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:I02	CPC004_HEPG2_6H_X2	I02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_HEPG2_6H_X1_F1B4_DUO52HI53LO:N08	CPC016_HEPG2_6H_X1	N08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_HEPG2_6H_X3_F1B4_DUO52HI53LO:N08	CPC016_HEPG2_6H_X3	N08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_HEPG2_6H_X4_F1B4_DUO52HI53LO:N08	CPC016_HEPG2_6H_X4	N08	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:I02	CPC004_HEPG2_6H_X3.L2	I02	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:J06	CPC004_HEPG2_6H_X1	J06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:J06	CPC004_HEPG2_6H_X2	J06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:J06	CPC004_HEPG2_6H_X3.L2	J06	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:L07	CPC015_HEPG2_6H_X2.L2	L07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:L07	CPC015_HEPG2_6H_X3.L2	L07	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HEPG2_6H_X1_B5_DUO52HI53LO:J03	CPC004_HEPG2_6H_X1	J03	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HEPG2_6H_X1_B4_DUO52HI53LO:G22	CPC010_HEPG2_6H_X1	G22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HEPG2_6H_X2_B4_DUO52HI53LO:G22	CPC010_HEPG2_6H_X2	G22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HEPG2_6H_X3_B4_DUO52HI53LO:G22	CPC010_HEPG2_6H_X3	G22	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_HEPG2_6H_X2.L2_F2B5_DUO52HI53LO:K18	CPC015_HEPG2_6H_X2.L2	K18	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_HEPG2_6H_X3.L2_F1B5_DUO52HI53LO:K18	CPC015_HEPG2_6H_X3.L2	K18	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HEPG2_6H_X2_F1B5_DUO52HI53LO:J03	CPC004_HEPG2_6H_X2	J03	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HEPG2_6H_X3.L2_F2B5_DUO52HI53LO:J03	CPC004_HEPG2_6H_X3.L2	J03	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_HEPG2_6H_X1_F1B4_DUO52HI53LO:F21	CPC017_HEPG2_6H_X1	F21	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_HEPG2_6H_X3_F1B4_DUO52HI53LO:F21	CPC017_HEPG2_6H_X3	F21	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_HEPG2_6H_X4_F1B4_DUO52HI53LO:F21	CPC017_HEPG2_6H_X4	F21	trt_cp	10.0	um	6	h	HEPG2	cell line	HEPG2	-666	-666	tumor	liver	hepatocellular carcinoma	adherent	HB-8065	ATCC	15	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:J08	CPC004_HT29_6H_X1	J08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:J08	CPC004_HT29_6H_X2	J08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:J08	CPC004_HT29_6H_X3	J08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:J08	CPC004_HT29_6H_X4	J08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:J08	CPC004_HT29_6H_X5	J08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_HT29_6H_X1_B4_DUO52HI53LO:L09	CPC015_HT29_6H_X1	L09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_HT29_6H_X3_B4_DUO52HI53LO:L09	CPC015_HT29_6H_X3	L09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_HT29_6H_X5_B5_DUO52HI53LO:L09	CPC015_HT29_6H_X5	L09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HT29_6H_X1_B3_DUO52HI53LO:G10	CPC011_HT29_6H_X1	G10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HT29_6H_X2_B3_DUO52HI53LO:G10	CPC011_HT29_6H_X2	G10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HT29_6H_X4_B5_DUO52HI53LO:G10	CPC011_HT29_6H_X4	G10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HT29_6H_X5_B5_DUO52HI53LO:G10	CPC011_HT29_6H_X5	G10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HT29_6H_X1_B3_DUO52HI53LO:B03	CPC011_HT29_6H_X1	B03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HT29_6H_X2_B3_DUO52HI53LO:B03	CPC011_HT29_6H_X2	B03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HT29_6H_X4_B5_DUO52HI53LO:B03	CPC011_HT29_6H_X4	B03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_HT29_6H_X5_B5_DUO52HI53LO:B03	CPC011_HT29_6H_X5	B03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_HT29_6H_X1_B4_DUO52HI53LO:J10	CPC015_HT29_6H_X1	J10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_HT29_6H_X3_B4_DUO52HI53LO:J10	CPC015_HT29_6H_X3	J10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_HT29_6H_X5_B5_DUO52HI53LO:J10	CPC015_HT29_6H_X5	J10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:E01	CPC004_HT29_6H_X1	E01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:E01	CPC004_HT29_6H_X2	E01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:E01	CPC004_HT29_6H_X3	E01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:E01	CPC004_HT29_6H_X4	E01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:E01	CPC004_HT29_6H_X5	E01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:K18	CPC017_HT29_6H_X5	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:F24	CPC020_HT29_6H_X1.L2	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:H08	CPC020_HT29_6H_X1.L2	H08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:F24	CPC020_HT29_6H_X2.L2	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:H08	CPC020_HT29_6H_X2.L2	H08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HT29_6H_X4_B5_DUO52HI53LO:F24	CPC020_HT29_6H_X4	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HT29_6H_X4_B5_DUO52HI53LO:H08	CPC020_HT29_6H_X4	H08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HT29_6H_X5_B5_DUO52HI53LO:F24	CPC020_HT29_6H_X5	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_HT29_6H_X5_B5_DUO52HI53LO:H08	CPC020_HT29_6H_X5	H08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_HT29_6H_X1_B4_DUO52HI53LO:K18	CPC017_HT29_6H_X1	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_HT29_6H_X2_B4_DUO52HI53LO:K18	CPC017_HT29_6H_X2	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_HT29_6H_X3_B4_DUO52HI53LO:K18	CPC017_HT29_6H_X3	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_HT29_6H_X4_B5_DUO52HI53LO:K18	CPC017_HT29_6H_X4	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HT29_24H_X1_B3_DUO52HI53LO:F24	CPC005_HT29_24H_X1	F24	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HT29_24H_X2_B3_DUO52HI53LO:F24	CPC005_HT29_24H_X2	F24	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HT29_24H_X3_B3_DUO52HI53LO:F24	CPC005_HT29_24H_X3	F24	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HT29_6H_X1_B3_DUO52HI53LO:F24	CPC005_HT29_6H_X1	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HT29_6H_X2_B3_DUO52HI53LO:F24	CPC005_HT29_6H_X2	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_HT29_6H_X3_B3_DUO52HI53LO:F24	CPC005_HT29_6H_X3	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HT29_6H_X1_B3_DUO52HI53LO:B24	CPC009_HT29_6H_X1	B24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HT29_6H_X3_B3_DUO52HI53LO:B24	CPC009_HT29_6H_X3	B24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_HT29_6H_X5_B5_DUO52HI53LO:B24	CPC009_HT29_6H_X5	B24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_HT29_6H_X1_B3_DUO52HI53LO:P10	CPC011_HT29_6H_X1	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_HT29_6H_X2_B3_DUO52HI53LO:P10	CPC011_HT29_6H_X2	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_HT29_6H_X4_B5_DUO52HI53LO:P10	CPC011_HT29_6H_X4	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_HT29_6H_X5_B5_DUO52HI53LO:P10	CPC011_HT29_6H_X5	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HT29_24H_X1_B3_DUO52HI53LO:F24	CPC005_HT29_24H_X1	F24	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HT29_24H_X2_B3_DUO52HI53LO:F24	CPC005_HT29_24H_X2	F24	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HT29_24H_X3_B3_DUO52HI53LO:F24	CPC005_HT29_24H_X3	F24	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HT29_6H_X1_B3_DUO52HI53LO:F24	CPC005_HT29_6H_X1	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HT29_6H_X2_B3_DUO52HI53LO:F24	CPC005_HT29_6H_X2	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_HT29_6H_X3_B3_DUO52HI53LO:F24	CPC005_HT29_6H_X3	F24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HT29_6H_X1_B3_DUO52HI53LO:B24	CPC009_HT29_6H_X1	B24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HT29_6H_X3_B3_DUO52HI53LO:B24	CPC009_HT29_6H_X3	B24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_HT29_6H_X5_B5_DUO52HI53LO:B24	CPC009_HT29_6H_X5	B24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_HT29_6H_X1_B3_DUO52HI53LO:P10	CPC011_HT29_6H_X1	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_HT29_6H_X2_B3_DUO52HI53LO:P10	CPC011_HT29_6H_X2	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_HT29_6H_X4_B5_DUO52HI53LO:P10	CPC011_HT29_6H_X4	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_HT29_6H_X5_B5_DUO52HI53LO:P10	CPC011_HT29_6H_X5	P10	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_HT29_6H_X4_F1B5_DUO52HI53LO:F20	CPC018_HT29_6H_X4	F20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:P19	CPC020_HT29_6H_X1.L2	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:P19	CPC020_HT29_6H_X2.L2	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_HT29_6H_X5_B5_DUO52HI53LO:P19	CPC020_HT29_6H_X5	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_HT29_6H_X1_B4_DUO52HI53LO:F20	CPC018_HT29_6H_X1	F20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_HT29_6H_X2_B4_DUO52HI53LO:F20	CPC018_HT29_6H_X2	F20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_HT29_6H_X3_B4_DUO52HI53LO:F20	CPC018_HT29_6H_X3	F20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_HT29_6H_X5_B5_DUO52HI53LO:F20	CPC018_HT29_6H_X5	F20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:E11	CPC004_HT29_6H_X1	E11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:E11	CPC004_HT29_6H_X2	E11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:E11	CPC004_HT29_6H_X3	E11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:E11	CPC004_HT29_6H_X4	E11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:E11	CPC004_HT29_6H_X5	E11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:M02	CPC017_HT29_6H_X5	M02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:F21	CPC020_HT29_6H_X1.L2	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:F21	CPC020_HT29_6H_X2.L2	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_HT29_6H_X4_B5_DUO52HI53LO:F21	CPC020_HT29_6H_X4	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_HT29_6H_X5_B5_DUO52HI53LO:F21	CPC020_HT29_6H_X5	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_HT29_6H_X1_B4_DUO52HI53LO:M02	CPC017_HT29_6H_X1	M02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_HT29_6H_X2_B4_DUO52HI53LO:M02	CPC017_HT29_6H_X2	M02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_HT29_6H_X3_B4_DUO52HI53LO:M02	CPC017_HT29_6H_X3	M02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_HT29_6H_X4_B5_DUO52HI53LO:M02	CPC017_HT29_6H_X4	M02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:K17	CPC004_HT29_6H_X1	K17	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:K17	CPC004_HT29_6H_X2	K17	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:K17	CPC004_HT29_6H_X3	K17	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:K17	CPC004_HT29_6H_X4	K17	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:K17	CPC004_HT29_6H_X5	K17	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_HT29_6H_X4_F1B5_DUO52HI53LO:A20	CPC018_HT29_6H_X4	A20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_HT29_6H_X1_B4_DUO52HI53LO:A20	CPC018_HT29_6H_X1	A20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_HT29_6H_X2_B4_DUO52HI53LO:A20	CPC018_HT29_6H_X2	A20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_HT29_6H_X3_B4_DUO52HI53LO:A20	CPC018_HT29_6H_X3	A20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_HT29_6H_X5_B5_DUO52HI53LO:A20	CPC018_HT29_6H_X5	A20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:G23	CPC004_HT29_6H_X1	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:G23	CPC004_HT29_6H_X2	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:G23	CPC004_HT29_6H_X3	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:G23	CPC004_HT29_6H_X4	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:G23	CPC004_HT29_6H_X5	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:O16	CPC017_HT29_6H_X5	O16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_HT29_6H_X1_B3_DUO52HI53LO:G15	CPC011_HT29_6H_X1	G15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_HT29_6H_X2_B3_DUO52HI53LO:G15	CPC011_HT29_6H_X2	G15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_HT29_6H_X4_B5_DUO52HI53LO:G15	CPC011_HT29_6H_X4	G15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_HT29_6H_X5_B5_DUO52HI53LO:G15	CPC011_HT29_6H_X5	G15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_HT29_6H_X1_B4_DUO52HI53LO:O16	CPC017_HT29_6H_X1	O16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_HT29_6H_X2_B4_DUO52HI53LO:O16	CPC017_HT29_6H_X2	O16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_HT29_6H_X3_B4_DUO52HI53LO:O16	CPC017_HT29_6H_X3	O16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_HT29_6H_X4_B5_DUO52HI53LO:O16	CPC017_HT29_6H_X4	O16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:I07	CPC017_HT29_6H_X5	I07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:O02	CPC020_HT29_6H_X1.L2	O02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:O02	CPC020_HT29_6H_X2.L2	O02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_HT29_6H_X4_B5_DUO52HI53LO:O02	CPC020_HT29_6H_X4	O02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_HT29_6H_X5_B5_DUO52HI53LO:O02	CPC020_HT29_6H_X5	O02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_HT29_6H_X1_B4_DUO52HI53LO:I07	CPC017_HT29_6H_X1	I07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_HT29_6H_X2_B4_DUO52HI53LO:I07	CPC017_HT29_6H_X2	I07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_HT29_6H_X3_B4_DUO52HI53LO:I07	CPC017_HT29_6H_X3	I07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HT29_24H_X1_B3_DUO52HI53LO:P19	CPC005_HT29_24H_X1	P19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HT29_24H_X2_B3_DUO52HI53LO:P19	CPC005_HT29_24H_X2	P19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HT29_24H_X3_B3_DUO52HI53LO:P19	CPC005_HT29_24H_X3	P19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HT29_6H_X1_B3_DUO52HI53LO:P19	CPC005_HT29_6H_X1	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HT29_6H_X2_B3_DUO52HI53LO:P19	CPC005_HT29_6H_X2	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_HT29_6H_X3_B3_DUO52HI53LO:P19	CPC005_HT29_6H_X3	P19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HT29_6H_X1_B3_DUO52HI53LO:J24	CPC009_HT29_6H_X1	J24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HT29_6H_X3_B3_DUO52HI53LO:J24	CPC009_HT29_6H_X3	J24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_HT29_6H_X5_B5_DUO52HI53LO:J24	CPC009_HT29_6H_X5	J24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_HT29_6H_X1_B3_DUO52HI53LO:E15	CPC011_HT29_6H_X1	E15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_HT29_6H_X2_B3_DUO52HI53LO:E15	CPC011_HT29_6H_X2	E15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_HT29_6H_X4_B5_DUO52HI53LO:E15	CPC011_HT29_6H_X4	E15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_HT29_6H_X5_B5_DUO52HI53LO:E15	CPC011_HT29_6H_X5	E15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:M15	CPC016_HT29_6H_X5	M15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_HT29_6H_X1_B4_DUO52HI53LO:M15	CPC016_HT29_6H_X1	M15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_HT29_6H_X2_B4_DUO52HI53LO:M15	CPC016_HT29_6H_X2	M15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_HT29_6H_X3_B4_DUO52HI53LO:M15	CPC016_HT29_6H_X3	M15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_HT29_6H_X4_B5_DUO52HI53LO:M15	CPC016_HT29_6H_X4	M15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HT29_6H_X1_B3_DUO52HI53LO:K23	CPC009_HT29_6H_X1	K23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HT29_6H_X3_B3_DUO52HI53LO:K23	CPC009_HT29_6H_X3	K23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_HT29_6H_X5_B5_DUO52HI53LO:K23	CPC009_HT29_6H_X5	K23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_HT29_6H_X1_B3_DUO52HI53LO:I11	CPC011_HT29_6H_X1	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_HT29_6H_X2_B3_DUO52HI53LO:I11	CPC011_HT29_6H_X2	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_HT29_6H_X4_B5_DUO52HI53LO:I11	CPC011_HT29_6H_X4	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_HT29_6H_X5_B5_DUO52HI53LO:I11	CPC011_HT29_6H_X5	I11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HT29_24H_X1_B3_DUO52HI53LO:C12	CPC005_HT29_24H_X1	C12	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HT29_24H_X2_B3_DUO52HI53LO:C12	CPC005_HT29_24H_X2	C12	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HT29_24H_X3_B3_DUO52HI53LO:C12	CPC005_HT29_24H_X3	C12	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HT29_6H_X1_B3_DUO52HI53LO:C12	CPC005_HT29_6H_X1	C12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HT29_6H_X2_B3_DUO52HI53LO:C12	CPC005_HT29_6H_X2	C12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_HT29_6H_X3_B3_DUO52HI53LO:C12	CPC005_HT29_6H_X3	C12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:H14	CPC020_HT29_6H_X1.L2	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:L24	CPC020_HT29_6H_X1.L2	L24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:H14	CPC020_HT29_6H_X2.L2	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:L24	CPC020_HT29_6H_X2.L2	L24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HT29_6H_X4_B5_DUO52HI53LO:H14	CPC020_HT29_6H_X4	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HT29_6H_X4_B5_DUO52HI53LO:L24	CPC020_HT29_6H_X4	L24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HT29_6H_X5_B5_DUO52HI53LO:H14	CPC020_HT29_6H_X5	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_HT29_6H_X5_B5_DUO52HI53LO:L24	CPC020_HT29_6H_X5	L24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:M20	CPC016_HT29_6H_X5	M20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_HT29_6H_X1_B4_DUO52HI53LO:M20	CPC016_HT29_6H_X1	M20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_HT29_6H_X2_B4_DUO52HI53LO:M20	CPC016_HT29_6H_X2	M20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_HT29_6H_X3_B4_DUO52HI53LO:M20	CPC016_HT29_6H_X3	M20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_HT29_6H_X4_B5_DUO52HI53LO:M20	CPC016_HT29_6H_X4	M20	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HT29_24H_X1_B3_DUO52HI53LO:N07	CPC005_HT29_24H_X1	N07	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HT29_24H_X2_B3_DUO52HI53LO:N07	CPC005_HT29_24H_X2	N07	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HT29_24H_X3_B3_DUO52HI53LO:N07	CPC005_HT29_24H_X3	N07	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HT29_6H_X1_B3_DUO52HI53LO:N07	CPC005_HT29_6H_X1	N07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HT29_6H_X2_B3_DUO52HI53LO:N07	CPC005_HT29_6H_X2	N07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_HT29_6H_X3_B3_DUO52HI53LO:N07	CPC005_HT29_6H_X3	N07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_HT29_6H_X4_F1B5_DUO52HI53LO:H09	CPC018_HT29_6H_X4	H09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_HT29_6H_X1_B3_DUO52HI53LO:O15	CPC011_HT29_6H_X1	O15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_HT29_6H_X2_B3_DUO52HI53LO:O15	CPC011_HT29_6H_X2	O15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_HT29_6H_X4_B5_DUO52HI53LO:O15	CPC011_HT29_6H_X4	O15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_HT29_6H_X5_B5_DUO52HI53LO:O15	CPC011_HT29_6H_X5	O15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_HT29_6H_X1_B4_DUO52HI53LO:H09	CPC018_HT29_6H_X1	H09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_HT29_6H_X2_B4_DUO52HI53LO:H09	CPC018_HT29_6H_X2	H09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_HT29_6H_X3_B4_DUO52HI53LO:H09	CPC018_HT29_6H_X3	H09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_HT29_6H_X5_B5_DUO52HI53LO:H09	CPC018_HT29_6H_X5	H09	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:O06	CPC016_HT29_6H_X5	O06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_HT29_6H_X1_B4_DUO52HI53LO:O06	CPC016_HT29_6H_X1	O06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_HT29_6H_X2_B4_DUO52HI53LO:O06	CPC016_HT29_6H_X2	O06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_HT29_6H_X3_B4_DUO52HI53LO:O06	CPC016_HT29_6H_X3	O06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_HT29_6H_X4_B5_DUO52HI53LO:O06	CPC016_HT29_6H_X4	O06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:A16	CPC004_HT29_6H_X1	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:A16	CPC004_HT29_6H_X2	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:A16	CPC004_HT29_6H_X3	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:A16	CPC004_HT29_6H_X4	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:A16	CPC004_HT29_6H_X5	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:H06	CPC016_HT29_6H_X5	H06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_HT29_6H_X1_B3_DUO52HI53LO:G23	CPC011_HT29_6H_X1	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_HT29_6H_X2_B3_DUO52HI53LO:G23	CPC011_HT29_6H_X2	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_HT29_6H_X4_B5_DUO52HI53LO:G23	CPC011_HT29_6H_X4	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_HT29_6H_X5_B5_DUO52HI53LO:G23	CPC011_HT29_6H_X5	G23	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_HT29_6H_X1_B4_DUO52HI53LO:H06	CPC016_HT29_6H_X1	H06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_HT29_6H_X2_B4_DUO52HI53LO:H06	CPC016_HT29_6H_X2	H06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_HT29_6H_X3_B4_DUO52HI53LO:H06	CPC016_HT29_6H_X3	H06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_HT29_6H_X4_B5_DUO52HI53LO:H06	CPC016_HT29_6H_X4	H06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:D15	CPC020_HT29_6H_X1.L2	D15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:D15	CPC020_HT29_6H_X2.L2	D15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_HT29_6H_X4_B5_DUO52HI53LO:D15	CPC020_HT29_6H_X4	D15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_HT29_6H_X5_B5_DUO52HI53LO:D15	CPC020_HT29_6H_X5	D15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_HT29_6H_X1_B3_DUO52HI53LO:A16	CPC011_HT29_6H_X1	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_HT29_6H_X2_B3_DUO52HI53LO:A16	CPC011_HT29_6H_X2	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_HT29_6H_X4_B5_DUO52HI53LO:A16	CPC011_HT29_6H_X4	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_HT29_6H_X5_B5_DUO52HI53LO:A16	CPC011_HT29_6H_X5	A16	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:K22	CPC016_HT29_6H_X5	K22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_HT29_6H_X1_B3_DUO52HI53LO:J05	CPC011_HT29_6H_X1	J05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_HT29_6H_X2_B3_DUO52HI53LO:J05	CPC011_HT29_6H_X2	J05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_HT29_6H_X4_B5_DUO52HI53LO:J05	CPC011_HT29_6H_X4	J05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_HT29_6H_X5_B5_DUO52HI53LO:J05	CPC011_HT29_6H_X5	J05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_HT29_6H_X1_B4_DUO52HI53LO:K22	CPC016_HT29_6H_X1	K22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_HT29_6H_X2_B4_DUO52HI53LO:K22	CPC016_HT29_6H_X2	K22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_HT29_6H_X3_B4_DUO52HI53LO:K22	CPC016_HT29_6H_X3	K22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_HT29_6H_X4_B5_DUO52HI53LO:K22	CPC016_HT29_6H_X4	K22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_HT29_6H_X4_F1B5_DUO52HI53LO:J19	CPC018_HT29_6H_X4	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_HT29_6H_X1_B4_DUO52HI53LO:J19	CPC018_HT29_6H_X1	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_HT29_6H_X2_B4_DUO52HI53LO:J19	CPC018_HT29_6H_X2	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_HT29_6H_X3_B4_DUO52HI53LO:J19	CPC018_HT29_6H_X3	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_HT29_6H_X5_B5_DUO52HI53LO:J19	CPC018_HT29_6H_X5	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_HT29_6H_X1.L2_F1B5_DUO52HI53LO:B15	CPC020_HT29_6H_X1.L2	B15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_HT29_6H_X2.L2_B6_DUO52HI53LO:B15	CPC020_HT29_6H_X2.L2	B15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_HT29_6H_X4_B5_DUO52HI53LO:B15	CPC020_HT29_6H_X4	B15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_HT29_6H_X5_B5_DUO52HI53LO:B15	CPC020_HT29_6H_X5	B15	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_HT29_6H_X1_B3_DUO52HI53LO:I12	CPC011_HT29_6H_X1	I12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_HT29_6H_X2_B3_DUO52HI53LO:I12	CPC011_HT29_6H_X2	I12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_HT29_6H_X4_B5_DUO52HI53LO:I12	CPC011_HT29_6H_X4	I12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_HT29_6H_X5_B5_DUO52HI53LO:I12	CPC011_HT29_6H_X5	I12	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:H24	CPC004_HT29_6H_X1	H24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:H24	CPC004_HT29_6H_X2	H24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:H24	CPC004_HT29_6H_X3	H24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:H24	CPC004_HT29_6H_X4	H24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:H24	CPC004_HT29_6H_X5	H24	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_HT29_6H_X1_B3_DUO52HI53LO:I21	CPC011_HT29_6H_X1	I21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_HT29_6H_X2_B3_DUO52HI53LO:I21	CPC011_HT29_6H_X2	I21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_HT29_6H_X4_B5_DUO52HI53LO:I21	CPC011_HT29_6H_X4	I21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_HT29_6H_X5_B5_DUO52HI53LO:I21	CPC011_HT29_6H_X5	I21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_HT29_6H_X1_B4_DUO52HI53LO:L01	CPC015_HT29_6H_X1	L01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_HT29_6H_X3_B4_DUO52HI53LO:L01	CPC015_HT29_6H_X3	L01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_HT29_6H_X5_B5_DUO52HI53LO:L01	CPC015_HT29_6H_X5	L01	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:J02	CPC004_HT29_6H_X1	J02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:J02	CPC004_HT29_6H_X2	J02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:J02	CPC004_HT29_6H_X3	J02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:J02	CPC004_HT29_6H_X4	J02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:J02	CPC004_HT29_6H_X5	J02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_HT29_6H_X1_B4_DUO52HI53LO:L03	CPC015_HT29_6H_X1	L03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_HT29_6H_X3_B4_DUO52HI53LO:L03	CPC015_HT29_6H_X3	L03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_HT29_6H_X5_B5_DUO52HI53LO:L03	CPC015_HT29_6H_X5	L03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:H13	CPC004_HT29_6H_X1	H13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:H13	CPC004_HT29_6H_X2	H13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:H13	CPC004_HT29_6H_X3	H13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:H13	CPC004_HT29_6H_X4	H13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:H13	CPC004_HT29_6H_X5	H13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_HT29_6H_X1_B3_DUO52HI53LO:L11	CPC011_HT29_6H_X1	L11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_HT29_6H_X2_B3_DUO52HI53LO:L11	CPC011_HT29_6H_X2	L11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_HT29_6H_X4_B5_DUO52HI53LO:L11	CPC011_HT29_6H_X4	L11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_HT29_6H_X5_B5_DUO52HI53LO:L11	CPC011_HT29_6H_X5	L11	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_HT29_6H_X1_B4_DUO52HI53LO:K04	CPC015_HT29_6H_X1	K04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_HT29_6H_X3_B4_DUO52HI53LO:K04	CPC015_HT29_6H_X3	K04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_HT29_6H_X5_B5_DUO52HI53LO:K04	CPC015_HT29_6H_X5	K04	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HT29_24H_X1_B3_DUO52HI53LO:E19	CPC005_HT29_24H_X1	E19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HT29_24H_X2_B3_DUO52HI53LO:E19	CPC005_HT29_24H_X2	E19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HT29_24H_X3_B3_DUO52HI53LO:E19	CPC005_HT29_24H_X3	E19	trt_cp	10.0	um	24	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HT29_6H_X1_B3_DUO52HI53LO:E19	CPC005_HT29_6H_X1	E19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HT29_6H_X2_B3_DUO52HI53LO:E19	CPC005_HT29_6H_X2	E19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_HT29_6H_X3_B3_DUO52HI53LO:E19	CPC005_HT29_6H_X3	E19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:I06	CPC004_HT29_6H_X1	I06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:I06	CPC004_HT29_6H_X2	I06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:I06	CPC004_HT29_6H_X3	I06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:I06	CPC004_HT29_6H_X4	I06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:I06	CPC004_HT29_6H_X5	I06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:N14	CPC016_HT29_6H_X5	N14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_HT29_6H_X1_B3_DUO52HI53LO:K13	CPC011_HT29_6H_X1	K13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_HT29_6H_X2_B3_DUO52HI53LO:K13	CPC011_HT29_6H_X2	K13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_HT29_6H_X4_B5_DUO52HI53LO:K13	CPC011_HT29_6H_X4	K13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_HT29_6H_X5_B5_DUO52HI53LO:K13	CPC011_HT29_6H_X5	K13	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_HT29_6H_X1_B4_DUO52HI53LO:N14	CPC016_HT29_6H_X1	N14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_HT29_6H_X2_B4_DUO52HI53LO:N14	CPC016_HT29_6H_X2	N14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_HT29_6H_X3_B4_DUO52HI53LO:N14	CPC016_HT29_6H_X3	N14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_HT29_6H_X4_B5_DUO52HI53LO:N14	CPC016_HT29_6H_X4	N14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:I02	CPC004_HT29_6H_X1	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:I02	CPC004_HT29_6H_X2	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:I02	CPC004_HT29_6H_X3	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:I02	CPC004_HT29_6H_X4	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:I02	CPC004_HT29_6H_X5	I02	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_HT29_6H_X5_F1B5_DUO52HI53LO:N08	CPC016_HT29_6H_X5	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_HT29_6H_X1_B4_DUO52HI53LO:N08	CPC016_HT29_6H_X1	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_HT29_6H_X2_B4_DUO52HI53LO:N08	CPC016_HT29_6H_X2	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_HT29_6H_X3_B4_DUO52HI53LO:N08	CPC016_HT29_6H_X3	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_HT29_6H_X4_B5_DUO52HI53LO:N08	CPC016_HT29_6H_X4	N08	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:J06	CPC004_HT29_6H_X1	J06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:J06	CPC004_HT29_6H_X2	J06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:J06	CPC004_HT29_6H_X3	J06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:J06	CPC004_HT29_6H_X4	J06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:J06	CPC004_HT29_6H_X5	J06	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_HT29_6H_X1_B3_DUO52HI53LO:J19	CPC011_HT29_6H_X1	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_HT29_6H_X2_B3_DUO52HI53LO:J19	CPC011_HT29_6H_X2	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_HT29_6H_X4_B5_DUO52HI53LO:J19	CPC011_HT29_6H_X4	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_HT29_6H_X5_B5_DUO52HI53LO:J19	CPC011_HT29_6H_X5	J19	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_HT29_6H_X1_B4_DUO52HI53LO:L07	CPC015_HT29_6H_X1	L07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_HT29_6H_X3_B4_DUO52HI53LO:L07	CPC015_HT29_6H_X3	L07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_HT29_6H_X5_B5_DUO52HI53LO:L07	CPC015_HT29_6H_X5	L07	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_HT29_6H_X1_B3_DUO52HI53LO:H14	CPC011_HT29_6H_X1	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_HT29_6H_X2_B3_DUO52HI53LO:H14	CPC011_HT29_6H_X2	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_HT29_6H_X4_B5_DUO52HI53LO:H14	CPC011_HT29_6H_X4	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_HT29_6H_X5_B5_DUO52HI53LO:H14	CPC011_HT29_6H_X5	H14	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HT29_6H_X1_B3_DUO52HI53LO:J03	CPC004_HT29_6H_X1	J03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HT29_6H_X2_B3_DUO52HI53LO:J03	CPC004_HT29_6H_X2	J03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HT29_6H_X3_B3_DUO52HI53LO:J03	CPC004_HT29_6H_X3	J03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HT29_6H_X4_B5_DUO52HI53LO:J03	CPC004_HT29_6H_X4	J03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_HT29_6H_X5_B5_DUO52HI53LO:J03	CPC004_HT29_6H_X5	J03	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HT29_6H_X1_B3_DUO52HI53LO:G22	CPC010_HT29_6H_X1	G22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HT29_6H_X2_B3_DUO52HI53LO:G22	CPC010_HT29_6H_X2	G22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HT29_6H_X3_B3_DUO52HI53LO:G22	CPC010_HT29_6H_X3	G22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HT29_6H_X4_B5_DUO52HI53LO:G22	CPC010_HT29_6H_X4	G22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_HT29_6H_X5_B5_DUO52HI53LO:G22	CPC010_HT29_6H_X5	G22	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_HT29_6H_X1_B3_DUO52HI53LO:I05	CPC011_HT29_6H_X1	I05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_HT29_6H_X2_B3_DUO52HI53LO:I05	CPC011_HT29_6H_X2	I05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_HT29_6H_X4_B5_DUO52HI53LO:I05	CPC011_HT29_6H_X4	I05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_HT29_6H_X5_B5_DUO52HI53LO:I05	CPC011_HT29_6H_X5	I05	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_HT29_6H_X1_B4_DUO52HI53LO:K18	CPC015_HT29_6H_X1	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_HT29_6H_X3_B4_DUO52HI53LO:K18	CPC015_HT29_6H_X3	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_HT29_6H_X5_B5_DUO52HI53LO:K18	CPC015_HT29_6H_X5	K18	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_HT29_6H_X5_F1B5_DUO52HI53LO:F21	CPC017_HT29_6H_X5	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_HT29_6H_X1_B4_DUO52HI53LO:F21	CPC017_HT29_6H_X1	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_HT29_6H_X2_B4_DUO52HI53LO:F21	CPC017_HT29_6H_X2	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_HT29_6H_X3_B4_DUO52HI53LO:F21	CPC017_HT29_6H_X3	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_HT29_6H_X4_B5_DUO52HI53LO:F21	CPC017_HT29_6H_X4	F21	trt_cp	10.0	um	6	h	HT29	cell line	HT29	-666	-666	tumor	large intestine	colorectal adenocarcinoma	adherent	HTB-38	ATCC	44	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:J08	CPC004_MCF7_6H_X1	J08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:J08	CPC004_MCF7_6H_X2	J08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:J08	CPC004_MCF7_6H_X4	J08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:J08	CPC004_MCF7_6H_X5	J08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:G10	CPC011_MCF7_24H_X4	G10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:G10	CPC011_MCF7_24H_X5	G10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:L09	CPC015_MCF7_24H_X1	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:L09	CPC015_MCF7_24H_X2	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:L09	CPC015_MCF7_24H_X3	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:L09	CPC015_MCF7_24H_X4	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:L09	CPC015_MCF7_24H_X5	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:L09	CPC015_MCF7_6H_X1	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:L09	CPC015_MCF7_6H_X2	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:L09	CPC015_MCF7_6H_X3	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:L09	CPC015_MCF7_6H_X3	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:L09	CPC015_MCF7_6H_X4	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:L09	CPC015_MCF7_6H_X5	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:B20	CPD001_MCF7_24H_X1	B20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:B20	CPD001_MCF7_24H_X2	B20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:B20	CPD001_MCF7_24H_X3	B20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:B20	CPD001_MCF7_6H_X1.A2	B20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:B20	CPD001_MCF7_6H_X1	B20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:B20	CPD001_MCF7_6H_X2	B20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:B20	CPD001_MCF7_6H_X3	B20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:B03	CPC011_MCF7_24H_X4	B03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:B03	CPC011_MCF7_24H_X5	B03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:G10	CPC011_MCF7_6H_X1	G10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:G10	CPC011_MCF7_6H_X3	G10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:B03	CPC011_MCF7_6H_X1	B03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:B03	CPC011_MCF7_6H_X3	B03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:J10	CPC015_MCF7_24H_X1	J10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:J10	CPC015_MCF7_24H_X2	J10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:J10	CPC015_MCF7_24H_X3	J10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:J10	CPC015_MCF7_24H_X4	J10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:J10	CPC015_MCF7_24H_X5	J10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:J10	CPC015_MCF7_6H_X4	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:J10	CPC015_MCF7_6H_X5	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:O09	CPD001_MCF7_24H_X1	O09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:O09	CPD001_MCF7_24H_X2	O09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:O09	CPD001_MCF7_24H_X3	O09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:O09	CPD001_MCF7_6H_X1.A2	O09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:O09	CPD001_MCF7_6H_X1	O09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:O09	CPD001_MCF7_6H_X2	O09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:O09	CPD001_MCF7_6H_X3	O09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:J10	CPC015_MCF7_6H_X1	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:J10	CPC015_MCF7_6H_X2	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:J10	CPC015_MCF7_6H_X3	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:J10	CPC015_MCF7_6H_X3	J10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:E01	CPC004_MCF7_6H_X1	E01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:E01	CPC004_MCF7_6H_X2	E01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:E01	CPC004_MCF7_6H_X4	E01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:E01	CPC004_MCF7_6H_X5	E01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:K18	CPC017_MCF7_24H_X1	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:K18	CPC017_MCF7_24H_X2	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:K18	CPC017_MCF7_24H_X3	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:K18	CPC017_MCF7_24H_X4	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_MCF7_24H_X5_B5_DUO52HI53LO:K18	CPC017_MCF7_24H_X5	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:K18	CPC017_MCF7_6H_X5	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:F24	CPC020_MCF7_24H_X1	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:H08	CPC020_MCF7_24H_X1	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:F24	CPC020_MCF7_24H_X2	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:H08	CPC020_MCF7_24H_X2	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:F24	CPC020_MCF7_24H_X3	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:H08	CPC020_MCF7_24H_X3	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:F24	CPC020_MCF7_24H_X4	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:H08	CPC020_MCF7_24H_X4	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:F24	CPC020_MCF7_24H_X5	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:H08	CPC020_MCF7_24H_X5	H08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:F24	CPC020_MCF7_6H_X1	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:H08	CPC020_MCF7_6H_X1	H08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:F24	CPC020_MCF7_6H_X2	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:H08	CPC020_MCF7_6H_X2	H08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:F24	CPC020_MCF7_6H_X3	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:H08	CPC020_MCF7_6H_X3	H08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:F24	CPC020_MCF7_6H_X5	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:H08	CPC020_MCF7_6H_X5	H08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:K18	CPC017_MCF7_6H_X1	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:K18	CPC017_MCF7_6H_X2	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:K18	CPC017_MCF7_6H_X3	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X1	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X2	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X3	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:F24	CPC005_MCF7_24H_X4	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X1	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X2	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X2	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X3	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_MCF7_6H_X5_F1B5_DUO52HI53LO:F24	CPC005_MCF7_6H_X5	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_MCF7_24H_X4_B5_DUO52HI53LO:B24	CPC009_MCF7_24H_X4	B24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_MCF7_24H_X5_B5_DUO52HI53LO:B24	CPC009_MCF7_24H_X5	B24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_MCF7_6H_X1_B3_DUO52HI53LO:B24	CPC009_MCF7_6H_X1	B24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_MCF7_6H_X2_B3_DUO52HI53LO:B24	CPC009_MCF7_6H_X2	B24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_MCF7_6H_X3.A2_F1B3_DUO52HI53LO:B24	CPC009_MCF7_6H_X3.A2	B24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:L06	CPD002_MCF7_24H_X1	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:L06	CPD002_MCF7_24H_X2	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:L06	CPD002_MCF7_24H_X3	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:L06	CPD002_MCF7_6H_X1	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:L06	CPD002_MCF7_6H_X2	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:L06	CPD002_MCF7_6H_X3	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X5	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:P10	CPC011_MCF7_24H_X4	P10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:P10	CPC011_MCF7_24H_X5	P10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:P10	CPC011_MCF7_6H_X1	P10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:P10	CPC011_MCF7_6H_X3	P10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X1	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X2	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X3	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:F24	CPC005_MCF7_24H_X4	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X1	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X2	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X2	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:F24	CPC005_MCF7_6H_X3	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_MCF7_6H_X5_F1B5_DUO52HI53LO:F24	CPC005_MCF7_6H_X5	F24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_MCF7_24H_X4_B5_DUO52HI53LO:B24	CPC009_MCF7_24H_X4	B24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_MCF7_24H_X5_B5_DUO52HI53LO:B24	CPC009_MCF7_24H_X5	B24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_MCF7_6H_X1_B3_DUO52HI53LO:B24	CPC009_MCF7_6H_X1	B24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_MCF7_6H_X2_B3_DUO52HI53LO:B24	CPC009_MCF7_6H_X2	B24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_MCF7_6H_X3.A2_F1B3_DUO52HI53LO:B24	CPC009_MCF7_6H_X3.A2	B24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:L06	CPD002_MCF7_24H_X1	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:L06	CPD002_MCF7_24H_X2	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:L06	CPD002_MCF7_24H_X3	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:L06	CPD002_MCF7_6H_X1	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:L06	CPD002_MCF7_6H_X2	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:L06	CPD002_MCF7_6H_X3	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:F24	CPC005_MCF7_24H_X5	F24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:P10	CPC011_MCF7_24H_X4	P10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:P10	CPC011_MCF7_24H_X5	P10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:P10	CPC011_MCF7_6H_X1	P10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:P10	CPC011_MCF7_6H_X3	P10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_MCF7_24H_X1_B4_DUO52HI53LO:F20	CPC018_MCF7_24H_X1	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_MCF7_24H_X2_B4_DUO52HI53LO:F20	CPC018_MCF7_24H_X2	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_MCF7_24H_X3_B4_DUO52HI53LO:F20	CPC018_MCF7_24H_X3	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_MCF7_24H_X4_B5_DUO52HI53LO:F20	CPC018_MCF7_24H_X4	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:P19	CPC020_MCF7_24H_X1	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:P19	CPC020_MCF7_24H_X2	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:P19	CPC020_MCF7_24H_X3	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:P19	CPC020_MCF7_24H_X4	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:P19	CPC020_MCF7_24H_X5	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:P19	CPC020_MCF7_6H_X1	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:P19	CPC020_MCF7_6H_X2	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:P19	CPC020_MCF7_6H_X3	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:P19	CPC020_MCF7_6H_X5	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:F20	CPD001_MCF7_24H_X1	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:F20	CPD001_MCF7_24H_X2	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:F20	CPD001_MCF7_24H_X3	F20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:F20	CPD001_MCF7_6H_X1.A2	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:F20	CPD001_MCF7_6H_X1	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:F20	CPD001_MCF7_6H_X2	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:F20	CPD001_MCF7_6H_X3	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_MCF7_6H_X1_B4_DUO52HI53LO:F20	CPC018_MCF7_6H_X1	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_MCF7_6H_X2_B4_DUO52HI53LO:F20	CPC018_MCF7_6H_X2	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_MCF7_6H_X3_B4_DUO52HI53LO:F20	CPC018_MCF7_6H_X3	F20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:E11	CPC004_MCF7_6H_X1	E11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:E11	CPC004_MCF7_6H_X2	E11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:M02	CPC017_MCF7_24H_X1	M02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:M02	CPC017_MCF7_24H_X2	M02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:M02	CPC017_MCF7_24H_X3	M02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:M02	CPC017_MCF7_24H_X4	M02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_MCF7_24H_X5_B5_DUO52HI53LO:M02	CPC017_MCF7_24H_X5	M02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:M02	CPC017_MCF7_6H_X5	M02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:F21	CPC020_MCF7_24H_X1	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:F21	CPC020_MCF7_24H_X2	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:F21	CPC020_MCF7_24H_X3	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:F21	CPC020_MCF7_24H_X5	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:F21	CPC020_MCF7_6H_X1	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:F21	CPC020_MCF7_6H_X2	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:F21	CPC020_MCF7_6H_X3	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:F21	CPC020_MCF7_6H_X5	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:E02	CPD001_MCF7_24H_X1	E02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:E02	CPD001_MCF7_24H_X2	E02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:E02	CPD001_MCF7_24H_X3	E02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:E02	CPD001_MCF7_6H_X1.A2	E02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:E02	CPD001_MCF7_6H_X1	E02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:E02	CPD001_MCF7_6H_X2	E02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:E02	CPD001_MCF7_6H_X3	E02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:E11	CPC004_MCF7_6H_X4	E11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:E11	CPC004_MCF7_6H_X5	E11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:M02	CPC017_MCF7_6H_X1	M02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:M02	CPC017_MCF7_6H_X2	M02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:M02	CPC017_MCF7_6H_X3	M02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:K17	CPC004_MCF7_6H_X1	K17	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:K17	CPC004_MCF7_6H_X2	K17	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:K17	CPC004_MCF7_6H_X4	K17	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:K17	CPC004_MCF7_6H_X5	K17	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_MCF7_24H_X1_B4_DUO52HI53LO:A20	CPC018_MCF7_24H_X1	A20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_MCF7_24H_X2_B4_DUO52HI53LO:A20	CPC018_MCF7_24H_X2	A20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_MCF7_24H_X3_B4_DUO52HI53LO:A20	CPC018_MCF7_24H_X3	A20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_MCF7_24H_X4_B5_DUO52HI53LO:A20	CPC018_MCF7_24H_X4	A20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:F08	CPD001_MCF7_24H_X1	F08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:F08	CPD001_MCF7_24H_X2	F08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:F08	CPD001_MCF7_24H_X3	F08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:F08	CPD001_MCF7_6H_X1.A2	F08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:F08	CPD001_MCF7_6H_X1	F08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:F08	CPD001_MCF7_6H_X2	F08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:F08	CPD001_MCF7_6H_X3	F08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_MCF7_6H_X1_B4_DUO52HI53LO:A20	CPC018_MCF7_6H_X1	A20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_MCF7_6H_X2_B4_DUO52HI53LO:A20	CPC018_MCF7_6H_X2	A20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_MCF7_6H_X3_B4_DUO52HI53LO:A20	CPC018_MCF7_6H_X3	A20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:G23	CPC004_MCF7_6H_X1	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:G23	CPC004_MCF7_6H_X2	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:G23	CPC004_MCF7_6H_X4	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:G23	CPC004_MCF7_6H_X5	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:O16	CPC017_MCF7_24H_X1	O16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:O16	CPC017_MCF7_24H_X2	O16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:O16	CPC017_MCF7_24H_X3	O16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:O16	CPC017_MCF7_24H_X4	O16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_MCF7_24H_X5_B5_DUO52HI53LO:O16	CPC017_MCF7_24H_X5	O16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:O16	CPC017_MCF7_6H_X5	O16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:G15	CPC011_MCF7_24H_X4	G15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:G15	CPC011_MCF7_24H_X5	G15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:G15	CPC011_MCF7_6H_X1	G15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:G15	CPC011_MCF7_6H_X3	G15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:O16	CPC017_MCF7_6H_X1	O16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:O16	CPC017_MCF7_6H_X2	O16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:O16	CPC017_MCF7_6H_X3	O16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:I07	CPC017_MCF7_24H_X1	I07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:I07	CPC017_MCF7_24H_X2	I07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:I07	CPC017_MCF7_24H_X3	I07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:I07	CPC017_MCF7_24H_X4	I07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_MCF7_24H_X5_B5_DUO52HI53LO:I07	CPC017_MCF7_24H_X5	I07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:I07	CPC017_MCF7_6H_X5	I07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:O02	CPC020_MCF7_24H_X1	O02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:O02	CPC020_MCF7_24H_X2	O02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:O02	CPC020_MCF7_24H_X3	O02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:O02	CPC020_MCF7_24H_X4	O02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:O02	CPC020_MCF7_24H_X5	O02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:O02	CPC020_MCF7_6H_X1	O02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:O02	CPC020_MCF7_6H_X2	O02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:O02	CPC020_MCF7_6H_X3	O02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:O02	CPC020_MCF7_6H_X5	O02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:I07	CPC017_MCF7_6H_X1	I07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:I07	CPC017_MCF7_6H_X2	I07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:I07	CPC017_MCF7_6H_X3	I07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:P19	CPC005_MCF7_24H_X1	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:P19	CPC005_MCF7_24H_X2	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:P19	CPC005_MCF7_24H_X3	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:P19	CPC005_MCF7_24H_X4	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:P19	CPC005_MCF7_6H_X1	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:P19	CPC005_MCF7_6H_X2	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:P19	CPC005_MCF7_6H_X2	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:P19	CPC005_MCF7_6H_X3	P19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_MCF7_24H_X4_B5_DUO52HI53LO:J24	CPC009_MCF7_24H_X4	J24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_MCF7_24H_X5_B5_DUO52HI53LO:J24	CPC009_MCF7_24H_X5	J24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_MCF7_6H_X3.A2_F1B3_DUO52HI53LO:J24	CPC009_MCF7_6H_X3.A2	J24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:G04	CPD002_MCF7_24H_X1	G04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:G04	CPD002_MCF7_24H_X2	G04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:G04	CPD002_MCF7_24H_X3	G04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:G04	CPD002_MCF7_6H_X1	G04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:G04	CPD002_MCF7_6H_X2	G04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:G04	CPD002_MCF7_6H_X3	G04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:P19	CPC005_MCF7_24H_X5	P19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_MCF7_6H_X1_B3_DUO52HI53LO:J24	CPC009_MCF7_6H_X1	J24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_MCF7_6H_X2_B3_DUO52HI53LO:J24	CPC009_MCF7_6H_X2	J24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:E15	CPC011_MCF7_24H_X4	E15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:E15	CPC011_MCF7_24H_X5	E15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:E15	CPC011_MCF7_6H_X1	E15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:E15	CPC011_MCF7_6H_X3	E15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:M15	CPC016_MCF7_24H_X2	M15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:M15	CPC016_MCF7_24H_X3	M15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:M15	CPC016_MCF7_24H_X4	M15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:M15	CPC016_MCF7_24H_X5	M15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:M15	CPC016_MCF7_6H_X5	M15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:H11	CPD003_MCF7_24H_X1	H11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:H11	CPD003_MCF7_24H_X2.L2	H11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:H11	CPD003_MCF7_24H_X3.L2	H11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:H11	CPD003_MCF7_24H_X3	H11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:H11	CPD003_MCF7_6H_X1	H11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:H11	CPD003_MCF7_6H_X2	H11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:M15	CPC016_MCF7_6H_X1	M15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:M15	CPC016_MCF7_6H_X2	M15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_MCF7_24H_X4_B5_DUO52HI53LO:K23	CPC009_MCF7_24H_X4	K23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_MCF7_24H_X5_B5_DUO52HI53LO:K23	CPC009_MCF7_24H_X5	K23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_MCF7_6H_X1_B3_DUO52HI53LO:K23	CPC009_MCF7_6H_X1	K23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_MCF7_6H_X2_B3_DUO52HI53LO:K23	CPC009_MCF7_6H_X2	K23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_MCF7_6H_X3.A2_F1B3_DUO52HI53LO:K23	CPC009_MCF7_6H_X3.A2	K23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:B21	CPD001_MCF7_24H_X1	B21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:B21	CPD001_MCF7_24H_X2	B21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:B21	CPD001_MCF7_24H_X3	B21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:B21	CPD001_MCF7_6H_X1.A2	B21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:B21	CPD001_MCF7_6H_X1	B21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:B21	CPD001_MCF7_6H_X2	B21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:B21	CPD001_MCF7_6H_X3	B21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:I11	CPC011_MCF7_24H_X4	I11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:I11	CPC011_MCF7_24H_X5	I11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:I11	CPC011_MCF7_6H_X1	I11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:I11	CPC011_MCF7_6H_X3	I11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:C12	CPC005_MCF7_24H_X1	C12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:C12	CPC005_MCF7_24H_X2	C12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:C12	CPC005_MCF7_24H_X3	C12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:C12	CPC005_MCF7_24H_X4	C12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:C12	CPC005_MCF7_6H_X1	C12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:C12	CPC005_MCF7_6H_X2	C12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:C12	CPC005_MCF7_6H_X2	C12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:C12	CPC005_MCF7_6H_X3	C12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_MCF7_6H_X5_F1B5_DUO52HI53LO:C12	CPC005_MCF7_6H_X5	C12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:H14	CPC020_MCF7_24H_X1	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:L24	CPC020_MCF7_24H_X1	L24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:H14	CPC020_MCF7_24H_X2	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:L24	CPC020_MCF7_24H_X2	L24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:H14	CPC020_MCF7_24H_X3	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:L24	CPC020_MCF7_24H_X3	L24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:H14	CPC020_MCF7_24H_X4	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:L24	CPC020_MCF7_24H_X4	L24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:H14	CPC020_MCF7_24H_X5	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:L24	CPC020_MCF7_24H_X5	L24	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:H14	CPC020_MCF7_6H_X1	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:L24	CPC020_MCF7_6H_X1	L24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:H14	CPC020_MCF7_6H_X2	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:L24	CPC020_MCF7_6H_X2	L24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:H14	CPC020_MCF7_6H_X3	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:L24	CPC020_MCF7_6H_X3	L24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:H14	CPC020_MCF7_6H_X5	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:L24	CPC020_MCF7_6H_X5	L24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:O05	CPD001_MCF7_24H_X1	O05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:O05	CPD001_MCF7_24H_X2	O05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:O05	CPD001_MCF7_24H_X3	O05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:O05	CPD001_MCF7_6H_X1.A2	O05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:O05	CPD001_MCF7_6H_X1	O05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:O05	CPD001_MCF7_6H_X2	O05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:O05	CPD001_MCF7_6H_X3	O05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:C12	CPC005_MCF7_24H_X5	C12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:M20	CPC016_MCF7_24H_X2	M20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:M20	CPC016_MCF7_24H_X3	M20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:M20	CPC016_MCF7_24H_X4	M20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:M20	CPC016_MCF7_24H_X5	M20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:M20	CPC016_MCF7_6H_X5	M20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:P01	CPD002_MCF7_24H_X1	P01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:P01	CPD002_MCF7_24H_X2	P01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:P01	CPD002_MCF7_24H_X3	P01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:M20	CPC016_MCF7_6H_X1	M20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:M20	CPC016_MCF7_6H_X2	M20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:P01	CPD002_MCF7_6H_X1	P01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:P01	CPD002_MCF7_6H_X2	P01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:P01	CPD002_MCF7_6H_X3	P01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:N07	CPC005_MCF7_24H_X1	N07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:N07	CPC005_MCF7_24H_X2	N07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:N07	CPC005_MCF7_24H_X3	N07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:N07	CPC005_MCF7_24H_X4	N07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:N07	CPC005_MCF7_6H_X1	N07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:N07	CPC005_MCF7_6H_X2	N07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:N07	CPC005_MCF7_6H_X3	N07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:F23	CPD001_MCF7_24H_X1	F23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:F23	CPD001_MCF7_24H_X2	F23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:F23	CPD001_MCF7_24H_X3	F23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:F23	CPD001_MCF7_6H_X1.A2	F23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:F23	CPD001_MCF7_6H_X1	F23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:F23	CPD001_MCF7_6H_X2	F23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:F23	CPD001_MCF7_6H_X3	F23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:N07	CPC005_MCF7_24H_X5	N07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:N07	CPC005_MCF7_6H_X2	N07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_MCF7_6H_X5_F1B5_DUO52HI53LO:N07	CPC005_MCF7_6H_X5	N07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:O15	CPC011_MCF7_24H_X4	O15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:O15	CPC011_MCF7_24H_X5	O15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_MCF7_24H_X1_B4_DUO52HI53LO:H09	CPC018_MCF7_24H_X1	H09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_MCF7_24H_X2_B4_DUO52HI53LO:H09	CPC018_MCF7_24H_X2	H09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_MCF7_24H_X3_B4_DUO52HI53LO:H09	CPC018_MCF7_24H_X3	H09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_MCF7_24H_X4_B5_DUO52HI53LO:H09	CPC018_MCF7_24H_X4	H09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:O15	CPC011_MCF7_6H_X1	O15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:O15	CPC011_MCF7_6H_X3	O15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_MCF7_6H_X1_B4_DUO52HI53LO:H09	CPC018_MCF7_6H_X1	H09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_MCF7_6H_X2_B4_DUO52HI53LO:H09	CPC018_MCF7_6H_X2	H09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_MCF7_6H_X3_B4_DUO52HI53LO:H09	CPC018_MCF7_6H_X3	H09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:O06	CPC016_MCF7_24H_X2	O06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:O06	CPC016_MCF7_24H_X3	O06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:O06	CPC016_MCF7_24H_X4	O06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:O06	CPC016_MCF7_24H_X5	O06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:O06	CPC016_MCF7_6H_X5	O06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:C20	CPD001_MCF7_24H_X1	C20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:C20	CPD001_MCF7_24H_X2	C20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:C20	CPD001_MCF7_24H_X3	C20	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:C20	CPD001_MCF7_6H_X1.A2	C20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:C20	CPD001_MCF7_6H_X1	C20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:C20	CPD001_MCF7_6H_X2	C20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:C20	CPD001_MCF7_6H_X3	C20	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:O06	CPC016_MCF7_6H_X2	O06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:A16	CPC004_MCF7_6H_X1	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:A16	CPC004_MCF7_6H_X2	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:A16	CPC004_MCF7_6H_X4	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:A16	CPC004_MCF7_6H_X5	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:H06	CPC016_MCF7_24H_X2	H06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:H06	CPC016_MCF7_24H_X3	H06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:H06	CPC016_MCF7_24H_X4	H06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:H06	CPC016_MCF7_24H_X5	H06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:H06	CPC016_MCF7_6H_X5	H06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:G23	CPC011_MCF7_24H_X4	G23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:G23	CPC011_MCF7_24H_X5	G23	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:G23	CPC011_MCF7_6H_X1	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:G23	CPC011_MCF7_6H_X3	G23	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:H06	CPC016_MCF7_6H_X1	H06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:H06	CPC016_MCF7_6H_X2	H06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:O14	CPD002_MCF7_24H_X1	O14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:O14	CPD002_MCF7_24H_X2	O14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:O14	CPD002_MCF7_24H_X3	O14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:O14	CPD002_MCF7_6H_X1	O14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:O14	CPD002_MCF7_6H_X2	O14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:O14	CPD002_MCF7_6H_X3	O14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:D15	CPC020_MCF7_24H_X1	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:D15	CPC020_MCF7_24H_X2	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:D15	CPC020_MCF7_24H_X3	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:D15	CPC020_MCF7_24H_X4	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:D15	CPC020_MCF7_24H_X5	D15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:D15	CPC020_MCF7_6H_X1	D15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:D15	CPC020_MCF7_6H_X2	D15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:D15	CPC020_MCF7_6H_X3	D15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:D15	CPC020_MCF7_6H_X5	D15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:G02	CPD001_MCF7_6H_X1.A2	G02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:A16	CPC011_MCF7_24H_X4	A16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:A16	CPC011_MCF7_24H_X5	A16	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:A16	CPC011_MCF7_6H_X1	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:A16	CPC011_MCF7_6H_X3	A16	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:G02	CPD001_MCF7_24H_X1	G02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:G02	CPD001_MCF7_24H_X2	G02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:G02	CPD001_MCF7_24H_X3	G02	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:G02	CPD001_MCF7_6H_X1	G02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:G02	CPD001_MCF7_6H_X2	G02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:G02	CPD001_MCF7_6H_X3	G02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:K22	CPC016_MCF7_24H_X2	K22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:K22	CPC016_MCF7_24H_X3	K22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:K22	CPC016_MCF7_24H_X4	K22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:K22	CPC016_MCF7_24H_X5	K22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:K22	CPC016_MCF7_6H_X5	K22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:J05	CPC011_MCF7_24H_X4	J05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:J05	CPC011_MCF7_24H_X5	J05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:J05	CPC011_MCF7_6H_X1	J05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:J05	CPC011_MCF7_6H_X3	J05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:K22	CPC016_MCF7_6H_X1	K22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:K22	CPC016_MCF7_6H_X2	K22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_MCF7_24H_X1_B4_DUO52HI53LO:J19	CPC018_MCF7_24H_X1	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_MCF7_24H_X2_B4_DUO52HI53LO:J19	CPC018_MCF7_24H_X2	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_MCF7_24H_X3_B4_DUO52HI53LO:J19	CPC018_MCF7_24H_X3	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_MCF7_24H_X4_B5_DUO52HI53LO:J19	CPC018_MCF7_24H_X4	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:D10	CPD001_MCF7_24H_X1	D10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:D10	CPD001_MCF7_24H_X2	D10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:D10	CPD001_MCF7_24H_X3	D10	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:D10	CPD001_MCF7_6H_X1.A2	D10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:D10	CPD001_MCF7_6H_X1	D10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:D10	CPD001_MCF7_6H_X2	D10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:D10	CPD001_MCF7_6H_X3	D10	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_MCF7_6H_X1_B4_DUO52HI53LO:J19	CPC018_MCF7_6H_X1	J19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_MCF7_6H_X2_B4_DUO52HI53LO:J19	CPC018_MCF7_6H_X2	J19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_MCF7_6H_X3_B4_DUO52HI53LO:J19	CPC018_MCF7_6H_X3	J19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_MCF7_24H_X1_F1B4_DUO52HI53LO:B15	CPC020_MCF7_24H_X1	B15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_MCF7_24H_X2_F1B4_DUO52HI53LO:B15	CPC020_MCF7_24H_X2	B15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_MCF7_24H_X3_F1B4_DUO52HI53LO:B15	CPC020_MCF7_24H_X3	B15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_MCF7_24H_X4_F2B4_DUO52HI53LO:B15	CPC020_MCF7_24H_X4	B15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_MCF7_24H_X5_B5_DUO52HI53LO:B15	CPC020_MCF7_24H_X5	B15	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_MCF7_6H_X1_B4_DUO52HI53LO:B15	CPC020_MCF7_6H_X1	B15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_MCF7_6H_X2_B4_DUO52HI53LO:B15	CPC020_MCF7_6H_X2	B15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_MCF7_6H_X3_B4_DUO52HI53LO:B15	CPC020_MCF7_6H_X3	B15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_MCF7_6H_X5_F1B5_DUO52HI53LO:B15	CPC020_MCF7_6H_X5	B15	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:I12	CPC011_MCF7_24H_X4	I12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:I12	CPC011_MCF7_24H_X5	I12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:I12	CPC011_MCF7_6H_X1	I12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:I12	CPC011_MCF7_6H_X3	I12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:H24	CPC004_MCF7_6H_X1	H24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:H24	CPC004_MCF7_6H_X2	H24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:H24	CPC004_MCF7_6H_X4	H24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:H24	CPC004_MCF7_6H_X5	H24	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:L01	CPC015_MCF7_24H_X1	L01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:L01	CPC015_MCF7_24H_X2	L01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:L01	CPC015_MCF7_24H_X3	L01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:L01	CPC015_MCF7_24H_X4	L01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:L01	CPC015_MCF7_24H_X5	L01	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:L01	CPC015_MCF7_6H_X4	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:L01	CPC015_MCF7_6H_X5	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:K03	CPD003_MCF7_24H_X1	K03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:K03	CPD003_MCF7_24H_X2.L2	K03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:K03	CPD003_MCF7_24H_X3.L2	K03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:K03	CPD003_MCF7_24H_X3	K03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:K03	CPD003_MCF7_6H_X1	K03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:K03	CPD003_MCF7_6H_X2	K03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:I21	CPC011_MCF7_24H_X4	I21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:I21	CPC011_MCF7_24H_X5	I21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:I21	CPC011_MCF7_6H_X1	I21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:I21	CPC011_MCF7_6H_X3	I21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:L01	CPC015_MCF7_6H_X1	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:L01	CPC015_MCF7_6H_X2	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:L01	CPC015_MCF7_6H_X3	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:L01	CPC015_MCF7_6H_X3	L01	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:J02	CPC004_MCF7_6H_X1	J02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:J02	CPC004_MCF7_6H_X2	J02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:L03	CPC015_MCF7_24H_X1	L03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:L03	CPC015_MCF7_24H_X2	L03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:L03	CPC015_MCF7_24H_X3	L03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:L03	CPC015_MCF7_24H_X4	L03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:L03	CPC015_MCF7_24H_X5	L03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:L03	CPC015_MCF7_6H_X4	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:L03	CPC015_MCF7_6H_X5	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:I22	CPD003_MCF7_24H_X1	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:I22	CPD003_MCF7_24H_X3	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:I22	CPD003_MCF7_6H_X1	I22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:I22	CPD003_MCF7_6H_X2	I22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:J02	CPC004_MCF7_6H_X4	J02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:J02	CPC004_MCF7_6H_X5	J02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:L03	CPC015_MCF7_6H_X1	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:L03	CPC015_MCF7_6H_X2	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:L03	CPC015_MCF7_6H_X3	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:L03	CPC015_MCF7_6H_X3	L03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:I22	CPD003_MCF7_24H_X2.L2	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:I22	CPD003_MCF7_24H_X3.L2	I22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K57174586	2	2	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:L09	CPD003_MCF7_24H_X2.L2	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K57174586	2	2	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:L09	CPD003_MCF7_24H_X3.L2	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K57174586	2	2	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:L09	CPD003_MCF7_24H_X1	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K57174586	2	2	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:L09	CPD003_MCF7_24H_X3	L09	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K57174586	2	2	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:L09	CPD003_MCF7_6H_X1	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K57174586	2	2	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:L09	CPD003_MCF7_6H_X2	L09	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:H13	CPC004_MCF7_6H_X1	H13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:H13	CPC004_MCF7_6H_X2	H13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:H13	CPC004_MCF7_6H_X4	H13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:H13	CPC004_MCF7_6H_X5	H13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:K04	CPC015_MCF7_24H_X1	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:K04	CPC015_MCF7_24H_X2	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:K04	CPC015_MCF7_24H_X3	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:K04	CPC015_MCF7_24H_X4	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:K04	CPC015_MCF7_24H_X5	K04	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:K04	CPC015_MCF7_6H_X4	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:K04	CPC015_MCF7_6H_X5	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:L11	CPC011_MCF7_24H_X4	L11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:L11	CPC011_MCF7_24H_X5	L11	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:L11	CPC011_MCF7_6H_X1	L11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:L11	CPC011_MCF7_6H_X3	L11	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:K04	CPC015_MCF7_6H_X1	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:K04	CPC015_MCF7_6H_X2	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:K04	CPC015_MCF7_6H_X3	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:K04	CPC015_MCF7_6H_X3	K04	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_MCF7_24H_X1_B4_DUO52HI53LO:E19	CPC005_MCF7_24H_X1	E19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_MCF7_24H_X2_B4_DUO52HI53LO:E19	CPC005_MCF7_24H_X2	E19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_MCF7_24H_X3_B4_DUO52HI53LO:E19	CPC005_MCF7_24H_X3	E19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_MCF7_24H_X4_B5_DUO52HI53LO:E19	CPC005_MCF7_24H_X4	E19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_MCF7_6H_X1_B3_DUO52HI53LO:E19	CPC005_MCF7_6H_X1	E19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_MCF7_6H_X2_B3_DUO52HI53LO:E19	CPC005_MCF7_6H_X2	E19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_MCF7_6H_X2_F1B3_DUO52HI53LO:E19	CPC005_MCF7_6H_X2	E19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_MCF7_6H_X3_B3_DUO52HI53LO:E19	CPC005_MCF7_6H_X3	E19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_MCF7_6H_X5_F1B5_DUO52HI53LO:E19	CPC005_MCF7_6H_X5	E19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_MCF7_24H_X5_F2B4_DUO52HI53LO:E19	CPC005_MCF7_24H_X5	E19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:D07	CPD001_MCF7_24H_X1	D07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:D07	CPD001_MCF7_24H_X2	D07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:D07	CPD001_MCF7_24H_X3	D07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:D07	CPD001_MCF7_6H_X1.A2	D07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:D07	CPD001_MCF7_6H_X1	D07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:D07	CPD001_MCF7_6H_X2	D07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:D07	CPD001_MCF7_6H_X3	D07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:I06	CPC004_MCF7_6H_X1	I06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:I06	CPC004_MCF7_6H_X2	I06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:I06	CPC004_MCF7_6H_X4	I06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:I06	CPC004_MCF7_6H_X5	I06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:N14	CPC016_MCF7_24H_X2	N14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:N14	CPC016_MCF7_24H_X3	N14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:N14	CPC016_MCF7_24H_X4	N14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:N14	CPC016_MCF7_24H_X5	N14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:N14	CPC016_MCF7_6H_X5	N14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPD001_MCF7_24H_X1_B6_DUO52HI53LO:L06	CPD001_MCF7_24H_X1	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPD001_MCF7_24H_X2_B6_DUO52HI53LO:L06	CPD001_MCF7_24H_X2	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPD001_MCF7_24H_X3_B6_DUO52HI53LO:L06	CPD001_MCF7_24H_X3	L06	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPD001_MCF7_6H_X1.A2_B6_DUO52HI53LO:L06	CPD001_MCF7_6H_X1.A2	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPD001_MCF7_6H_X1_B6_DUO52HI53LO:L06	CPD001_MCF7_6H_X1	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPD001_MCF7_6H_X2_B6_DUO52HI53LO:L06	CPD001_MCF7_6H_X2	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPD001_MCF7_6H_X3_B6_DUO52HI53LO:L06	CPD001_MCF7_6H_X3	L06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:K13	CPC011_MCF7_24H_X4	K13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:K13	CPC011_MCF7_24H_X5	K13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:K13	CPC011_MCF7_6H_X1	K13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:K13	CPC011_MCF7_6H_X3	K13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:N14	CPC016_MCF7_6H_X2	N14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:I02	CPC004_MCF7_6H_X1	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:I02	CPC004_MCF7_6H_X2	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:I02	CPC004_MCF7_6H_X4	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:I02	CPC004_MCF7_6H_X5	I02	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_MCF7_24H_X2_B4_DUO52HI53LO:N08	CPC016_MCF7_24H_X2	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_MCF7_24H_X3_B4_DUO52HI53LO:N08	CPC016_MCF7_24H_X3	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_MCF7_24H_X4_B5_DUO52HI53LO:N08	CPC016_MCF7_24H_X4	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_MCF7_24H_X5_B5_DUO52HI53LO:N08	CPC016_MCF7_24H_X5	N08	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_MCF7_6H_X5_F2B5_DUO52HI53LO:N08	CPC016_MCF7_6H_X5	N08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPD003_MCF7_24H_X1_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X1	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPD003_MCF7_24H_X2.L2_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X2.L2	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPD003_MCF7_24H_X3.L2_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X3.L2	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPD003_MCF7_24H_X3_B6_DUO52HI53LO:A13	CPD003_MCF7_24H_X3	A13	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPD003_MCF7_6H_X1_B6_DUO52HI53LO:A13	CPD003_MCF7_6H_X1	A13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPD003_MCF7_6H_X2_B6_DUO52HI53LO:A13	CPD003_MCF7_6H_X2	A13	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_MCF7_6H_X1_B4_DUO52HI53LO:N08	CPC016_MCF7_6H_X1	N08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_MCF7_6H_X2_B4_DUO52HI53LO:N08	CPC016_MCF7_6H_X2	N08	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:J06	CPC004_MCF7_6H_X1	J06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:J06	CPC004_MCF7_6H_X2	J06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:J06	CPC004_MCF7_6H_X4	J06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:J06	CPC004_MCF7_6H_X5	J06	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:J19	CPC011_MCF7_24H_X4	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:J19	CPC011_MCF7_24H_X5	J19	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:L07	CPC015_MCF7_24H_X1	L07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:L07	CPC015_MCF7_24H_X2	L07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:L07	CPC015_MCF7_24H_X3	L07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:L07	CPC015_MCF7_24H_X4	L07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:L07	CPC015_MCF7_24H_X5	L07	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:L07	CPC015_MCF7_6H_X4	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:L07	CPC015_MCF7_6H_X5	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:J19	CPC011_MCF7_6H_X1	J19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:J19	CPC011_MCF7_6H_X3	J19	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:L07	CPC015_MCF7_6H_X1	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:L07	CPC015_MCF7_6H_X2	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:L07	CPC015_MCF7_6H_X3	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:L07	CPC015_MCF7_6H_X3	L07	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:L12	CPD002_MCF7_24H_X1	L12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:L12	CPD002_MCF7_24H_X2	L12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:L12	CPD002_MCF7_24H_X3	L12	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:L12	CPD002_MCF7_6H_X1	L12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:L12	CPD002_MCF7_6H_X2	L12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:L12	CPD002_MCF7_6H_X3	L12	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:H14	CPC011_MCF7_24H_X4	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:H14	CPC011_MCF7_24H_X5	H14	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:H14	CPC011_MCF7_6H_X1	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:H14	CPC011_MCF7_6H_X3	H14	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_MCF7_6H_X1_B3_DUO52HI53LO:J03	CPC004_MCF7_6H_X1	J03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_MCF7_6H_X2_B3_DUO52HI53LO:J03	CPC004_MCF7_6H_X2	J03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_MCF7_6H_X4_F1B5_DUO52HI53LO:J03	CPC004_MCF7_6H_X4	J03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_MCF7_6H_X5_F1B5_DUO52HI53LO:J03	CPC004_MCF7_6H_X5	J03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_MCF7_24H_X1_B5_DUO52HI53LO:G22	CPC010_MCF7_24H_X1	G22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_MCF7_24H_X2_B5_DUO52HI53LO:G22	CPC010_MCF7_24H_X2	G22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_MCF7_24H_X3_B5_DUO52HI53LO:G22	CPC010_MCF7_24H_X3	G22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_MCF7_24H_X5_B5_DUO52HI53LO:G22	CPC010_MCF7_24H_X5	G22	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_MCF7_6H_X2_B3_DUO52HI53LO:G22	CPC010_MCF7_6H_X2	G22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_MCF7_6H_X3_B3_DUO52HI53LO:G22	CPC010_MCF7_6H_X3	G22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_MCF7_6H_X4_F1B5_DUO52HI53LO:G22	CPC010_MCF7_6H_X4	G22	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_MCF7_24H_X1_B4_DUO52HI53LO:K18	CPC015_MCF7_24H_X1	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_MCF7_24H_X2_B4_DUO52HI53LO:K18	CPC015_MCF7_24H_X2	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_MCF7_24H_X3_B4_DUO52HI53LO:K18	CPC015_MCF7_24H_X3	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_MCF7_24H_X4_B5_DUO52HI53LO:K18	CPC015_MCF7_24H_X4	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_MCF7_24H_X5_F1B5_DUO52HI53LO:K18	CPC015_MCF7_24H_X5	K18	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_MCF7_6H_X4_F2B4_DUO52HI53LO:K18	CPC015_MCF7_6H_X4	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_MCF7_6H_X5_F1B5_DUO52HI53LO:K18	CPC015_MCF7_6H_X5	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_MCF7_24H_X4_B5_DUO52HI53LO:I05	CPC011_MCF7_24H_X4	I05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_MCF7_24H_X5_B5_DUO52HI53LO:I05	CPC011_MCF7_24H_X5	I05	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_MCF7_6H_X1_B3_DUO52HI53LO:I05	CPC011_MCF7_6H_X1	I05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_MCF7_6H_X3_B3_DUO52HI53LO:I05	CPC011_MCF7_6H_X3	I05	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_MCF7_6H_X1_B4_DUO52HI53LO:K18	CPC015_MCF7_6H_X1	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_MCF7_6H_X2_B4_DUO52HI53LO:K18	CPC015_MCF7_6H_X2	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_MCF7_6H_X3_B3_DUO52HI53LO:K18	CPC015_MCF7_6H_X3	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_MCF7_6H_X3_B4_DUO52HI53LO:K18	CPC015_MCF7_6H_X3	K18	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_MCF7_24H_X1_B4_DUO52HI53LO:F21	CPC017_MCF7_24H_X1	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_MCF7_24H_X2_B4_DUO52HI53LO:F21	CPC017_MCF7_24H_X2	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_MCF7_24H_X3_B4_DUO52HI53LO:F21	CPC017_MCF7_24H_X3	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_MCF7_24H_X4_B5_DUO52HI53LO:F21	CPC017_MCF7_24H_X4	F21	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_MCF7_6H_X5_F2B4_DUO52HI53LO:F21	CPC017_MCF7_6H_X5	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_MCF7_6H_X1_B4_DUO52HI53LO:F21	CPC017_MCF7_6H_X1	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_MCF7_6H_X2_B4_DUO52HI53LO:F21	CPC017_MCF7_6H_X2	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_MCF7_6H_X3_B4_DUO52HI53LO:F21	CPC017_MCF7_6H_X3	F21	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_MCF7_24H_X1_B6_DUO52HI53LO:F03	CPD002_MCF7_24H_X1	F03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_MCF7_24H_X2_B6_DUO52HI53LO:F03	CPD002_MCF7_24H_X2	F03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_MCF7_24H_X3_B6_DUO52HI53LO:F03	CPD002_MCF7_24H_X3	F03	trt_cp	10.0	um	24	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_MCF7_6H_X1_B6_DUO52HI53LO:F03	CPD002_MCF7_6H_X1	F03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_MCF7_6H_X2_B6_DUO52HI53LO:F03	CPD002_MCF7_6H_X2	F03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_MCF7_6H_X3_B6_DUO52HI53LO:F03	CPD002_MCF7_6H_X3	F03	trt_cp	10.0	um	6	h	MCF7	cell line	MCF7	-666	-666	tumor	breast	adenocarcinoma	adherent	HTB-22	ATCC	69	F	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_PC3_24H_X1_B3_DUO52HI53LO:J08	CPC004_PC3_24H_X1	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:J08	CPC004_PC3_24H_X2	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:J08	CPC004_PC3_24H_X3	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:J08	CPC004_PC3_24H_X4	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:J08	CPC004_PC3_24H_X5	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:J08	CPC004_PC3_6H_X5	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPD001_PC3_24H_X1_B6_DUO52HI53LO:B20	CPD001_PC3_24H_X1	B20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPD001_PC3_24H_X2_B6_DUO52HI53LO:B20	CPD001_PC3_24H_X2	B20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPD001_PC3_24H_X3_B6_DUO52HI53LO:B20	CPD001_PC3_24H_X3	B20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:J08	CPC004_PC3_6H_X1	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:J08	CPC004_PC3_6H_X2	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_PC3_6H_X3_B3_DUO52HI53LO:J08	CPC004_PC3_6H_X3	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:J08	CPC004_PC3_6H_X4	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_24H_X1_B3_DUO52HI53LO:G10	CPC011_PC3_24H_X1	G10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_24H_X2_B3_DUO52HI53LO:G10	CPC011_PC3_24H_X2	G10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_24H_X4_B5_DUO52HI53LO:G10	CPC011_PC3_24H_X4	G10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_24H_X5_B5_DUO52HI53LO:G10	CPC011_PC3_24H_X5	G10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_24H_X1_B3_DUO52HI53LO:B03	CPC011_PC3_24H_X1	B03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_24H_X2_B3_DUO52HI53LO:B03	CPC011_PC3_24H_X2	B03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_24H_X4_B5_DUO52HI53LO:B03	CPC011_PC3_24H_X4	B03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_24H_X5_B5_DUO52HI53LO:B03	CPC011_PC3_24H_X5	B03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_6H_X1_B3_DUO52HI53LO:G10	CPC011_PC3_6H_X1	G10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_6H_X3_B3_DUO52HI53LO:G10	CPC011_PC3_6H_X3	G10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_6H_X4_B5_DUO52HI53LO:G10	CPC011_PC3_6H_X4	G10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_6H_X5_B5_DUO52HI53LO:G10	CPC011_PC3_6H_X5	G10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_6H_X1_B3_DUO52HI53LO:B03	CPC011_PC3_6H_X1	B03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_6H_X3_B3_DUO52HI53LO:B03	CPC011_PC3_6H_X3	B03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_6H_X4_B5_DUO52HI53LO:B03	CPC011_PC3_6H_X4	B03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_PC3_6H_X5_B5_DUO52HI53LO:B03	CPC011_PC3_6H_X5	B03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_PC3_24H_X1_B3_DUO52HI53LO:I02	CPC003_PC3_24H_X1	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_PC3_24H_X2_B3_DUO52HI53LO:I02	CPC003_PC3_24H_X2	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_PC3_24H_X3_B3_DUO52HI53LO:I02	CPC003_PC3_24H_X3	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_PC3_24H_X5_B5_DUO52HI53LO:I02	CPC003_PC3_24H_X5	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_PC3_6H_X1_B3_DUO52HI53LO:I02	CPC003_PC3_6H_X1	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_PC3_6H_X3_B3_DUO52HI53LO:I02	CPC003_PC3_6H_X3	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_PC3_6H_X4_F2B4_DUO52HI53LO:I02	CPC003_PC3_6H_X4	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_PC3_6H_X5_F1B5_DUO52HI53LO:I02	CPC003_PC3_6H_X5	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPD001_PC3_24H_X1_B6_DUO52HI53LO:O09	CPD001_PC3_24H_X1	O09	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPD001_PC3_24H_X2_B6_DUO52HI53LO:O09	CPD001_PC3_24H_X2	O09	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPD001_PC3_24H_X3_B6_DUO52HI53LO:O09	CPD001_PC3_24H_X3	O09	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_PC3_24H_X4_F1B5_DUO52HI53LO:I02	CPC003_PC3_24H_X4	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_PC3_24H_X1_B3_DUO52HI53LO:E01	CPC004_PC3_24H_X1	E01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:E01	CPC004_PC3_24H_X2	E01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:E01	CPC004_PC3_24H_X3	E01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:E01	CPC004_PC3_24H_X4	E01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:E01	CPC004_PC3_24H_X5	E01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:E01	CPC004_PC3_6H_X5	E01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_24H_X1_B5_DUO52HI53LO:F24	CPC020_PC3_24H_X1	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_24H_X1_B5_DUO52HI53LO:H08	CPC020_PC3_24H_X1	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_24H_X2_B5_DUO52HI53LO:F24	CPC020_PC3_24H_X2	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_24H_X2_B5_DUO52HI53LO:H08	CPC020_PC3_24H_X2	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_24H_X3_B5_DUO52HI53LO:F24	CPC020_PC3_24H_X3	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_24H_X3_B5_DUO52HI53LO:H08	CPC020_PC3_24H_X3	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_24H_X4_B5_DUO52HI53LO:F24	CPC020_PC3_24H_X4	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_24H_X4_B5_DUO52HI53LO:H08	CPC020_PC3_24H_X4	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_24H_X5_B5_DUO52HI53LO:F24	CPC020_PC3_24H_X5	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_24H_X5_B5_DUO52HI53LO:H08	CPC020_PC3_24H_X5	H08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:F24	CPC020_PC3_6H_X4	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:H08	CPC020_PC3_6H_X4	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:E01	CPC004_PC3_6H_X1	E01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:E01	CPC004_PC3_6H_X2	E01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_PC3_6H_X3_B3_DUO52HI53LO:E01	CPC004_PC3_6H_X3	E01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:E01	CPC004_PC3_6H_X4	E01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_6H_X1_B4_DUO52HI53LO:F24	CPC020_PC3_6H_X1	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_6H_X1_B4_DUO52HI53LO:H08	CPC020_PC3_6H_X1	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_6H_X2_B4_DUO52HI53LO:F24	CPC020_PC3_6H_X2	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_6H_X2_B4_DUO52HI53LO:H08	CPC020_PC3_6H_X2	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_6H_X3_B4_DUO52HI53LO:F24	CPC020_PC3_6H_X3	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_6H_X3_B4_DUO52HI53LO:H08	CPC020_PC3_6H_X3	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_PC3_6H_X5_B5_DUO52HI53LO:H08	CPC020_PC3_6H_X5	H08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_PC3_24H_X1_B4_DUO52HI53LO:F24	CPC005_PC3_24H_X1	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_PC3_24H_X2_B4_DUO52HI53LO:F24	CPC005_PC3_24H_X2	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_PC3_24H_X3_B4_DUO52HI53LO:F24	CPC005_PC3_24H_X3	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_PC3_24H_X4_B5_DUO52HI53LO:F24	CPC005_PC3_24H_X4	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_PC3_24H_X5_B5_DUO52HI53LO:F24	CPC005_PC3_24H_X5	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_PC3_6H_X1_B3_DUO52HI53LO:F24	CPC005_PC3_6H_X1	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_PC3_6H_X2_B3_DUO52HI53LO:F24	CPC005_PC3_6H_X2	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_PC3_6H_X3_B3_DUO52HI53LO:F24	CPC005_PC3_6H_X3	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:F24	CPC005_PC3_6H_X5	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_24H_X1_F1B4_DUO52HI53LO:B24	CPC009_PC3_24H_X1	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_24H_X2_F1B4_DUO52HI53LO:B24	CPC009_PC3_24H_X2	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_24H_X3_F1B4_DUO52HI53LO:B24	CPC009_PC3_24H_X3	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_24H_X4_B5_DUO52HI53LO:B24	CPC009_PC3_24H_X4	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_24H_X5_F1B5_DUO52HI53LO:B24	CPC009_PC3_24H_X5	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X3.A2_B4_DUO52HI53LO:B24	CPC009_PC3_6H_X3.A2	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X3_F1B3_DUO52HI53LO:B24	CPC009_PC3_6H_X3	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X4_F1B5_DUO52HI53LO:B24	CPC009_PC3_6H_X4	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X5_F1B5_DUO52HI53LO:B24	CPC009_PC3_6H_X5	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_PC3_24H_X1_B6_DUO52HI53LO:L06	CPD002_PC3_24H_X1	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_PC3_24H_X2_B6_DUO52HI53LO:L06	CPD002_PC3_24H_X2	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_PC3_24H_X3_B6_DUO52HI53LO:L06	CPD002_PC3_24H_X3	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_PC3_6H_X1_B6_DUO52HI53LO:L06	CPD002_PC3_6H_X1	L06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_PC3_6H_X2_B6_DUO52HI53LO:L06	CPD002_PC3_6H_X2	L06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPD002_PC3_6H_X3_B6_DUO52HI53LO:L06	CPD002_PC3_6H_X3	L06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X1_B3_DUO52HI53LO:B24	CPC009_PC3_6H_X1	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X2_B3_DUO52HI53LO:B24	CPC009_PC3_6H_X2	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X3_B3_DUO52HI53LO:B24	CPC009_PC3_6H_X3	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_PC3_24H_X1_B3_DUO52HI53LO:P10	CPC011_PC3_24H_X1	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_PC3_24H_X2_B3_DUO52HI53LO:P10	CPC011_PC3_24H_X2	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_PC3_24H_X4_B5_DUO52HI53LO:P10	CPC011_PC3_24H_X4	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_PC3_24H_X5_B5_DUO52HI53LO:P10	CPC011_PC3_24H_X5	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_PC3_6H_X1_B3_DUO52HI53LO:P10	CPC011_PC3_6H_X1	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_PC3_6H_X3_B3_DUO52HI53LO:P10	CPC011_PC3_6H_X3	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_PC3_6H_X4_B5_DUO52HI53LO:P10	CPC011_PC3_6H_X4	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_PC3_6H_X5_B5_DUO52HI53LO:P10	CPC011_PC3_6H_X5	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_PC3_24H_X1_B4_DUO52HI53LO:F24	CPC005_PC3_24H_X1	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_PC3_24H_X2_B4_DUO52HI53LO:F24	CPC005_PC3_24H_X2	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_PC3_24H_X3_B4_DUO52HI53LO:F24	CPC005_PC3_24H_X3	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_PC3_24H_X4_B5_DUO52HI53LO:F24	CPC005_PC3_24H_X4	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_PC3_24H_X5_B5_DUO52HI53LO:F24	CPC005_PC3_24H_X5	F24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_PC3_6H_X1_B3_DUO52HI53LO:F24	CPC005_PC3_6H_X1	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_PC3_6H_X2_B3_DUO52HI53LO:F24	CPC005_PC3_6H_X2	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_PC3_6H_X3_B3_DUO52HI53LO:F24	CPC005_PC3_6H_X3	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:F24	CPC005_PC3_6H_X5	F24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_24H_X1_F1B4_DUO52HI53LO:B24	CPC009_PC3_24H_X1	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_24H_X2_F1B4_DUO52HI53LO:B24	CPC009_PC3_24H_X2	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_24H_X3_F1B4_DUO52HI53LO:B24	CPC009_PC3_24H_X3	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_24H_X4_B5_DUO52HI53LO:B24	CPC009_PC3_24H_X4	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_24H_X5_F1B5_DUO52HI53LO:B24	CPC009_PC3_24H_X5	B24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X3.A2_B4_DUO52HI53LO:B24	CPC009_PC3_6H_X3.A2	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X3_F1B3_DUO52HI53LO:B24	CPC009_PC3_6H_X3	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X4_F1B5_DUO52HI53LO:B24	CPC009_PC3_6H_X4	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X5_F1B5_DUO52HI53LO:B24	CPC009_PC3_6H_X5	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_PC3_24H_X1_B6_DUO52HI53LO:L06	CPD002_PC3_24H_X1	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_PC3_24H_X2_B6_DUO52HI53LO:L06	CPD002_PC3_24H_X2	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_PC3_24H_X3_B6_DUO52HI53LO:L06	CPD002_PC3_24H_X3	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_PC3_6H_X1_B6_DUO52HI53LO:L06	CPD002_PC3_6H_X1	L06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_PC3_6H_X2_B6_DUO52HI53LO:L06	CPD002_PC3_6H_X2	L06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPD002_PC3_6H_X3_B6_DUO52HI53LO:L06	CPD002_PC3_6H_X3	L06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X1_B3_DUO52HI53LO:B24	CPC009_PC3_6H_X1	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X2_B3_DUO52HI53LO:B24	CPC009_PC3_6H_X2	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_PC3_6H_X3_B3_DUO52HI53LO:B24	CPC009_PC3_6H_X3	B24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_PC3_24H_X1_B3_DUO52HI53LO:P10	CPC011_PC3_24H_X1	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_PC3_24H_X2_B3_DUO52HI53LO:P10	CPC011_PC3_24H_X2	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_PC3_24H_X4_B5_DUO52HI53LO:P10	CPC011_PC3_24H_X4	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_PC3_24H_X5_B5_DUO52HI53LO:P10	CPC011_PC3_24H_X5	P10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_PC3_6H_X1_B3_DUO52HI53LO:P10	CPC011_PC3_6H_X1	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_PC3_6H_X3_B3_DUO52HI53LO:P10	CPC011_PC3_6H_X3	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_PC3_6H_X4_B5_DUO52HI53LO:P10	CPC011_PC3_6H_X4	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_PC3_6H_X5_B5_DUO52HI53LO:P10	CPC011_PC3_6H_X5	P10	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_PC3_24H_X1_B3_DUO52HI53LO:G20	CPC002_PC3_24H_X1	G20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_PC3_24H_X2_B3_DUO52HI53LO:G20	CPC002_PC3_24H_X2	G20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_PC3_24H_X3_B3_DUO52HI53LO:G20	CPC002_PC3_24H_X3	G20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_PC3_24H_X4_B4_DUO52HI53LO:G20	CPC002_PC3_24H_X4	G20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_PC3_6H_X1_B3_DUO52HI53LO:G20	CPC002_PC3_6H_X1	G20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_PC3_6H_X2_B3_DUO52HI53LO:G20	CPC002_PC3_6H_X2	G20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_PC3_6H_X3_B3_DUO52HI53LO:G20	CPC002_PC3_6H_X3	G20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_PC3_6H_X4_B4_DUO52HI53LO:G20	CPC002_PC3_6H_X4	G20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:G20	CPC002_PC3_6H_X5	G20	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_PC3_24H_X1_B5_DUO52HI53LO:P19	CPC020_PC3_24H_X1	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_PC3_24H_X2_B5_DUO52HI53LO:P19	CPC020_PC3_24H_X2	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_PC3_24H_X3_B5_DUO52HI53LO:P19	CPC020_PC3_24H_X3	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_PC3_24H_X4_B5_DUO52HI53LO:P19	CPC020_PC3_24H_X4	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_PC3_24H_X5_B5_DUO52HI53LO:P19	CPC020_PC3_24H_X5	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:P19	CPC020_PC3_6H_X4	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPD001_PC3_24H_X1_B6_DUO52HI53LO:F20	CPD001_PC3_24H_X1	F20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPD001_PC3_24H_X2_B6_DUO52HI53LO:F20	CPD001_PC3_24H_X2	F20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPD001_PC3_24H_X3_B6_DUO52HI53LO:F20	CPD001_PC3_24H_X3	F20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:G20	CPC002_PC3_24H_X5	G20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_PC3_6H_X1_B4_DUO52HI53LO:P19	CPC020_PC3_6H_X1	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_PC3_6H_X2_B4_DUO52HI53LO:P19	CPC020_PC3_6H_X2	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_PC3_6H_X3_B4_DUO52HI53LO:P19	CPC020_PC3_6H_X3	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_PC3_6H_X5_B5_DUO52HI53LO:P19	CPC020_PC3_6H_X5	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_PC3_24H_X1_B3_DUO52HI53LO:E11	CPC004_PC3_24H_X1	E11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:E11	CPC004_PC3_24H_X2	E11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:E11	CPC004_PC3_24H_X3	E11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:E11	CPC004_PC3_24H_X4	E11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:E11	CPC004_PC3_24H_X5	E11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:E11	CPC004_PC3_6H_X1	E11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:E11	CPC004_PC3_6H_X2	E11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_PC3_6H_X3_B3_DUO52HI53LO:E11	CPC004_PC3_6H_X3	E11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:E11	CPC004_PC3_6H_X4	E11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:E11	CPC004_PC3_6H_X5	E11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_PC3_24H_X1_B5_DUO52HI53LO:F21	CPC020_PC3_24H_X1	F21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_PC3_24H_X2_B5_DUO52HI53LO:F21	CPC020_PC3_24H_X2	F21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_PC3_24H_X3_B5_DUO52HI53LO:F21	CPC020_PC3_24H_X3	F21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_PC3_24H_X4_B5_DUO52HI53LO:F21	CPC020_PC3_24H_X4	F21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_PC3_24H_X5_B5_DUO52HI53LO:F21	CPC020_PC3_24H_X5	F21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:F21	CPC020_PC3_6H_X4	F21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPD001_PC3_24H_X1_B6_DUO52HI53LO:E02	CPD001_PC3_24H_X1	E02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPD001_PC3_24H_X2_B6_DUO52HI53LO:E02	CPD001_PC3_24H_X2	E02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPD001_PC3_24H_X3_B6_DUO52HI53LO:E02	CPD001_PC3_24H_X3	E02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_PC3_6H_X1_B4_DUO52HI53LO:F21	CPC020_PC3_6H_X1	F21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_PC3_6H_X2_B4_DUO52HI53LO:F21	CPC020_PC3_6H_X2	F21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_PC3_6H_X3_B4_DUO52HI53LO:F21	CPC020_PC3_6H_X3	F21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_PC3_24H_X1_B3_DUO52HI53LO:K17	CPC004_PC3_24H_X1	K17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:K17	CPC004_PC3_24H_X2	K17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:K17	CPC004_PC3_24H_X3	K17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:K17	CPC004_PC3_24H_X4	K17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:K17	CPC004_PC3_24H_X5	K17	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:K17	CPC004_PC3_6H_X1	K17	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:K17	CPC004_PC3_6H_X2	K17	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:K17	CPC004_PC3_6H_X4	K17	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:K17	CPC004_PC3_6H_X5	K17	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPD001_PC3_24H_X1_B6_DUO52HI53LO:F08	CPD001_PC3_24H_X1	F08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPD001_PC3_24H_X2_B6_DUO52HI53LO:F08	CPD001_PC3_24H_X2	F08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPD001_PC3_24H_X3_B6_DUO52HI53LO:F08	CPD001_PC3_24H_X3	F08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_PC3_24H_X1_B3_DUO52HI53LO:G23	CPC004_PC3_24H_X1	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:G23	CPC004_PC3_24H_X2	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:G23	CPC004_PC3_24H_X3	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:G23	CPC004_PC3_24H_X4	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:G23	CPC004_PC3_24H_X5	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:G23	CPC004_PC3_6H_X1	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:G23	CPC004_PC3_6H_X2	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_PC3_6H_X3_B3_DUO52HI53LO:G23	CPC004_PC3_6H_X3	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:G23	CPC004_PC3_6H_X4	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:G23	CPC004_PC3_6H_X5	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_PC3_24H_X1_B3_DUO52HI53LO:G15	CPC011_PC3_24H_X1	G15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_PC3_24H_X2_B3_DUO52HI53LO:G15	CPC011_PC3_24H_X2	G15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_PC3_24H_X4_B5_DUO52HI53LO:G15	CPC011_PC3_24H_X4	G15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_PC3_24H_X5_B5_DUO52HI53LO:G15	CPC011_PC3_24H_X5	G15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_PC3_6H_X1_B3_DUO52HI53LO:G15	CPC011_PC3_6H_X1	G15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_PC3_6H_X3_B3_DUO52HI53LO:G15	CPC011_PC3_6H_X3	G15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_PC3_6H_X4_B5_DUO52HI53LO:G15	CPC011_PC3_6H_X4	G15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_PC3_6H_X5_B5_DUO52HI53LO:G15	CPC011_PC3_6H_X5	G15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_PC3_24H_X1_B3_DUO52HI53LO:F11	CPC002_PC3_24H_X1	F11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_PC3_24H_X2_B3_DUO52HI53LO:F11	CPC002_PC3_24H_X2	F11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_PC3_24H_X3_B3_DUO52HI53LO:F11	CPC002_PC3_24H_X3	F11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_PC3_24H_X4_B4_DUO52HI53LO:F11	CPC002_PC3_24H_X4	F11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:F11	CPC002_PC3_24H_X5	F11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_PC3_6H_X1_B3_DUO52HI53LO:F11	CPC002_PC3_6H_X1	F11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_PC3_6H_X2_B3_DUO52HI53LO:F11	CPC002_PC3_6H_X2	F11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_PC3_6H_X3_B3_DUO52HI53LO:F11	CPC002_PC3_6H_X3	F11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_PC3_6H_X4_B4_DUO52HI53LO:F11	CPC002_PC3_6H_X4	F11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:F11	CPC002_PC3_6H_X5	F11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:O02	CPC020_PC3_6H_X4	O02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_PC3_24H_X1_B5_DUO52HI53LO:O02	CPC020_PC3_24H_X1	O02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_PC3_24H_X2_B5_DUO52HI53LO:O02	CPC020_PC3_24H_X2	O02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_PC3_24H_X3_B5_DUO52HI53LO:O02	CPC020_PC3_24H_X3	O02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_PC3_24H_X4_B5_DUO52HI53LO:O02	CPC020_PC3_24H_X4	O02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_PC3_24H_X5_B5_DUO52HI53LO:O02	CPC020_PC3_24H_X5	O02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_PC3_6H_X1_B4_DUO52HI53LO:O02	CPC020_PC3_6H_X1	O02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_PC3_6H_X2_B4_DUO52HI53LO:O02	CPC020_PC3_6H_X2	O02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_PC3_6H_X3_B4_DUO52HI53LO:O02	CPC020_PC3_6H_X3	O02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_PC3_6H_X5_B5_DUO52HI53LO:O02	CPC020_PC3_6H_X5	O02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_PC3_24H_X1_B4_DUO52HI53LO:P19	CPC005_PC3_24H_X1	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_PC3_24H_X2_B4_DUO52HI53LO:P19	CPC005_PC3_24H_X2	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_PC3_24H_X3_B4_DUO52HI53LO:P19	CPC005_PC3_24H_X3	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_PC3_24H_X4_B5_DUO52HI53LO:P19	CPC005_PC3_24H_X4	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_PC3_24H_X5_B5_DUO52HI53LO:P19	CPC005_PC3_24H_X5	P19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_PC3_6H_X1_B3_DUO52HI53LO:P19	CPC005_PC3_6H_X1	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_PC3_6H_X2_B3_DUO52HI53LO:P19	CPC005_PC3_6H_X2	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_PC3_6H_X3_B3_DUO52HI53LO:P19	CPC005_PC3_6H_X3	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:P19	CPC005_PC3_6H_X5	P19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_PC3_24H_X1_F1B4_DUO52HI53LO:J24	CPC009_PC3_24H_X1	J24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_PC3_24H_X2_F1B4_DUO52HI53LO:J24	CPC009_PC3_24H_X2	J24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_PC3_24H_X3_F1B4_DUO52HI53LO:J24	CPC009_PC3_24H_X3	J24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_PC3_24H_X5_F1B5_DUO52HI53LO:J24	CPC009_PC3_24H_X5	J24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_PC3_6H_X3.A2_B4_DUO52HI53LO:J24	CPC009_PC3_6H_X3.A2	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_PC3_6H_X3_F1B3_DUO52HI53LO:J24	CPC009_PC3_6H_X3	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_PC3_6H_X5_F1B5_DUO52HI53LO:J24	CPC009_PC3_6H_X5	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_PC3_24H_X1_B6_DUO52HI53LO:G04	CPD002_PC3_24H_X1	G04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_PC3_24H_X2_B6_DUO52HI53LO:G04	CPD002_PC3_24H_X2	G04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_PC3_24H_X3_B6_DUO52HI53LO:G04	CPD002_PC3_24H_X3	G04	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_PC3_6H_X1_B6_DUO52HI53LO:G04	CPD002_PC3_6H_X1	G04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_PC3_6H_X2_B6_DUO52HI53LO:G04	CPD002_PC3_6H_X2	G04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPD002_PC3_6H_X3_B6_DUO52HI53LO:G04	CPD002_PC3_6H_X3	G04	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_PC3_24H_X4_B5_DUO52HI53LO:J24	CPC009_PC3_24H_X4	J24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_PC3_6H_X1_B3_DUO52HI53LO:J24	CPC009_PC3_6H_X1	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_PC3_6H_X2_B3_DUO52HI53LO:J24	CPC009_PC3_6H_X2	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_PC3_6H_X3_B3_DUO52HI53LO:J24	CPC009_PC3_6H_X3	J24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_PC3_24H_X1_B3_DUO52HI53LO:E15	CPC011_PC3_24H_X1	E15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_PC3_24H_X2_B3_DUO52HI53LO:E15	CPC011_PC3_24H_X2	E15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_PC3_24H_X4_B5_DUO52HI53LO:E15	CPC011_PC3_24H_X4	E15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_PC3_24H_X5_B5_DUO52HI53LO:E15	CPC011_PC3_24H_X5	E15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_PC3_6H_X1_B3_DUO52HI53LO:E15	CPC011_PC3_6H_X1	E15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_PC3_6H_X3_B3_DUO52HI53LO:E15	CPC011_PC3_6H_X3	E15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_PC3_6H_X4_B5_DUO52HI53LO:E15	CPC011_PC3_6H_X4	E15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_PC3_6H_X5_B5_DUO52HI53LO:E15	CPC011_PC3_6H_X5	E15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_PC3_24H_X1_B3_DUO52HI53LO:P05	CPC003_PC3_24H_X1	P05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_PC3_24H_X2_B3_DUO52HI53LO:P05	CPC003_PC3_24H_X2	P05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_PC3_24H_X3_B3_DUO52HI53LO:P05	CPC003_PC3_24H_X3	P05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_PC3_24H_X4_F1B5_DUO52HI53LO:P05	CPC003_PC3_24H_X4	P05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_PC3_24H_X5_B5_DUO52HI53LO:P05	CPC003_PC3_24H_X5	P05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_PC3_6H_X1_B3_DUO52HI53LO:P05	CPC003_PC3_6H_X1	P05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_PC3_6H_X3_B3_DUO52HI53LO:P05	CPC003_PC3_6H_X3	P05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_PC3_6H_X4_F2B4_DUO52HI53LO:P05	CPC003_PC3_6H_X4	P05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_PC3_6H_X5_F1B5_DUO52HI53LO:P05	CPC003_PC3_6H_X5	P05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:H11	CPD003_PC3_24H_X1.L2	H11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:H11	CPD003_PC3_24H_X2.L2	H11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPD003_PC3_6H_X1_B6_DUO52HI53LO:H11	CPD003_PC3_6H_X1	H11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:H11	CPD003_PC3_6H_X3.A2	H11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPD003_PC3_6H_X3_B6_DUO52HI53LO:H11	CPD003_PC3_6H_X3	H11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_PC3_24H_X1_F1B4_DUO52HI53LO:K23	CPC009_PC3_24H_X1	K23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_PC3_24H_X2_F1B4_DUO52HI53LO:K23	CPC009_PC3_24H_X2	K23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_PC3_24H_X3_F1B4_DUO52HI53LO:K23	CPC009_PC3_24H_X3	K23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_PC3_24H_X4_B5_DUO52HI53LO:K23	CPC009_PC3_24H_X4	K23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_PC3_24H_X5_F1B5_DUO52HI53LO:K23	CPC009_PC3_24H_X5	K23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_PC3_6H_X3.A2_B4_DUO52HI53LO:K23	CPC009_PC3_6H_X3.A2	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_PC3_6H_X3_F1B3_DUO52HI53LO:K23	CPC009_PC3_6H_X3	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_PC3_6H_X5_F1B5_DUO52HI53LO:K23	CPC009_PC3_6H_X5	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPD001_PC3_24H_X1_B6_DUO52HI53LO:B21	CPD001_PC3_24H_X1	B21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPD001_PC3_24H_X2_B6_DUO52HI53LO:B21	CPD001_PC3_24H_X2	B21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPD001_PC3_24H_X3_B6_DUO52HI53LO:B21	CPD001_PC3_24H_X3	B21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_PC3_6H_X1_B3_DUO52HI53LO:K23	CPC009_PC3_6H_X1	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_PC3_6H_X2_B3_DUO52HI53LO:K23	CPC009_PC3_6H_X2	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_PC3_6H_X3_B3_DUO52HI53LO:K23	CPC009_PC3_6H_X3	K23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_PC3_24H_X1_B3_DUO52HI53LO:I11	CPC011_PC3_24H_X1	I11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_PC3_24H_X2_B3_DUO52HI53LO:I11	CPC011_PC3_24H_X2	I11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_PC3_24H_X4_B5_DUO52HI53LO:I11	CPC011_PC3_24H_X4	I11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_PC3_24H_X5_B5_DUO52HI53LO:I11	CPC011_PC3_24H_X5	I11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_PC3_6H_X1_B3_DUO52HI53LO:I11	CPC011_PC3_6H_X1	I11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_PC3_6H_X3_B3_DUO52HI53LO:I11	CPC011_PC3_6H_X3	I11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_PC3_6H_X4_B5_DUO52HI53LO:I11	CPC011_PC3_6H_X4	I11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_PC3_6H_X5_B5_DUO52HI53LO:I11	CPC011_PC3_6H_X5	I11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_PC3_24H_X1_B4_DUO52HI53LO:C12	CPC005_PC3_24H_X1	C12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_PC3_24H_X2_B4_DUO52HI53LO:C12	CPC005_PC3_24H_X2	C12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_PC3_24H_X3_B4_DUO52HI53LO:C12	CPC005_PC3_24H_X3	C12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_PC3_24H_X4_B5_DUO52HI53LO:C12	CPC005_PC3_24H_X4	C12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_PC3_24H_X5_B5_DUO52HI53LO:C12	CPC005_PC3_24H_X5	C12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_PC3_6H_X1_B3_DUO52HI53LO:C12	CPC005_PC3_6H_X1	C12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_PC3_6H_X2_B3_DUO52HI53LO:C12	CPC005_PC3_6H_X2	C12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_PC3_6H_X3_B3_DUO52HI53LO:C12	CPC005_PC3_6H_X3	C12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:C12	CPC005_PC3_6H_X5	C12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_24H_X1_B5_DUO52HI53LO:H14	CPC020_PC3_24H_X1	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_24H_X1_B5_DUO52HI53LO:L24	CPC020_PC3_24H_X1	L24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_24H_X2_B5_DUO52HI53LO:H14	CPC020_PC3_24H_X2	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_24H_X3_B5_DUO52HI53LO:H14	CPC020_PC3_24H_X3	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_24H_X3_B5_DUO52HI53LO:L24	CPC020_PC3_24H_X3	L24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_24H_X4_B5_DUO52HI53LO:H14	CPC020_PC3_24H_X4	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_24H_X5_B5_DUO52HI53LO:H14	CPC020_PC3_24H_X5	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_24H_X5_B5_DUO52HI53LO:L24	CPC020_PC3_24H_X5	L24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:H14	CPC020_PC3_6H_X4	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:L24	CPC020_PC3_6H_X4	L24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPD001_PC3_24H_X1_B6_DUO52HI53LO:O05	CPD001_PC3_24H_X1	O05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPD001_PC3_24H_X2_B6_DUO52HI53LO:O05	CPD001_PC3_24H_X2	O05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPD001_PC3_24H_X3_B6_DUO52HI53LO:O05	CPD001_PC3_24H_X3	O05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_6H_X1_B4_DUO52HI53LO:H14	CPC020_PC3_6H_X1	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_6H_X1_B4_DUO52HI53LO:L24	CPC020_PC3_6H_X1	L24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_6H_X2_B4_DUO52HI53LO:H14	CPC020_PC3_6H_X2	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_6H_X2_B4_DUO52HI53LO:L24	CPC020_PC3_6H_X2	L24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_6H_X3_B4_DUO52HI53LO:H14	CPC020_PC3_6H_X3	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_6H_X3_B4_DUO52HI53LO:L24	CPC020_PC3_6H_X3	L24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_PC3_6H_X5_B5_DUO52HI53LO:H14	CPC020_PC3_6H_X5	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_PC3_24H_X1_B3_DUO52HI53LO:H22	CPC002_PC3_24H_X1	H22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_PC3_24H_X2_B3_DUO52HI53LO:H22	CPC002_PC3_24H_X2	H22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_PC3_24H_X3_B3_DUO52HI53LO:H22	CPC002_PC3_24H_X3	H22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_PC3_24H_X4_B4_DUO52HI53LO:H22	CPC002_PC3_24H_X4	H22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:H22	CPC002_PC3_24H_X5	H22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_PC3_6H_X1_B3_DUO52HI53LO:H22	CPC002_PC3_6H_X1	H22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_PC3_6H_X2_B3_DUO52HI53LO:H22	CPC002_PC3_6H_X2	H22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_PC3_6H_X3_B3_DUO52HI53LO:H22	CPC002_PC3_6H_X3	H22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_PC3_6H_X4_B4_DUO52HI53LO:H22	CPC002_PC3_6H_X4	H22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:H22	CPC002_PC3_6H_X5	H22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPD002_PC3_24H_X1_B6_DUO52HI53LO:P01	CPD002_PC3_24H_X1	P01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPD002_PC3_24H_X3_B6_DUO52HI53LO:P01	CPD002_PC3_24H_X3	P01	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPD002_PC3_6H_X1_B6_DUO52HI53LO:P01	CPD002_PC3_6H_X1	P01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPD002_PC3_6H_X2_B6_DUO52HI53LO:P01	CPD002_PC3_6H_X2	P01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPD002_PC3_6H_X3_B6_DUO52HI53LO:P01	CPD002_PC3_6H_X3	P01	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_PC3_24H_X1_B4_DUO52HI53LO:N07	CPC005_PC3_24H_X1	N07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_PC3_24H_X2_B4_DUO52HI53LO:N07	CPC005_PC3_24H_X2	N07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_PC3_24H_X3_B4_DUO52HI53LO:N07	CPC005_PC3_24H_X3	N07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_PC3_24H_X4_B5_DUO52HI53LO:N07	CPC005_PC3_24H_X4	N07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_PC3_24H_X5_B5_DUO52HI53LO:N07	CPC005_PC3_24H_X5	N07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_PC3_6H_X1_B3_DUO52HI53LO:N07	CPC005_PC3_6H_X1	N07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_PC3_6H_X2_B3_DUO52HI53LO:N07	CPC005_PC3_6H_X2	N07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_PC3_6H_X3_B3_DUO52HI53LO:N07	CPC005_PC3_6H_X3	N07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:N07	CPC005_PC3_6H_X5	N07	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPD001_PC3_24H_X1_B6_DUO52HI53LO:F23	CPD001_PC3_24H_X1	F23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPD001_PC3_24H_X2_B6_DUO52HI53LO:F23	CPD001_PC3_24H_X2	F23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPD001_PC3_24H_X3_B6_DUO52HI53LO:F23	CPD001_PC3_24H_X3	F23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_PC3_24H_X1_B3_DUO52HI53LO:K21	CPC002_PC3_24H_X1	K21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_PC3_24H_X2_B3_DUO52HI53LO:K21	CPC002_PC3_24H_X2	K21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_PC3_24H_X3_B3_DUO52HI53LO:K21	CPC002_PC3_24H_X3	K21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_PC3_24H_X4_B4_DUO52HI53LO:K21	CPC002_PC3_24H_X4	K21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:K21	CPC002_PC3_24H_X5	K21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_PC3_6H_X1_B3_DUO52HI53LO:K21	CPC002_PC3_6H_X1	K21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_PC3_6H_X2_B3_DUO52HI53LO:K21	CPC002_PC3_6H_X2	K21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_PC3_6H_X3_B3_DUO52HI53LO:K21	CPC002_PC3_6H_X3	K21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_PC3_6H_X4_B4_DUO52HI53LO:K21	CPC002_PC3_6H_X4	K21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:K21	CPC002_PC3_6H_X5	K21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_PC3_24H_X1_B3_DUO52HI53LO:O15	CPC011_PC3_24H_X1	O15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_PC3_24H_X2_B3_DUO52HI53LO:O15	CPC011_PC3_24H_X2	O15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_PC3_24H_X4_B5_DUO52HI53LO:O15	CPC011_PC3_24H_X4	O15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_PC3_24H_X5_B5_DUO52HI53LO:O15	CPC011_PC3_24H_X5	O15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_PC3_6H_X1_B3_DUO52HI53LO:O15	CPC011_PC3_6H_X1	O15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_PC3_6H_X3_B3_DUO52HI53LO:O15	CPC011_PC3_6H_X3	O15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_PC3_6H_X4_B5_DUO52HI53LO:O15	CPC011_PC3_6H_X4	O15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_PC3_6H_X5_B5_DUO52HI53LO:O15	CPC011_PC3_6H_X5	O15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_PC3_24H_X1_B3_DUO52HI53LO:J08	CPC002_PC3_24H_X1	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_PC3_24H_X2_B3_DUO52HI53LO:J08	CPC002_PC3_24H_X2	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_PC3_24H_X3_B3_DUO52HI53LO:J08	CPC002_PC3_24H_X3	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_PC3_24H_X4_B4_DUO52HI53LO:J08	CPC002_PC3_24H_X4	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:J08	CPC002_PC3_24H_X5	J08	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_PC3_6H_X1_B3_DUO52HI53LO:J08	CPC002_PC3_6H_X1	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_PC3_6H_X2_B3_DUO52HI53LO:J08	CPC002_PC3_6H_X2	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_PC3_6H_X3_B3_DUO52HI53LO:J08	CPC002_PC3_6H_X3	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_PC3_6H_X4_B4_DUO52HI53LO:J08	CPC002_PC3_6H_X4	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:J08	CPC002_PC3_6H_X5	J08	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPD001_PC3_24H_X1_B6_DUO52HI53LO:C20	CPD001_PC3_24H_X1	C20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPD001_PC3_24H_X2_B6_DUO52HI53LO:C20	CPD001_PC3_24H_X2	C20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPD001_PC3_24H_X3_B6_DUO52HI53LO:C20	CPD001_PC3_24H_X3	C20	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_PC3_24H_X1_B3_DUO52HI53LO:A16	CPC004_PC3_24H_X1	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:A16	CPC004_PC3_24H_X2	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:A16	CPC004_PC3_24H_X3	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:A16	CPC004_PC3_24H_X4	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:A16	CPC004_PC3_24H_X5	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:A16	CPC004_PC3_6H_X1	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:A16	CPC004_PC3_6H_X2	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:A16	CPC004_PC3_6H_X4	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:A16	CPC004_PC3_6H_X5	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_PC3_24H_X1_B3_DUO52HI53LO:G23	CPC011_PC3_24H_X1	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_PC3_24H_X2_B3_DUO52HI53LO:G23	CPC011_PC3_24H_X2	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_PC3_24H_X4_B5_DUO52HI53LO:G23	CPC011_PC3_24H_X4	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_PC3_24H_X5_B5_DUO52HI53LO:G23	CPC011_PC3_24H_X5	G23	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_PC3_6H_X1_B3_DUO52HI53LO:G23	CPC011_PC3_6H_X1	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_PC3_6H_X3_B3_DUO52HI53LO:G23	CPC011_PC3_6H_X3	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_PC3_6H_X4_B5_DUO52HI53LO:G23	CPC011_PC3_6H_X4	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_PC3_6H_X5_B5_DUO52HI53LO:G23	CPC011_PC3_6H_X5	G23	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_PC3_24H_X1_B6_DUO52HI53LO:O14	CPD002_PC3_24H_X1	O14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_PC3_24H_X2_B6_DUO52HI53LO:O14	CPD002_PC3_24H_X2	O14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_PC3_24H_X3_B6_DUO52HI53LO:O14	CPD002_PC3_24H_X3	O14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_PC3_6H_X1_B6_DUO52HI53LO:O14	CPD002_PC3_6H_X1	O14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_PC3_6H_X2_B6_DUO52HI53LO:O14	CPD002_PC3_6H_X2	O14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPD002_PC3_6H_X3_B6_DUO52HI53LO:O14	CPD002_PC3_6H_X3	O14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_PC3_24H_X1_B5_DUO52HI53LO:D15	CPC020_PC3_24H_X1	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_PC3_24H_X2_B5_DUO52HI53LO:D15	CPC020_PC3_24H_X2	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_PC3_24H_X3_B5_DUO52HI53LO:D15	CPC020_PC3_24H_X3	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_PC3_24H_X4_B5_DUO52HI53LO:D15	CPC020_PC3_24H_X4	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_PC3_24H_X5_B5_DUO52HI53LO:D15	CPC020_PC3_24H_X5	D15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_PC3_6H_X1_B4_DUO52HI53LO:D15	CPC020_PC3_6H_X1	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_PC3_6H_X2_B4_DUO52HI53LO:D15	CPC020_PC3_6H_X2	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_PC3_6H_X3_B4_DUO52HI53LO:D15	CPC020_PC3_6H_X3	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:D15	CPC020_PC3_6H_X4	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_PC3_6H_X5_B5_DUO52HI53LO:D15	CPC020_PC3_6H_X5	D15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_PC3_24H_X1_B3_DUO52HI53LO:A16	CPC011_PC3_24H_X1	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_PC3_24H_X2_B3_DUO52HI53LO:A16	CPC011_PC3_24H_X2	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_PC3_24H_X4_B5_DUO52HI53LO:A16	CPC011_PC3_24H_X4	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_PC3_24H_X5_B5_DUO52HI53LO:A16	CPC011_PC3_24H_X5	A16	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_PC3_6H_X1_B3_DUO52HI53LO:A16	CPC011_PC3_6H_X1	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_PC3_6H_X3_B3_DUO52HI53LO:A16	CPC011_PC3_6H_X3	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_PC3_6H_X4_B5_DUO52HI53LO:A16	CPC011_PC3_6H_X4	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_PC3_6H_X5_B5_DUO52HI53LO:A16	CPC011_PC3_6H_X5	A16	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPD001_PC3_24H_X1_B6_DUO52HI53LO:G02	CPD001_PC3_24H_X1	G02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPD001_PC3_24H_X2_B6_DUO52HI53LO:G02	CPD001_PC3_24H_X2	G02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPD001_PC3_24H_X3_B6_DUO52HI53LO:G02	CPD001_PC3_24H_X3	G02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_PC3_24H_X1_B3_DUO52HI53LO:H02	CPC002_PC3_24H_X1	H02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_PC3_24H_X2_B3_DUO52HI53LO:H02	CPC002_PC3_24H_X2	H02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_PC3_24H_X3_B3_DUO52HI53LO:H02	CPC002_PC3_24H_X3	H02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_PC3_24H_X4_B4_DUO52HI53LO:H02	CPC002_PC3_24H_X4	H02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:H02	CPC002_PC3_24H_X5	H02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_PC3_6H_X1_B3_DUO52HI53LO:H02	CPC002_PC3_6H_X1	H02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_PC3_6H_X2_B3_DUO52HI53LO:H02	CPC002_PC3_6H_X2	H02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_PC3_6H_X3_B3_DUO52HI53LO:H02	CPC002_PC3_6H_X3	H02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_PC3_6H_X4_B4_DUO52HI53LO:H02	CPC002_PC3_6H_X4	H02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:H02	CPC002_PC3_6H_X5	H02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_PC3_24H_X1_B3_DUO52HI53LO:J05	CPC011_PC3_24H_X1	J05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_PC3_24H_X2_B3_DUO52HI53LO:J05	CPC011_PC3_24H_X2	J05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_PC3_24H_X4_B5_DUO52HI53LO:J05	CPC011_PC3_24H_X4	J05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_PC3_24H_X5_B5_DUO52HI53LO:J05	CPC011_PC3_24H_X5	J05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_PC3_6H_X1_B3_DUO52HI53LO:J05	CPC011_PC3_6H_X1	J05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_PC3_6H_X3_B3_DUO52HI53LO:J05	CPC011_PC3_6H_X3	J05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_PC3_6H_X4_B5_DUO52HI53LO:J05	CPC011_PC3_6H_X4	J05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_PC3_6H_X5_B5_DUO52HI53LO:J05	CPC011_PC3_6H_X5	J05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_PC3_24H_X1_B3_DUO52HI53LO:O11	CPC002_PC3_24H_X1	O11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_PC3_24H_X3_B3_DUO52HI53LO:O11	CPC002_PC3_24H_X3	O11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_PC3_24H_X4_B4_DUO52HI53LO:O11	CPC002_PC3_24H_X4	O11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_PC3_24H_X5_F1B5_DUO52HI53LO:O11	CPC002_PC3_24H_X5	O11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_PC3_6H_X1_B3_DUO52HI53LO:O11	CPC002_PC3_6H_X1	O11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_PC3_6H_X2_B3_DUO52HI53LO:O11	CPC002_PC3_6H_X2	O11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_PC3_6H_X3_B3_DUO52HI53LO:O11	CPC002_PC3_6H_X3	O11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_PC3_6H_X4_B4_DUO52HI53LO:O11	CPC002_PC3_6H_X4	O11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_PC3_6H_X5_F1B5_DUO52HI53LO:O11	CPC002_PC3_6H_X5	O11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPD001_PC3_24H_X1_B6_DUO52HI53LO:D10	CPD001_PC3_24H_X1	D10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPD001_PC3_24H_X2_B6_DUO52HI53LO:D10	CPD001_PC3_24H_X2	D10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPD001_PC3_24H_X3_B6_DUO52HI53LO:D10	CPD001_PC3_24H_X3	D10	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_PC3_24H_X1_B5_DUO52HI53LO:B15	CPC020_PC3_24H_X1	B15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_PC3_24H_X2_B5_DUO52HI53LO:B15	CPC020_PC3_24H_X2	B15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_PC3_24H_X3_B5_DUO52HI53LO:B15	CPC020_PC3_24H_X3	B15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_PC3_24H_X4_B5_DUO52HI53LO:B15	CPC020_PC3_24H_X4	B15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_PC3_24H_X5_B5_DUO52HI53LO:B15	CPC020_PC3_24H_X5	B15	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_PC3_6H_X4_F1B4_DUO52HI53LO:B15	CPC020_PC3_6H_X4	B15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_PC3_6H_X1_B4_DUO52HI53LO:B15	CPC020_PC3_6H_X1	B15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_PC3_6H_X2_B4_DUO52HI53LO:B15	CPC020_PC3_6H_X2	B15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_PC3_6H_X3_B4_DUO52HI53LO:B15	CPC020_PC3_6H_X3	B15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_PC3_6H_X5_B5_DUO52HI53LO:B15	CPC020_PC3_6H_X5	B15	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_PC3_24H_X1_B3_DUO52HI53LO:I12	CPC011_PC3_24H_X1	I12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_PC3_24H_X2_B3_DUO52HI53LO:I12	CPC011_PC3_24H_X2	I12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_PC3_24H_X4_B5_DUO52HI53LO:I12	CPC011_PC3_24H_X4	I12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_PC3_24H_X5_B5_DUO52HI53LO:I12	CPC011_PC3_24H_X5	I12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_PC3_6H_X1_B3_DUO52HI53LO:I12	CPC011_PC3_6H_X1	I12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_PC3_6H_X3_B3_DUO52HI53LO:I12	CPC011_PC3_6H_X3	I12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_PC3_6H_X4_B5_DUO52HI53LO:I12	CPC011_PC3_6H_X4	I12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_PC3_6H_X5_B5_DUO52HI53LO:I12	CPC011_PC3_6H_X5	I12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_PC3_24H_X1_B3_DUO52HI53LO:H24	CPC004_PC3_24H_X1	H24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:H24	CPC004_PC3_24H_X2	H24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:H24	CPC004_PC3_24H_X3	H24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:H24	CPC004_PC3_24H_X4	H24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:H24	CPC004_PC3_24H_X5	H24	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:H24	CPC004_PC3_6H_X1	H24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:H24	CPC004_PC3_6H_X2	H24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_PC3_6H_X3_B3_DUO52HI53LO:H24	CPC004_PC3_6H_X3	H24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:H24	CPC004_PC3_6H_X4	H24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:H24	CPC004_PC3_6H_X5	H24	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:K03	CPD003_PC3_24H_X1.L2	K03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:K03	CPD003_PC3_24H_X2.L2	K03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPD003_PC3_6H_X1_B6_DUO52HI53LO:K03	CPD003_PC3_6H_X1	K03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:K03	CPD003_PC3_6H_X3.A2	K03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPD003_PC3_6H_X3_B6_DUO52HI53LO:K03	CPD003_PC3_6H_X3	K03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_PC3_24H_X1_B3_DUO52HI53LO:I21	CPC011_PC3_24H_X1	I21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_PC3_24H_X2_B3_DUO52HI53LO:I21	CPC011_PC3_24H_X2	I21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_PC3_24H_X4_B5_DUO52HI53LO:I21	CPC011_PC3_24H_X4	I21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_PC3_24H_X5_B5_DUO52HI53LO:I21	CPC011_PC3_24H_X5	I21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_PC3_6H_X1_B3_DUO52HI53LO:I21	CPC011_PC3_6H_X1	I21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_PC3_6H_X3_B3_DUO52HI53LO:I21	CPC011_PC3_6H_X3	I21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_PC3_6H_X4_B5_DUO52HI53LO:I21	CPC011_PC3_6H_X4	I21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_PC3_6H_X5_B5_DUO52HI53LO:I21	CPC011_PC3_6H_X5	I21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_PC3_24H_X1_B3_DUO52HI53LO:J02	CPC004_PC3_24H_X1	J02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:J02	CPC004_PC3_24H_X2	J02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:J02	CPC004_PC3_24H_X3	J02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:J02	CPC004_PC3_24H_X4	J02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:J02	CPC004_PC3_24H_X5	J02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:J02	CPC004_PC3_6H_X1	J02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:J02	CPC004_PC3_6H_X2	J02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_PC3_6H_X3_B3_DUO52HI53LO:J02	CPC004_PC3_6H_X3	J02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:J02	CPC004_PC3_6H_X4	J02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:J02	CPC004_PC3_6H_X5	J02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:I22	CPD003_PC3_24H_X1.L2	I22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:I22	CPD003_PC3_24H_X2.L2	I22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPD003_PC3_6H_X1_B6_DUO52HI53LO:I22	CPD003_PC3_6H_X1	I22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:I22	CPD003_PC3_6H_X3.A2	I22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPD003_PC3_6H_X3_B6_DUO52HI53LO:I22	CPD003_PC3_6H_X3	I22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K57174586	2	2	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:L09	CPD003_PC3_24H_X1.L2	L09	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K57174586	2	2	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:L09	CPD003_PC3_24H_X2.L2	L09	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K57174586	2	2	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:L09	CPD003_PC3_6H_X3.A2	L09	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K57174586	2	2	CPD003_PC3_6H_X1_B6_DUO52HI53LO:L09	CPD003_PC3_6H_X1	L09	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K57174586	2	2	CPD003_PC3_6H_X3_B6_DUO52HI53LO:L09	CPD003_PC3_6H_X3	L09	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:H13	CPC004_PC3_24H_X2	H13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:H13	CPC004_PC3_24H_X3	H13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:H13	CPC004_PC3_24H_X4	H13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:H13	CPC004_PC3_24H_X5	H13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:H13	CPC004_PC3_6H_X1	H13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:H13	CPC004_PC3_6H_X2	H13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_PC3_6H_X3_B3_DUO52HI53LO:H13	CPC004_PC3_6H_X3	H13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:H13	CPC004_PC3_6H_X4	H13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:H13	CPC004_PC3_6H_X5	H13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_PC3_24H_X1_B3_DUO52HI53LO:L11	CPC011_PC3_24H_X1	L11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_PC3_24H_X2_B3_DUO52HI53LO:L11	CPC011_PC3_24H_X2	L11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_PC3_24H_X4_B5_DUO52HI53LO:L11	CPC011_PC3_24H_X4	L11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_PC3_24H_X5_B5_DUO52HI53LO:L11	CPC011_PC3_24H_X5	L11	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_PC3_6H_X1_B3_DUO52HI53LO:L11	CPC011_PC3_6H_X1	L11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_PC3_6H_X3_B3_DUO52HI53LO:L11	CPC011_PC3_6H_X3	L11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_PC3_6H_X4_B5_DUO52HI53LO:L11	CPC011_PC3_6H_X4	L11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_PC3_6H_X5_B5_DUO52HI53LO:L11	CPC011_PC3_6H_X5	L11	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_PC3_24H_X1_B4_DUO52HI53LO:E19	CPC005_PC3_24H_X1	E19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_PC3_24H_X2_B4_DUO52HI53LO:E19	CPC005_PC3_24H_X2	E19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_PC3_24H_X3_B4_DUO52HI53LO:E19	CPC005_PC3_24H_X3	E19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_PC3_24H_X4_B5_DUO52HI53LO:E19	CPC005_PC3_24H_X4	E19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_PC3_24H_X5_B5_DUO52HI53LO:E19	CPC005_PC3_24H_X5	E19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_PC3_6H_X1_B3_DUO52HI53LO:E19	CPC005_PC3_6H_X1	E19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_PC3_6H_X2_B3_DUO52HI53LO:E19	CPC005_PC3_6H_X2	E19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_PC3_6H_X3_B3_DUO52HI53LO:E19	CPC005_PC3_6H_X3	E19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_PC3_6H_X5_F1B5_DUO52HI53LO:E19	CPC005_PC3_6H_X5	E19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	CPD001_PC3_24H_X1_B6_DUO52HI53LO:D07	CPD001_PC3_24H_X1	D07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	CPD001_PC3_24H_X2_B6_DUO52HI53LO:D07	CPD001_PC3_24H_X2	D07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	CPD001_PC3_24H_X3_B6_DUO52HI53LO:D07	CPD001_PC3_24H_X3	D07	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_PC3_24H_X1_B3_DUO52HI53LO:I06	CPC004_PC3_24H_X1	I06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:I06	CPC004_PC3_24H_X2	I06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:I06	CPC004_PC3_24H_X3	I06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:I06	CPC004_PC3_24H_X4	I06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:I06	CPC004_PC3_24H_X5	I06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:I06	CPC004_PC3_6H_X1	I06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:I06	CPC004_PC3_6H_X2	I06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_PC3_6H_X3_B3_DUO52HI53LO:I06	CPC004_PC3_6H_X3	I06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:I06	CPC004_PC3_6H_X4	I06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:I06	CPC004_PC3_6H_X5	I06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPD001_PC3_24H_X1_B6_DUO52HI53LO:L06	CPD001_PC3_24H_X1	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPD001_PC3_24H_X2_B6_DUO52HI53LO:L06	CPD001_PC3_24H_X2	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPD001_PC3_24H_X3_B6_DUO52HI53LO:L06	CPD001_PC3_24H_X3	L06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_PC3_24H_X1_B3_DUO52HI53LO:K13	CPC011_PC3_24H_X1	K13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_PC3_24H_X2_B3_DUO52HI53LO:K13	CPC011_PC3_24H_X2	K13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_PC3_24H_X4_B5_DUO52HI53LO:K13	CPC011_PC3_24H_X4	K13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_PC3_24H_X5_B5_DUO52HI53LO:K13	CPC011_PC3_24H_X5	K13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_PC3_6H_X1_B3_DUO52HI53LO:K13	CPC011_PC3_6H_X1	K13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_PC3_6H_X3_B3_DUO52HI53LO:K13	CPC011_PC3_6H_X3	K13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_PC3_6H_X4_B5_DUO52HI53LO:K13	CPC011_PC3_6H_X4	K13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_PC3_6H_X5_B5_DUO52HI53LO:K13	CPC011_PC3_6H_X5	K13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_PC3_24H_X1_B3_DUO52HI53LO:I02	CPC004_PC3_24H_X1	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:I02	CPC004_PC3_24H_X2	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:I02	CPC004_PC3_24H_X3	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:I02	CPC004_PC3_24H_X4	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:I02	CPC004_PC3_24H_X5	I02	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:I02	CPC004_PC3_6H_X1	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:I02	CPC004_PC3_6H_X2	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_PC3_6H_X3_B3_DUO52HI53LO:I02	CPC004_PC3_6H_X3	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:I02	CPC004_PC3_6H_X4	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:I02	CPC004_PC3_6H_X5	I02	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPD003_PC3_24H_X1.L2_B6_DUO52HI53LO:A13	CPD003_PC3_24H_X1.L2	A13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPD003_PC3_24H_X2.L2_B6_DUO52HI53LO:A13	CPD003_PC3_24H_X2.L2	A13	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPD003_PC3_6H_X1_B6_DUO52HI53LO:A13	CPD003_PC3_6H_X1	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPD003_PC3_6H_X3.A2_B6_DUO52HI53LO:A13	CPD003_PC3_6H_X3.A2	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPD003_PC3_6H_X3_B6_DUO52HI53LO:A13	CPD003_PC3_6H_X3	A13	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_PC3_24H_X1_B3_DUO52HI53LO:J06	CPC004_PC3_24H_X1	J06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:J06	CPC004_PC3_24H_X2	J06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:J06	CPC004_PC3_24H_X3	J06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:J06	CPC004_PC3_24H_X4	J06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:J06	CPC004_PC3_24H_X5	J06	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:J06	CPC004_PC3_6H_X1	J06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:J06	CPC004_PC3_6H_X2	J06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_PC3_6H_X3_B3_DUO52HI53LO:J06	CPC004_PC3_6H_X3	J06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:J06	CPC004_PC3_6H_X4	J06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:J06	CPC004_PC3_6H_X5	J06	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_PC3_24H_X1_B3_DUO52HI53LO:J19	CPC011_PC3_24H_X1	J19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_PC3_24H_X2_B3_DUO52HI53LO:J19	CPC011_PC3_24H_X2	J19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_PC3_24H_X4_B5_DUO52HI53LO:J19	CPC011_PC3_24H_X4	J19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_PC3_24H_X5_B5_DUO52HI53LO:J19	CPC011_PC3_24H_X5	J19	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_PC3_6H_X1_B3_DUO52HI53LO:J19	CPC011_PC3_6H_X1	J19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_PC3_6H_X3_B3_DUO52HI53LO:J19	CPC011_PC3_6H_X3	J19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_PC3_6H_X4_B5_DUO52HI53LO:J19	CPC011_PC3_6H_X4	J19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_PC3_6H_X5_B5_DUO52HI53LO:J19	CPC011_PC3_6H_X5	J19	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_PC3_24H_X1_B6_DUO52HI53LO:L12	CPD002_PC3_24H_X1	L12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_PC3_24H_X2_B6_DUO52HI53LO:L12	CPD002_PC3_24H_X2	L12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_PC3_24H_X3_B6_DUO52HI53LO:L12	CPD002_PC3_24H_X3	L12	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_PC3_6H_X1_B6_DUO52HI53LO:L12	CPD002_PC3_6H_X1	L12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_PC3_6H_X2_B6_DUO52HI53LO:L12	CPD002_PC3_6H_X2	L12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPD002_PC3_6H_X3_B6_DUO52HI53LO:L12	CPD002_PC3_6H_X3	L12	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_PC3_24H_X1_B3_DUO52HI53LO:H14	CPC011_PC3_24H_X1	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_PC3_24H_X2_B3_DUO52HI53LO:H14	CPC011_PC3_24H_X2	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_PC3_24H_X4_B5_DUO52HI53LO:H14	CPC011_PC3_24H_X4	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_PC3_24H_X5_B5_DUO52HI53LO:H14	CPC011_PC3_24H_X5	H14	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_PC3_6H_X1_B3_DUO52HI53LO:H14	CPC011_PC3_6H_X1	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_PC3_6H_X3_B3_DUO52HI53LO:H14	CPC011_PC3_6H_X3	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_PC3_6H_X4_B5_DUO52HI53LO:H14	CPC011_PC3_6H_X4	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_PC3_6H_X5_B5_DUO52HI53LO:H14	CPC011_PC3_6H_X5	H14	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_PC3_24H_X2_B3_DUO52HI53LO:J03	CPC004_PC3_24H_X2	J03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_PC3_24H_X3_B3_DUO52HI53LO:J03	CPC004_PC3_24H_X3	J03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_PC3_24H_X4_B4_DUO52HI53LO:J03	CPC004_PC3_24H_X4	J03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_PC3_24H_X5_B5_DUO52HI53LO:J03	CPC004_PC3_24H_X5	J03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_PC3_6H_X1_B3_DUO52HI53LO:J03	CPC004_PC3_6H_X1	J03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_PC3_6H_X2_B3_DUO52HI53LO:J03	CPC004_PC3_6H_X2	J03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_PC3_6H_X3_B3_DUO52HI53LO:J03	CPC004_PC3_6H_X3	J03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_PC3_6H_X4_B4_DUO52HI53LO:J03	CPC004_PC3_6H_X4	J03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_PC3_6H_X5_F1B5_DUO52HI53LO:J03	CPC004_PC3_6H_X5	J03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_PC3_24H_X1_F2B4_DUO52HI53LO:G22	CPC010_PC3_24H_X1	G22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_PC3_24H_X2_B5_DUO52HI53LO:G22	CPC010_PC3_24H_X2	G22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_PC3_24H_X3_B5_DUO52HI53LO:G22	CPC010_PC3_24H_X3	G22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_PC3_24H_X4_F2B4_DUO52HI53LO:G22	CPC010_PC3_24H_X4	G22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_PC3_24H_X5_B5_DUO52HI53LO:G22	CPC010_PC3_24H_X5	G22	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_PC3_6H_X1_B3_DUO52HI53LO:G22	CPC010_PC3_6H_X1	G22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_PC3_6H_X2_B3_DUO52HI53LO:G22	CPC010_PC3_6H_X2	G22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_PC3_6H_X3_B3_DUO52HI53LO:G22	CPC010_PC3_6H_X3	G22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_PC3_6H_X4_F1B5_DUO52HI53LO:G22	CPC010_PC3_6H_X4	G22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_PC3_6H_X5_F1B5_DUO52HI53LO:G22	CPC010_PC3_6H_X5	G22	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_PC3_24H_X1_B3_DUO52HI53LO:I05	CPC011_PC3_24H_X1	I05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_PC3_24H_X2_B3_DUO52HI53LO:I05	CPC011_PC3_24H_X2	I05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_PC3_24H_X4_B5_DUO52HI53LO:I05	CPC011_PC3_24H_X4	I05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_PC3_24H_X5_B5_DUO52HI53LO:I05	CPC011_PC3_24H_X5	I05	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_PC3_6H_X1_B3_DUO52HI53LO:I05	CPC011_PC3_6H_X1	I05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_PC3_6H_X3_B3_DUO52HI53LO:I05	CPC011_PC3_6H_X3	I05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_PC3_6H_X4_B5_DUO52HI53LO:I05	CPC011_PC3_6H_X4	I05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_PC3_6H_X5_B5_DUO52HI53LO:I05	CPC011_PC3_6H_X5	I05	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_PC3_24H_X1_B3_DUO52HI53LO:L21	CPC001_PC3_24H_X1	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_PC3_24H_X2_B3_DUO52HI53LO:L21	CPC001_PC3_24H_X2	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_PC3_24H_X3_B3_DUO52HI53LO:L21	CPC001_PC3_24H_X3	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_PC3_24H_X3_F1B3_DUO52HI53LO:L21	CPC001_PC3_24H_X3	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_PC3_24H_X4_F2B4_DUO52HI53LO:L21	CPC001_PC3_24H_X4	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_PC3_24H_X5_B5_DUO52HI53LO:L21	CPC001_PC3_24H_X5	L21	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_PC3_6H_X1_B3_DUO52HI53LO:L21	CPC001_PC3_6H_X1	L21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_PC3_6H_X2_B3_DUO52HI53LO:L21	CPC001_PC3_6H_X2	L21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_PC3_6H_X3_B3_DUO52HI53LO:L21	CPC001_PC3_6H_X3	L21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_PC3_6H_X5.L2_F2B5_DUO52HI53LO:L21	CPC001_PC3_6H_X5.L2	L21	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_PC3_24H_X1_B6_DUO52HI53LO:F03	CPD002_PC3_24H_X1	F03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_PC3_24H_X2_B6_DUO52HI53LO:F03	CPD002_PC3_24H_X2	F03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_PC3_24H_X3_B6_DUO52HI53LO:F03	CPD002_PC3_24H_X3	F03	trt_cp	10.0	um	24	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_PC3_6H_X1_B6_DUO52HI53LO:F03	CPD002_PC3_6H_X1	F03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_PC3_6H_X2_B6_DUO52HI53LO:F03	CPD002_PC3_6H_X2	F03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-K32480324	3	2	CPD002_PC3_6H_X3_B6_DUO52HI53LO:F03	CPD002_PC3_6H_X3	F03	trt_cp	10.0	um	6	h	PC3	cell line	PC3	-666	-666	tumor	prostate	adenocarcinoma	mix	CRL-1435	ATCC	62	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X1	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X2	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X3	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X4.A2	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X4	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:J08	CPC004_VCAP_24H_X5	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:J08	CPC004_VCAP_6H_X2	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:J08	CPC004_VCAP_6H_X3	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:J08	CPC004_VCAP_6H_X5	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:G10	CPC011_VCAP_24H_X1	G10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:G10	CPC011_VCAP_24H_X2	G10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:G10	CPC011_VCAP_24H_X3	G10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:G10	CPC011_VCAP_24H_X4	G10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:G10	CPC011_VCAP_24H_X5	G10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:B03	CPC011_VCAP_24H_X2	B03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:G10	CPC011_VCAP_6H_X2	G10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:G10	CPC011_VCAP_6H_X4	G10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:G10	CPC011_VCAP_6H_X5	G10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:B03	CPC011_VCAP_24H_X1	B03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:B03	CPC011_VCAP_24H_X3	B03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:B03	CPC011_VCAP_24H_X4	B03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:B03	CPC011_VCAP_24H_X5	B03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:G10	CPC011_VCAP_6H_X1	G10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:G10	CPC011_VCAP_6H_X3	G10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:B03	CPC011_VCAP_6H_X1	B03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:B03	CPC011_VCAP_6H_X2	B03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:B03	CPC011_VCAP_6H_X3	B03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:B03	CPC011_VCAP_6H_X4	B03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:B03	CPC011_VCAP_6H_X5	B03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_VCAP_24H_X1_B3_DUO52HI53LO:I02	CPC003_VCAP_24H_X1	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_VCAP_24H_X3_B3_DUO52HI53LO:I02	CPC003_VCAP_24H_X3	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_VCAP_6H_X2_B5_DUO52HI53LO:I02	CPC003_VCAP_6H_X2	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_VCAP_6H_X3_B5_DUO52HI53LO:I02	CPC003_VCAP_6H_X3	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_VCAP_6H_X4_B5_DUO52HI53LO:I02	CPC003_VCAP_6H_X4	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_VCAP_6H_X1_F2B4_DUO52HI53LO:I02	CPC003_VCAP_6H_X1	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC003_VCAP_6H_X5_F1B5_DUO52HI53LO:I02	CPC003_VCAP_6H_X5	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X1	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X2	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X3	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X4.A2	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X4	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:E01	CPC004_VCAP_24H_X5	E01	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:E01	CPC004_VCAP_6H_X1	E01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:E01	CPC004_VCAP_6H_X2	E01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:E01	CPC004_VCAP_6H_X3	E01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:E01	CPC004_VCAP_6H_X5	E01	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:F24	CPC020_VCAP_24H_X1	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:H08	CPC020_VCAP_24H_X1	H08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:F24	CPC020_VCAP_24H_X2	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:H08	CPC020_VCAP_24H_X2	H08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:F24	CPC020_VCAP_24H_X3	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:H08	CPC020_VCAP_24H_X3	H08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:F24	CPC020_VCAP_24H_X4	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:H08	CPC020_VCAP_24H_X4	H08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:F24	CPC020_VCAP_24H_X5	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:H08	CPC020_VCAP_24H_X5	H08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:F24	CPC020_VCAP_6H_X1	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:H08	CPC020_VCAP_6H_X1	H08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:F24	CPC020_VCAP_6H_X2	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:H08	CPC020_VCAP_6H_X2	H08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:F24	CPC020_VCAP_6H_X3	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:H08	CPC020_VCAP_6H_X3	H08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:F24	CPC020_VCAP_6H_X4	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:H08	CPC020_VCAP_6H_X4	H08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:F24	CPC020_VCAP_6H_X5	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:H08	CPC020_VCAP_6H_X5	H08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:F24	CPC005_VCAP_24H_X1	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:F24	CPC005_VCAP_24H_X2	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:F24	CPC005_VCAP_24H_X3	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:F24	CPC005_VCAP_6H_X1	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:F24	CPC005_VCAP_6H_X2	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:F24	CPC005_VCAP_6H_X4	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:F24	CPC005_VCAP_6H_X5	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_VCAP_24H_X1_B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X1	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_VCAP_24H_X2_F1B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X2	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_VCAP_24H_X4_F1B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X4	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_VCAP_24H_X5_F1B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X5	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_VCAP_6H_X1_F1B5_DUO52HI53LO:B24	CPC009_VCAP_6H_X1	B24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_VCAP_6H_X4_B5_DUO52HI53LO:B24	CPC009_VCAP_6H_X4	B24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_VCAP_6H_X5_B5_DUO52HI53LO:B24	CPC009_VCAP_6H_X5	B24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:F24	CPC005_VCAP_24H_X4	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:F24	CPC005_VCAP_24H_X5	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X1	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X2	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X3	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X4	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X5	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X1	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:P10	CPC011_VCAP_6H_X2	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X3	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X4	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X5	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:F24	CPC005_VCAP_24H_X1	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:F24	CPC005_VCAP_24H_X2	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:F24	CPC005_VCAP_24H_X3	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:F24	CPC005_VCAP_6H_X1	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:F24	CPC005_VCAP_6H_X2	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:F24	CPC005_VCAP_6H_X4	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:F24	CPC005_VCAP_6H_X5	F24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_VCAP_24H_X1_B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X1	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_VCAP_24H_X2_F1B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X2	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_VCAP_24H_X4_F1B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X4	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_VCAP_24H_X5_F1B5_DUO52HI53LO:B24	CPC009_VCAP_24H_X5	B24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_VCAP_6H_X1_F1B5_DUO52HI53LO:B24	CPC009_VCAP_6H_X1	B24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_VCAP_6H_X4_B5_DUO52HI53LO:B24	CPC009_VCAP_6H_X4	B24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_VCAP_6H_X5_B5_DUO52HI53LO:B24	CPC009_VCAP_6H_X5	B24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:F24	CPC005_VCAP_24H_X4	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:F24	CPC005_VCAP_24H_X5	F24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X1	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X2	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X3	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X4	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:P10	CPC011_VCAP_24H_X5	P10	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X1	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:P10	CPC011_VCAP_6H_X2	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X3	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X4	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:P10	CPC011_VCAP_6H_X5	P10	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:G20	CPC002_VCAP_24H_X1	G20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:G20	CPC002_VCAP_24H_X2	G20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:G20	CPC002_VCAP_24H_X3	G20	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:G20	CPC002_VCAP_6H_X5	G20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:P19	CPC020_VCAP_24H_X1	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:P19	CPC020_VCAP_24H_X2	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:P19	CPC020_VCAP_24H_X3	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:P19	CPC020_VCAP_24H_X4	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:P19	CPC020_VCAP_24H_X5	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:P19	CPC020_VCAP_6H_X1	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:P19	CPC020_VCAP_6H_X2	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:P19	CPC020_VCAP_6H_X3	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:P19	CPC020_VCAP_6H_X4	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:P19	CPC020_VCAP_6H_X5	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:G20	CPC002_VCAP_6H_X1	G20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:G20	CPC002_VCAP_6H_X2	G20	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X2	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X5	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:E11	CPC004_VCAP_6H_X1	E11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:E11	CPC004_VCAP_6H_X5	E11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:F21	CPC020_VCAP_24H_X1	F21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:F21	CPC020_VCAP_24H_X2	F21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:F21	CPC020_VCAP_24H_X3	F21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:F21	CPC020_VCAP_24H_X4	F21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:F21	CPC020_VCAP_24H_X5	F21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:F21	CPC020_VCAP_6H_X1	F21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:F21	CPC020_VCAP_6H_X2	F21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:F21	CPC020_VCAP_6H_X3	F21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:F21	CPC020_VCAP_6H_X4	F21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:F21	CPC020_VCAP_6H_X5	F21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X1	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X3	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X4.A2	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:E11	CPC004_VCAP_24H_X4	E11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:E11	CPC004_VCAP_6H_X2	E11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:E11	CPC004_VCAP_6H_X3	E11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:K17	CPC004_VCAP_24H_X1	K17	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:K17	CPC004_VCAP_24H_X2	K17	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:K17	CPC004_VCAP_24H_X3	K17	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:K17	CPC004_VCAP_24H_X4	K17	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:K17	CPC004_VCAP_24H_X5	K17	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:K17	CPC004_VCAP_6H_X2	K17	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:K17	CPC004_VCAP_6H_X3	K17	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:K17	CPC004_VCAP_6H_X5	K17	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X1	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X2	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X3	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X4	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X5	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:G23	CPC004_VCAP_6H_X1	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:G23	CPC004_VCAP_6H_X2	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:G23	CPC004_VCAP_6H_X3	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:G23	CPC004_VCAP_6H_X5	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:G23	CPC004_VCAP_24H_X4.A2	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:G15	CPC011_VCAP_24H_X1	G15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:G15	CPC011_VCAP_24H_X2	G15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:G15	CPC011_VCAP_24H_X3	G15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:G15	CPC011_VCAP_24H_X4	G15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:G15	CPC011_VCAP_24H_X5	G15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:G15	CPC011_VCAP_6H_X1	G15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:G15	CPC011_VCAP_6H_X2	G15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:G15	CPC011_VCAP_6H_X3	G15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:G15	CPC011_VCAP_6H_X4	G15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:G15	CPC011_VCAP_6H_X5	G15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:F11	CPC002_VCAP_24H_X1	F11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:F11	CPC002_VCAP_24H_X2	F11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:F11	CPC002_VCAP_24H_X3	F11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:F11	CPC002_VCAP_6H_X1	F11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:F11	CPC002_VCAP_6H_X2	F11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:F11	CPC002_VCAP_6H_X4	F11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:F11	CPC002_VCAP_6H_X5	F11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:O02	CPC020_VCAP_24H_X1	O02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:O02	CPC020_VCAP_24H_X2	O02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:O02	CPC020_VCAP_24H_X3	O02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:O02	CPC020_VCAP_24H_X4	O02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:O02	CPC020_VCAP_24H_X5	O02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:O02	CPC020_VCAP_6H_X1	O02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:O02	CPC020_VCAP_6H_X2	O02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:O02	CPC020_VCAP_6H_X3	O02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:O02	CPC020_VCAP_6H_X4	O02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:O02	CPC020_VCAP_6H_X5	O02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:P19	CPC005_VCAP_24H_X1	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:P19	CPC005_VCAP_24H_X2	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:P19	CPC005_VCAP_24H_X3	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:P19	CPC005_VCAP_6H_X1	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:P19	CPC005_VCAP_6H_X2	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:P19	CPC005_VCAP_6H_X4	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:P19	CPC005_VCAP_6H_X5	P19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_VCAP_24H_X1_B5_DUO52HI53LO:J24	CPC009_VCAP_24H_X1	J24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_VCAP_24H_X2_F1B5_DUO52HI53LO:J24	CPC009_VCAP_24H_X2	J24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_VCAP_24H_X4_F1B5_DUO52HI53LO:J24	CPC009_VCAP_24H_X4	J24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_VCAP_24H_X5_F1B5_DUO52HI53LO:J24	CPC009_VCAP_24H_X5	J24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_VCAP_6H_X1_F1B5_DUO52HI53LO:J24	CPC009_VCAP_6H_X1	J24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_VCAP_6H_X2_F1B3_DUO52HI53LO:J24	CPC009_VCAP_6H_X2	J24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:P19	CPC005_VCAP_24H_X4	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:P19	CPC005_VCAP_24H_X5	P19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_VCAP_6H_X4_B5_DUO52HI53LO:J24	CPC009_VCAP_6H_X4	J24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_VCAP_6H_X5_B5_DUO52HI53LO:J24	CPC009_VCAP_6H_X5	J24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:E15	CPC011_VCAP_24H_X2	E15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:E15	CPC011_VCAP_6H_X2	E15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:E15	CPC011_VCAP_6H_X4	E15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:E15	CPC011_VCAP_6H_X5	E15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:E15	CPC011_VCAP_24H_X1	E15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:E15	CPC011_VCAP_24H_X3	E15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:E15	CPC011_VCAP_24H_X4	E15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:E15	CPC011_VCAP_24H_X5	E15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:E15	CPC011_VCAP_6H_X1	E15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:E15	CPC011_VCAP_6H_X3	E15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_VCAP_24H_X1_B3_DUO52HI53LO:P05	CPC003_VCAP_24H_X1	P05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_VCAP_24H_X3_B3_DUO52HI53LO:P05	CPC003_VCAP_24H_X3	P05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_VCAP_6H_X1_F2B4_DUO52HI53LO:P05	CPC003_VCAP_6H_X1	P05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_VCAP_6H_X2_B5_DUO52HI53LO:P05	CPC003_VCAP_6H_X2	P05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_VCAP_6H_X3_B5_DUO52HI53LO:P05	CPC003_VCAP_6H_X3	P05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_VCAP_6H_X4_B5_DUO52HI53LO:P05	CPC003_VCAP_6H_X4	P05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC003_VCAP_6H_X5_F1B5_DUO52HI53LO:P05	CPC003_VCAP_6H_X5	P05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_VCAP_24H_X1_B5_DUO52HI53LO:K23	CPC009_VCAP_24H_X1	K23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_VCAP_24H_X2_F1B5_DUO52HI53LO:K23	CPC009_VCAP_24H_X2	K23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_VCAP_24H_X4_F1B5_DUO52HI53LO:K23	CPC009_VCAP_24H_X4	K23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_VCAP_24H_X5_F1B5_DUO52HI53LO:K23	CPC009_VCAP_24H_X5	K23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_VCAP_6H_X1_F1B5_DUO52HI53LO:K23	CPC009_VCAP_6H_X1	K23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_VCAP_6H_X2_F1B3_DUO52HI53LO:K23	CPC009_VCAP_6H_X2	K23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_VCAP_6H_X4_B5_DUO52HI53LO:K23	CPC009_VCAP_6H_X4	K23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_VCAP_6H_X5_B5_DUO52HI53LO:K23	CPC009_VCAP_6H_X5	K23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:I11	CPC011_VCAP_24H_X2	I11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:I11	CPC011_VCAP_24H_X1	I11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:I11	CPC011_VCAP_24H_X3	I11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:I11	CPC011_VCAP_24H_X4	I11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:I11	CPC011_VCAP_24H_X5	I11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:I11	CPC011_VCAP_6H_X1	I11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:I11	CPC011_VCAP_6H_X2	I11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:I11	CPC011_VCAP_6H_X3	I11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:I11	CPC011_VCAP_6H_X4	I11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:I11	CPC011_VCAP_6H_X5	I11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:C12	CPC005_VCAP_24H_X1	C12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:C12	CPC005_VCAP_24H_X2	C12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:C12	CPC005_VCAP_24H_X3	C12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:C12	CPC005_VCAP_6H_X1	C12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:C12	CPC005_VCAP_6H_X2	C12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:C12	CPC005_VCAP_6H_X4	C12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:C12	CPC005_VCAP_6H_X5	C12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:H14	CPC020_VCAP_24H_X1	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:L24	CPC020_VCAP_24H_X1	L24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:H14	CPC020_VCAP_24H_X2	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:L24	CPC020_VCAP_24H_X2	L24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:H14	CPC020_VCAP_24H_X3	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:L24	CPC020_VCAP_24H_X3	L24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:H14	CPC020_VCAP_24H_X4	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:L24	CPC020_VCAP_24H_X4	L24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:H14	CPC020_VCAP_24H_X5	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:L24	CPC020_VCAP_24H_X5	L24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:H14	CPC020_VCAP_6H_X1	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:L24	CPC020_VCAP_6H_X1	L24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:H14	CPC020_VCAP_6H_X2	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:L24	CPC020_VCAP_6H_X2	L24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:H14	CPC020_VCAP_6H_X3	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:L24	CPC020_VCAP_6H_X3	L24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:H14	CPC020_VCAP_6H_X4	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:L24	CPC020_VCAP_6H_X4	L24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:H14	CPC020_VCAP_6H_X5	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:L24	CPC020_VCAP_6H_X5	L24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:C12	CPC005_VCAP_24H_X4	C12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:C12	CPC005_VCAP_24H_X5	C12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:H22	CPC002_VCAP_24H_X1	H22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:H22	CPC002_VCAP_24H_X2	H22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:H22	CPC002_VCAP_24H_X3	H22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:H22	CPC002_VCAP_6H_X1	H22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:H22	CPC002_VCAP_6H_X2	H22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:H22	CPC002_VCAP_6H_X4	H22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:H22	CPC002_VCAP_6H_X5	H22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:N07	CPC005_VCAP_24H_X1	N07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:N07	CPC005_VCAP_24H_X2	N07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:N07	CPC005_VCAP_24H_X3	N07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:N07	CPC005_VCAP_6H_X4	N07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:N07	CPC005_VCAP_6H_X5	N07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:N07	CPC005_VCAP_24H_X4	N07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:N07	CPC005_VCAP_24H_X5	N07	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:N07	CPC005_VCAP_6H_X1	N07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:N07	CPC005_VCAP_6H_X2	N07	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:K21	CPC002_VCAP_24H_X1	K21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:K21	CPC002_VCAP_24H_X2	K21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:K21	CPC002_VCAP_24H_X3	K21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:K21	CPC002_VCAP_6H_X4	K21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:K21	CPC002_VCAP_6H_X5	K21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:O15	CPC011_VCAP_24H_X1	O15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:O15	CPC011_VCAP_24H_X2	O15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:O15	CPC011_VCAP_24H_X3	O15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:O15	CPC011_VCAP_24H_X4	O15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:O15	CPC011_VCAP_24H_X5	O15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:O15	CPC011_VCAP_6H_X2	O15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:O15	CPC011_VCAP_6H_X4	O15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:O15	CPC011_VCAP_6H_X5	O15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:K21	CPC002_VCAP_6H_X1	K21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:K21	CPC002_VCAP_6H_X2	K21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:O15	CPC011_VCAP_6H_X1	O15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:O15	CPC011_VCAP_6H_X3	O15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:J08	CPC002_VCAP_24H_X1	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:J08	CPC002_VCAP_24H_X2	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:J08	CPC002_VCAP_24H_X3	J08	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:J08	CPC002_VCAP_6H_X1	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:J08	CPC002_VCAP_6H_X2	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:J08	CPC002_VCAP_6H_X4	J08	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X1	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X2	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X3	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X4.A2	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X4	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:A16	CPC004_VCAP_24H_X5	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:A16	CPC004_VCAP_6H_X1	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:A16	CPC004_VCAP_6H_X2	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:A16	CPC004_VCAP_6H_X3	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:A16	CPC004_VCAP_6H_X5	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:G23	CPC011_VCAP_24H_X2	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:G23	CPC011_VCAP_6H_X2	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:G23	CPC011_VCAP_6H_X4	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:G23	CPC011_VCAP_6H_X5	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:G23	CPC011_VCAP_24H_X3	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:G23	CPC011_VCAP_24H_X4	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:G23	CPC011_VCAP_24H_X5	G23	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:G23	CPC011_VCAP_6H_X1	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:G23	CPC011_VCAP_6H_X3	G23	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:D15	CPC020_VCAP_24H_X1	D15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:D15	CPC020_VCAP_24H_X2	D15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:D15	CPC020_VCAP_24H_X3	D15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:D15	CPC020_VCAP_24H_X4	D15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:D15	CPC020_VCAP_24H_X5	D15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:D15	CPC020_VCAP_6H_X1	D15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:D15	CPC020_VCAP_6H_X2	D15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:D15	CPC020_VCAP_6H_X3	D15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:D15	CPC020_VCAP_6H_X4	D15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:D15	CPC020_VCAP_6H_X5	D15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:A16	CPC011_VCAP_24H_X1	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:A16	CPC011_VCAP_24H_X2	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:A16	CPC011_VCAP_24H_X3	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:A16	CPC011_VCAP_24H_X4	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:A16	CPC011_VCAP_24H_X5	A16	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:A16	CPC011_VCAP_6H_X1	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:A16	CPC011_VCAP_6H_X2	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:A16	CPC011_VCAP_6H_X3	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:A16	CPC011_VCAP_6H_X4	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:A16	CPC011_VCAP_6H_X5	A16	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:H02	CPC002_VCAP_24H_X1	H02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:H02	CPC002_VCAP_24H_X2	H02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:H02	CPC002_VCAP_24H_X3	H02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:H02	CPC002_VCAP_6H_X1	H02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:H02	CPC002_VCAP_6H_X2	H02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:H02	CPC002_VCAP_6H_X4	H02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:H02	CPC002_VCAP_6H_X5	H02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:J05	CPC011_VCAP_24H_X2	J05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:J05	CPC011_VCAP_24H_X1	J05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:J05	CPC011_VCAP_24H_X3	J05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:J05	CPC011_VCAP_24H_X4	J05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:J05	CPC011_VCAP_24H_X5	J05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:J05	CPC011_VCAP_6H_X2	J05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:J05	CPC011_VCAP_6H_X3	J05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:J05	CPC011_VCAP_6H_X4	J05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:J05	CPC011_VCAP_6H_X5	J05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_VCAP_24H_X1_B3_DUO52HI53LO:O11	CPC002_VCAP_24H_X1	O11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_VCAP_24H_X2_B3_DUO52HI53LO:O11	CPC002_VCAP_24H_X2	O11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_VCAP_24H_X3_B3_DUO52HI53LO:O11	CPC002_VCAP_24H_X3	O11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_VCAP_6H_X1_F1B5_DUO52HI53LO:O11	CPC002_VCAP_6H_X1	O11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_VCAP_6H_X2_F1B5_DUO52HI53LO:O11	CPC002_VCAP_6H_X2	O11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_VCAP_6H_X4_B5_DUO52HI53LO:O11	CPC002_VCAP_6H_X4	O11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC002_VCAP_6H_X5_B5_DUO52HI53LO:O11	CPC002_VCAP_6H_X5	O11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_VCAP_24H_X1_F1B5_DUO52HI53LO:B15	CPC020_VCAP_24H_X1	B15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_VCAP_24H_X2_F1B5_DUO52HI53LO:B15	CPC020_VCAP_24H_X2	B15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_VCAP_24H_X3_F1B5_DUO52HI53LO:B15	CPC020_VCAP_24H_X3	B15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_VCAP_24H_X4_B5_DUO52HI53LO:B15	CPC020_VCAP_24H_X4	B15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_VCAP_24H_X5_B5_DUO52HI53LO:B15	CPC020_VCAP_24H_X5	B15	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_VCAP_6H_X1_F1B3_DUO52HI53LO:B15	CPC020_VCAP_6H_X1	B15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_VCAP_6H_X2_B4_DUO52HI53LO:B15	CPC020_VCAP_6H_X2	B15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_VCAP_6H_X3_B4_DUO52HI53LO:B15	CPC020_VCAP_6H_X3	B15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_VCAP_6H_X4_B5_DUO52HI53LO:B15	CPC020_VCAP_6H_X4	B15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_VCAP_6H_X5_B5_DUO52HI53LO:B15	CPC020_VCAP_6H_X5	B15	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:I12	CPC011_VCAP_24H_X2	I12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:I12	CPC011_VCAP_24H_X1	I12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:I12	CPC011_VCAP_24H_X3	I12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:I12	CPC011_VCAP_24H_X4	I12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:I12	CPC011_VCAP_24H_X5	I12	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:I12	CPC011_VCAP_6H_X1	I12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:I12	CPC011_VCAP_6H_X2	I12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:I12	CPC011_VCAP_6H_X3	I12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:I12	CPC011_VCAP_6H_X4	I12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:I12	CPC011_VCAP_6H_X5	I12	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X2	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X5	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:H24	CPC004_VCAP_6H_X1	H24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:H24	CPC004_VCAP_6H_X2	H24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:H24	CPC004_VCAP_6H_X3	H24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:H24	CPC004_VCAP_6H_X5	H24	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:I21	CPC011_VCAP_24H_X2	I21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X1	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X3	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X4.A2	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:H24	CPC004_VCAP_24H_X4	H24	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:I21	CPC011_VCAP_24H_X1	I21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:I21	CPC011_VCAP_24H_X3	I21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:I21	CPC011_VCAP_24H_X4	I21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:I21	CPC011_VCAP_24H_X5	I21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:I21	CPC011_VCAP_6H_X1	I21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:I21	CPC011_VCAP_6H_X2	I21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:I21	CPC011_VCAP_6H_X3	I21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:I21	CPC011_VCAP_6H_X4	I21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:I21	CPC011_VCAP_6H_X5	I21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X2	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X5	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:J02	CPC004_VCAP_6H_X1	J02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:J02	CPC004_VCAP_6H_X5	J02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X1	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X3	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X4.A2	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:J02	CPC004_VCAP_24H_X4	J02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:J02	CPC004_VCAP_6H_X2	J02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:J02	CPC004_VCAP_6H_X3	J02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X2	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X5	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:H13	CPC004_VCAP_6H_X1	H13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:H13	CPC004_VCAP_6H_X2	H13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:H13	CPC004_VCAP_6H_X3	H13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:H13	CPC004_VCAP_6H_X5	H13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:L11	CPC011_VCAP_24H_X2	L11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X1	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X3	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X4.A2	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:H13	CPC004_VCAP_24H_X4	H13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:L11	CPC011_VCAP_24H_X1	L11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:L11	CPC011_VCAP_24H_X3	L11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:L11	CPC011_VCAP_24H_X4	L11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:L11	CPC011_VCAP_24H_X5	L11	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:L11	CPC011_VCAP_6H_X1	L11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:L11	CPC011_VCAP_6H_X2	L11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:L11	CPC011_VCAP_6H_X3	L11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:L11	CPC011_VCAP_6H_X4	L11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:L11	CPC011_VCAP_6H_X5	L11	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_VCAP_24H_X1_B3_DUO52HI53LO:E19	CPC005_VCAP_24H_X1	E19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_VCAP_24H_X2_B3_DUO52HI53LO:E19	CPC005_VCAP_24H_X2	E19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_VCAP_24H_X3_B3_DUO52HI53LO:E19	CPC005_VCAP_24H_X3	E19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_VCAP_6H_X1_F1B3_DUO52HI53LO:E19	CPC005_VCAP_6H_X1	E19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_VCAP_6H_X2_F1B3_DUO52HI53LO:E19	CPC005_VCAP_6H_X2	E19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_VCAP_6H_X4_B5_DUO52HI53LO:E19	CPC005_VCAP_6H_X4	E19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_VCAP_6H_X5_B5_DUO52HI53LO:E19	CPC005_VCAP_6H_X5	E19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_VCAP_24H_X4_F1B5_DUO52HI53LO:E19	CPC005_VCAP_24H_X4	E19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_VCAP_24H_X5_F2B4_DUO52HI53LO:E19	CPC005_VCAP_24H_X5	E19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X2	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X5	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:I06	CPC004_VCAP_6H_X1	I06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:I06	CPC004_VCAP_6H_X2	I06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:I06	CPC004_VCAP_6H_X3	I06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:I06	CPC004_VCAP_6H_X5	I06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:K13	CPC011_VCAP_24H_X2	K13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X1	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X3	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X4.A2	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:I06	CPC004_VCAP_24H_X4	I06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:K13	CPC011_VCAP_24H_X1	K13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:K13	CPC011_VCAP_24H_X3	K13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:K13	CPC011_VCAP_24H_X4	K13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:K13	CPC011_VCAP_24H_X5	K13	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:K13	CPC011_VCAP_6H_X1	K13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:K13	CPC011_VCAP_6H_X2	K13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:K13	CPC011_VCAP_6H_X3	K13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:K13	CPC011_VCAP_6H_X4	K13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:K13	CPC011_VCAP_6H_X5	K13	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X1	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X2	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X3	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X4	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X5	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X1	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X2	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X3	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:I02	CPC004_VCAP_6H_X5	I02	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:I02	CPC004_VCAP_24H_X4.A2	I02	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X1	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X2	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X3	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X4.A2	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X4	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:J06	CPC004_VCAP_24H_X5	J06	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:J06	CPC004_VCAP_6H_X1	J06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:J06	CPC004_VCAP_6H_X2	J06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:J06	CPC004_VCAP_6H_X3	J06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:J06	CPC004_VCAP_6H_X5	J06	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:J19	CPC011_VCAP_24H_X1	J19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:J19	CPC011_VCAP_24H_X2	J19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:J19	CPC011_VCAP_24H_X3	J19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:J19	CPC011_VCAP_24H_X4	J19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:J19	CPC011_VCAP_24H_X5	J19	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:J19	CPC011_VCAP_6H_X2	J19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:J19	CPC011_VCAP_6H_X4	J19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:J19	CPC011_VCAP_6H_X5	J19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:J19	CPC011_VCAP_6H_X1	J19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:J19	CPC011_VCAP_6H_X3	J19	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:H14	CPC011_VCAP_24H_X2	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:H14	CPC011_VCAP_6H_X2	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:H14	CPC011_VCAP_6H_X4	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:H14	CPC011_VCAP_6H_X5	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:H14	CPC011_VCAP_24H_X1	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:H14	CPC011_VCAP_24H_X3	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:H14	CPC011_VCAP_24H_X4	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:H14	CPC011_VCAP_24H_X5	H14	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:H14	CPC011_VCAP_6H_X1	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:H14	CPC011_VCAP_6H_X3	H14	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_VCAP_24H_X2_B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X2	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_VCAP_24H_X5_B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X5	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_VCAP_6H_X1_B5_DUO52HI53LO:J03	CPC004_VCAP_6H_X1	J03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_VCAP_6H_X2_F1B5_DUO52HI53LO:J03	CPC004_VCAP_6H_X2	J03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_VCAP_6H_X3_F1B5_DUO52HI53LO:J03	CPC004_VCAP_6H_X3	J03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_VCAP_6H_X5_B5_DUO52HI53LO:J03	CPC004_VCAP_6H_X5	J03	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_VCAP_24H_X1_B5_DUO52HI53LO:G22	CPC010_VCAP_24H_X1	G22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_VCAP_24H_X2_F1B5_DUO52HI53LO:G22	CPC010_VCAP_24H_X2	G22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_VCAP_24H_X3_F1B5_DUO52HI53LO:G22	CPC010_VCAP_24H_X3	G22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_VCAP_24H_X4_F1B5_DUO52HI53LO:G22	CPC010_VCAP_24H_X4	G22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_VCAP_24H_X5_F2B4_DUO52HI53LO:G22	CPC010_VCAP_24H_X5	G22	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_VCAP_6H_X1_F1B4_DUO52HI53LO:G22	CPC010_VCAP_6H_X1	G22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_VCAP_6H_X2_F1B4_DUO52HI53LO:G22	CPC010_VCAP_6H_X2	G22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_VCAP_6H_X3_F1B4_DUO52HI53LO:G22	CPC010_VCAP_6H_X3	G22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_VCAP_6H_X4_F2B4_DUO52HI53LO:G22	CPC010_VCAP_6H_X4	G22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_VCAP_6H_X5_B5_DUO52HI53LO:G22	CPC010_VCAP_6H_X5	G22	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_VCAP_24H_X2_F1B5_DUO52HI53LO:I05	CPC011_VCAP_24H_X2	I05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_VCAP_24H_X1_F1B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X1	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_VCAP_24H_X3_F1B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X3	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X4.A2	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC004_VCAP_24H_X4_F1B5_DUO52HI53LO:J03	CPC004_VCAP_24H_X4	J03	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_VCAP_24H_X1_B5_DUO52HI53LO:I05	CPC011_VCAP_24H_X1	I05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_VCAP_24H_X3_B5_DUO52HI53LO:I05	CPC011_VCAP_24H_X3	I05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_VCAP_24H_X4_B5_DUO52HI53LO:I05	CPC011_VCAP_24H_X4	I05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_VCAP_24H_X5_B5_DUO52HI53LO:I05	CPC011_VCAP_24H_X5	I05	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_VCAP_6H_X1_B5_DUO52HI53LO:I05	CPC011_VCAP_6H_X1	I05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_VCAP_6H_X2_F2B4_DUO52HI53LO:I05	CPC011_VCAP_6H_X2	I05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_VCAP_6H_X3_B5_DUO52HI53LO:I05	CPC011_VCAP_6H_X3	I05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_VCAP_6H_X4_F1B5_DUO52HI53LO:I05	CPC011_VCAP_6H_X4	I05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_VCAP_6H_X5_F1B5_DUO52HI53LO:I05	CPC011_VCAP_6H_X5	I05	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_VCAP_24H_X1_B3_DUO52HI53LO:L21	CPC001_VCAP_24H_X1	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_VCAP_24H_X2_B3_DUO52HI53LO:L21	CPC001_VCAP_24H_X2	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_VCAP_24H_X3_B3_DUO52HI53LO:L21	CPC001_VCAP_24H_X3	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_VCAP_24H_X4_F1B5_DUO52HI53LO:L21	CPC001_VCAP_24H_X4	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_VCAP_24H_X5_F2B4_DUO52HI53LO:L21	CPC001_VCAP_24H_X5	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_VCAP_6H_X1_F1B5_DUO52HI53LO:L21	CPC001_VCAP_6H_X1	L21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_VCAP_6H_X2_B5_DUO52HI53LO:L21	CPC001_VCAP_6H_X2	L21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_VCAP_6H_X3_F1B5_DUO52HI53LO:L21	CPC001_VCAP_6H_X3	L21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_VCAP_6H_X4_B5_DUO52HI53LO:L21	CPC001_VCAP_6H_X4	L21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_VCAP_24H_X4.A2_F1B5_DUO52HI53LO:L21	CPC001_VCAP_24H_X4.A2	L21	trt_cp	10.0	um	24	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC001_VCAP_6H_X1.A2_F1B5_DUO52HI53LO:L21	CPC001_VCAP_6H_X1.A2	L21	trt_cp	10.0	um	6	h	VCAP	cell line	VCAP	-666	-666	tumor	prostate	carcinoma	adherent	-666	ATCC	-666	M	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:G10	CPC011_A549_24H_X1	G10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:G10	CPC011_A549_24H_X3	G10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:G10	CPC011_A549_24H_X5	G10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:B03	CPC011_A549_24H_X1	B03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:B03	CPC011_A549_24H_X3	B03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:B03	CPC011_A549_24H_X5	B03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:G10	CPC011_A549_6H_X1	G10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:G10	CPC011_A549_6H_X2	G10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:G10	CPC011_A549_6H_X3	G10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:L09	CPC015_A549_24H_X1	L09	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:L09	CPC015_A549_24H_X2	L09	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:L09	CPC015_A549_24H_X3	L09	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:L09	CPC015_A549_6H_X1.L2	L09	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:L09	CPC015_A549_6H_X2.L2	L09	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:B03	CPC011_A549_6H_X1	B03	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:B03	CPC011_A549_6H_X2	B03	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:B03	CPC011_A549_6H_X3	B03	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:J10	CPC015_A549_24H_X1	J10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:J10	CPC015_A549_24H_X2	J10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:J10	CPC015_A549_24H_X3	J10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:J10	CPC015_A549_6H_X1.L2	J10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:J10	CPC015_A549_6H_X2.L2	J10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:K18	CPC017_A549_24H_X1	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:K18	CPC017_A549_24H_X2	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:K18	CPC017_A549_24H_X3	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:K18	CPC017_A549_6H_X1	K18	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:K18	CPC017_A549_6H_X2	K18	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:K18	CPC017_A549_6H_X3	K18	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:F24	CPC020_A549_6H_X1.L2	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:H08	CPC020_A549_6H_X1.L2	H08	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:F24	CPC020_A549_6H_X3.L2	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:H08	CPC020_A549_6H_X3.L2	H08	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A549_24H_X1_B3_DUO52HI53LO:F24	CPC005_A549_24H_X1	F24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A549_24H_X2_B3_DUO52HI53LO:F24	CPC005_A549_24H_X2	F24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A549_24H_X3_B3_DUO52HI53LO:F24	CPC005_A549_24H_X3	F24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A549_6H_X1_B3_DUO52HI53LO:F24	CPC005_A549_6H_X1	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A549_6H_X2_B3_DUO52HI53LO:F24	CPC005_A549_6H_X2	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC005_A549_6H_X3_B3_DUO52HI53LO:F24	CPC005_A549_6H_X3	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_A549_24H_X1_F1B6_DUO52HI53LO:B24	CPC009_A549_24H_X1	B24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_A549_24H_X4_F1B6_DUO52HI53LO:B24	CPC009_A549_24H_X4	B24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_A549_6H_X1_B4_DUO52HI53LO:B24	CPC009_A549_6H_X1	B24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_A549_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_A549_6H_X2	B24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC009_A549_6H_X3_B4_DUO52HI53LO:B24	CPC009_A549_6H_X3	B24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:P10	CPC011_A549_24H_X1	P10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:P10	CPC011_A549_24H_X3	P10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:P10	CPC011_A549_24H_X5	P10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:P10	CPC011_A549_6H_X1	P10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:P10	CPC011_A549_6H_X2	P10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB04	citalopram	BRD-A47598013	1	9	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:P10	CPC011_A549_6H_X3	P10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A549_24H_X1_B3_DUO52HI53LO:F24	CPC005_A549_24H_X1	F24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A549_24H_X2_B3_DUO52HI53LO:F24	CPC005_A549_24H_X2	F24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A549_24H_X3_B3_DUO52HI53LO:F24	CPC005_A549_24H_X3	F24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A549_6H_X1_B3_DUO52HI53LO:F24	CPC005_A549_6H_X1	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A549_6H_X2_B3_DUO52HI53LO:F24	CPC005_A549_6H_X2	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC005_A549_6H_X3_B3_DUO52HI53LO:F24	CPC005_A549_6H_X3	F24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_A549_24H_X1_F1B6_DUO52HI53LO:B24	CPC009_A549_24H_X1	B24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_A549_24H_X4_F1B6_DUO52HI53LO:B24	CPC009_A549_24H_X4	B24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_A549_6H_X1_B4_DUO52HI53LO:B24	CPC009_A549_6H_X1	B24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_A549_6H_X2_F1B3_DUO52HI53LO:B24	CPC009_A549_6H_X2	B24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC009_A549_6H_X3_B4_DUO52HI53LO:B24	CPC009_A549_6H_X3	B24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:P10	CPC011_A549_24H_X1	P10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:P10	CPC011_A549_24H_X3	P10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:P10	CPC011_A549_24H_X5	P10	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:P10	CPC011_A549_6H_X1	P10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:P10	CPC011_A549_6H_X2	P10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002771	N06AB10	citalopram	BRD-A47598013	1	9	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:P10	CPC011_A549_6H_X3	P10	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_A549_24H_X1_F1B6_DUO52HI53LO:F20	CPC018_A549_24H_X1	F20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_A549_24H_X2_F1B6_DUO52HI53LO:F20	CPC018_A549_24H_X2	F20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_A549_6H_X1_F1B3_DUO52HI53LO:F20	CPC018_A549_6H_X1	F20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_A549_6H_X2_F1B3_DUO52HI53LO:F20	CPC018_A549_6H_X2	F20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_A549_6H_X3_F1B4_DUO52HI53LO:F20	CPC018_A549_6H_X3	F20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:P19	CPC020_A549_6H_X1.L2	P19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:P19	CPC020_A549_6H_X3.L2	P19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:M02	CPC017_A549_24H_X1	M02	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:M02	CPC017_A549_24H_X2	M02	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:M02	CPC017_A549_24H_X3	M02	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:M02	CPC017_A549_6H_X1	M02	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:M02	CPC017_A549_6H_X2	M02	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:M02	CPC017_A549_6H_X3	M02	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:F21	CPC020_A549_6H_X1.L2	F21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:F21	CPC020_A549_6H_X3.L2	F21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_A549_24H_X1_F1B6_DUO52HI53LO:A20	CPC018_A549_24H_X1	A20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_A549_24H_X2_F1B6_DUO52HI53LO:A20	CPC018_A549_24H_X2	A20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_A549_6H_X1_F1B3_DUO52HI53LO:A20	CPC018_A549_6H_X1	A20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_A549_6H_X2_F1B3_DUO52HI53LO:A20	CPC018_A549_6H_X2	A20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_A549_6H_X3_F1B4_DUO52HI53LO:A20	CPC018_A549_6H_X3	A20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:O16	CPC017_A549_24H_X1	O16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:O16	CPC017_A549_24H_X2	O16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:O16	CPC017_A549_24H_X3	O16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:O16	CPC017_A549_6H_X1	O16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:O16	CPC017_A549_6H_X2	O16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:O16	CPC017_A549_6H_X3	O16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:G15	CPC011_A549_24H_X1	G15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:G15	CPC011_A549_24H_X3	G15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:G15	CPC011_A549_24H_X5	G15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:G15	CPC011_A549_6H_X1	G15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:G15	CPC011_A549_6H_X2	G15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:G15	CPC011_A549_6H_X3	G15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:I07	CPC017_A549_24H_X1	I07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:I07	CPC017_A549_24H_X2	I07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:I07	CPC017_A549_24H_X3	I07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:I07	CPC017_A549_6H_X1	I07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:I07	CPC017_A549_6H_X2	I07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:I07	CPC017_A549_6H_X3	I07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:O02	CPC020_A549_6H_X1.L2	O02	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:O02	CPC020_A549_6H_X3.L2	O02	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A549_24H_X1_B3_DUO52HI53LO:P19	CPC005_A549_24H_X1	P19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A549_24H_X2_B3_DUO52HI53LO:P19	CPC005_A549_24H_X2	P19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A549_24H_X3_B3_DUO52HI53LO:P19	CPC005_A549_24H_X3	P19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A549_6H_X1_B3_DUO52HI53LO:P19	CPC005_A549_6H_X1	P19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A549_6H_X2_B3_DUO52HI53LO:P19	CPC005_A549_6H_X2	P19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC005_A549_6H_X3_B3_DUO52HI53LO:P19	CPC005_A549_6H_X3	P19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_A549_24H_X1_F1B6_DUO52HI53LO:J24	CPC009_A549_24H_X1	J24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_A549_24H_X4_F1B6_DUO52HI53LO:J24	CPC009_A549_24H_X4	J24	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_A549_6H_X2_F1B3_DUO52HI53LO:J24	CPC009_A549_6H_X2	J24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_A549_6H_X1_B4_DUO52HI53LO:J24	CPC009_A549_6H_X1	J24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	CPC009_A549_6H_X3_B4_DUO52HI53LO:J24	CPC009_A549_6H_X3	J24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:E15	CPC011_A549_24H_X1	E15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:E15	CPC011_A549_24H_X3	E15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:E15	CPC011_A549_24H_X5	E15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:E15	CPC011_A549_6H_X1	E15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:E15	CPC011_A549_6H_X2	E15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K31534764	2	7	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:E15	CPC011_A549_6H_X3	E15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:M15	CPC016_A549_24H_X1	M15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:M15	CPC016_A549_24H_X2	M15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:M15	CPC016_A549_24H_X3	M15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:M15	CPC016_A549_6H_X1	M15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:M15	CPC016_A549_6H_X2	M15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_A549_24H_X1_F1B6_DUO52HI53LO:K23	CPC009_A549_24H_X1	K23	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_A549_24H_X4_F1B6_DUO52HI53LO:K23	CPC009_A549_24H_X4	K23	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_A549_6H_X1_B4_DUO52HI53LO:K23	CPC009_A549_6H_X1	K23	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC009_A549_6H_X2_F1B3_DUO52HI53LO:K23	CPC009_A549_6H_X2	K23	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:I11	CPC011_A549_24H_X1	I11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:I11	CPC011_A549_24H_X3	I11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:I11	CPC011_A549_24H_X5	I11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:I11	CPC011_A549_6H_X1	I11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:I11	CPC011_A549_6H_X2	I11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003675	N06AF03	phenelzine	BRD-K87024524	1	9	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:I11	CPC011_A549_6H_X3	I11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A549_24H_X1_B3_DUO52HI53LO:C12	CPC005_A549_24H_X1	C12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A549_24H_X2_B3_DUO52HI53LO:C12	CPC005_A549_24H_X2	C12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A549_24H_X3_B3_DUO52HI53LO:C12	CPC005_A549_24H_X3	C12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A549_6H_X1_B3_DUO52HI53LO:C12	CPC005_A549_6H_X1	C12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A549_6H_X2_B3_DUO52HI53LO:C12	CPC005_A549_6H_X2	C12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC005_A549_6H_X3_B3_DUO52HI53LO:C12	CPC005_A549_6H_X3	C12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:H14	CPC020_A549_6H_X1.L2	H14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:L24	CPC020_A549_6H_X1.L2	L24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:H14	CPC020_A549_6H_X3.L2	H14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:L24	CPC020_A549_6H_X3.L2	L24	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:M20	CPC016_A549_24H_X1	M20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:M20	CPC016_A549_24H_X2	M20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:M20	CPC016_A549_24H_X3	M20	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:M20	CPC016_A549_6H_X1	M20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:M20	CPC016_A549_6H_X2	M20	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A549_24H_X1_B3_DUO52HI53LO:N07	CPC005_A549_24H_X1	N07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A549_24H_X2_B3_DUO52HI53LO:N07	CPC005_A549_24H_X2	N07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A549_24H_X3_B3_DUO52HI53LO:N07	CPC005_A549_24H_X3	N07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A549_6H_X1_B3_DUO52HI53LO:N07	CPC005_A549_6H_X1	N07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A549_6H_X2_B3_DUO52HI53LO:N07	CPC005_A549_6H_X2	N07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K03319035	2	8	CPC005_A549_6H_X3_B3_DUO52HI53LO:N07	CPC005_A549_6H_X3	N07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:O15	CPC011_A549_24H_X1	O15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:O15	CPC011_A549_24H_X3	O15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:O15	CPC011_A549_24H_X5	O15	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:O15	CPC011_A549_6H_X1	O15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:O15	CPC011_A549_6H_X2	O15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:O15	CPC011_A549_6H_X3	O15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_A549_24H_X1_F1B6_DUO52HI53LO:H09	CPC018_A549_24H_X1	H09	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_A549_24H_X2_F1B6_DUO52HI53LO:H09	CPC018_A549_24H_X2	H09	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_A549_6H_X1_F1B3_DUO52HI53LO:H09	CPC018_A549_6H_X1	H09	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_A549_6H_X2_F1B3_DUO52HI53LO:H09	CPC018_A549_6H_X2	H09	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_A549_6H_X3_F1B4_DUO52HI53LO:H09	CPC018_A549_6H_X3	H09	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:O06	CPC016_A549_24H_X1	O06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:O06	CPC016_A549_24H_X2	O06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:O06	CPC016_A549_24H_X3	O06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:O06	CPC016_A549_6H_X1	O06	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:O06	CPC016_A549_6H_X2	O06	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:G23	CPC011_A549_24H_X1	G23	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:G23	CPC011_A549_24H_X3	G23	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:G23	CPC011_A549_24H_X5	G23	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:G23	CPC011_A549_6H_X1	G23	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:G23	CPC011_A549_6H_X2	G23	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:G23	CPC011_A549_6H_X3	G23	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:H06	CPC016_A549_24H_X1	H06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:H06	CPC016_A549_24H_X2	H06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:H06	CPC016_A549_24H_X3	H06	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:H06	CPC016_A549_6H_X1	H06	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:H06	CPC016_A549_6H_X2	H06	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:D15	CPC020_A549_6H_X1.L2	D15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004205	N06AX11	mirtazapine	BRD-K83153774	2	8	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:D15	CPC020_A549_6H_X3.L2	D15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:A16	CPC011_A549_24H_X1	A16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:A16	CPC011_A549_24H_X3	A16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:A16	CPC011_A549_24H_X5	A16	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:A16	CPC011_A549_6H_X1	A16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:A16	CPC011_A549_6H_X2	A16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004235	N06AG02	moclobemide	BRD-K07237224	1	7	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:A16	CPC011_A549_6H_X3	A16	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:J05	CPC011_A549_24H_X1	J05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:J05	CPC011_A549_24H_X3	J05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:J05	CPC011_A549_24H_X5	J05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:K22	CPC016_A549_24H_X1	K22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:K22	CPC016_A549_24H_X2	K22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:K22	CPC016_A549_24H_X3	K22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:K22	CPC016_A549_6H_X1	K22	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:K22	CPC016_A549_6H_X2	K22	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:J05	CPC011_A549_6H_X1	J05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:J05	CPC011_A549_6H_X2	J05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:J05	CPC011_A549_6H_X3	J05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_A549_24H_X1_F1B6_DUO52HI53LO:J19	CPC018_A549_24H_X1	J19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_A549_24H_X2_F1B6_DUO52HI53LO:J19	CPC018_A549_24H_X2	J19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_A549_6H_X1_F1B3_DUO52HI53LO:J19	CPC018_A549_6H_X1	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_A549_6H_X2_F1B3_DUO52HI53LO:J19	CPC018_A549_6H_X2	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_A549_6H_X3_F1B4_DUO52HI53LO:J19	CPC018_A549_6H_X3	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_A549_6H_X1.L2_F2B5_DUO52HI53LO:B15	CPC020_A549_6H_X1.L2	B15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-A62326914	3	8	CPC020_A549_6H_X3.L2_F2B5_DUO52HI53LO:B15	CPC020_A549_6H_X3.L2	B15	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:I12	CPC011_A549_24H_X1	I12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:I12	CPC011_A549_24H_X3	I12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:I12	CPC011_A549_24H_X5	I12	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:I12	CPC011_A549_6H_X1	I12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:I12	CPC011_A549_6H_X2	I12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K19277754	3	7	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:I12	CPC011_A549_6H_X3	I12	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:I21	CPC011_A549_24H_X1	I21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:I21	CPC011_A549_24H_X3	I21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:I21	CPC011_A549_24H_X5	I21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:L01	CPC015_A549_24H_X1	L01	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:L01	CPC015_A549_24H_X2	L01	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:L01	CPC015_A549_24H_X3	L01	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:L01	CPC015_A549_6H_X1.L2	L01	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:L01	CPC015_A549_6H_X2.L2	L01	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:I21	CPC011_A549_6H_X1	I21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:I21	CPC011_A549_6H_X2	I21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:I21	CPC011_A549_6H_X3	I21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:L03	CPC015_A549_24H_X1	L03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:L03	CPC015_A549_24H_X2	L03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:L03	CPC015_A549_24H_X3	L03	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:L03	CPC015_A549_6H_X1.L2	L03	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:L03	CPC015_A549_6H_X2.L2	L03	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:L11	CPC011_A549_24H_X1	L11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:L11	CPC011_A549_24H_X3	L11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:L11	CPC011_A549_24H_X5	L11	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:K04	CPC015_A549_24H_X1	K04	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:K04	CPC015_A549_24H_X2	K04	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:K04	CPC015_A549_24H_X3	K04	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:K04	CPC015_A549_6H_X1.L2	K04	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:K04	CPC015_A549_6H_X2.L2	K04	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:L11	CPC011_A549_6H_X1	L11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:L11	CPC011_A549_6H_X2	L11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:L11	CPC011_A549_6H_X3	L11	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A549_24H_X1_B3_DUO52HI53LO:E19	CPC005_A549_24H_X1	E19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A549_24H_X2_B3_DUO52HI53LO:E19	CPC005_A549_24H_X2	E19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A549_24H_X3_B3_DUO52HI53LO:E19	CPC005_A549_24H_X3	E19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A549_6H_X1_B3_DUO52HI53LO:E19	CPC005_A549_6H_X1	E19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A549_6H_X2_B3_DUO52HI53LO:E19	CPC005_A549_6H_X2	E19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005530	N06AF04	tranylcypromine	BRD-A43974575	3	8	CPC005_A549_6H_X3_B3_DUO52HI53LO:E19	CPC005_A549_6H_X3	E19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:K13	CPC011_A549_24H_X1	K13	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:K13	CPC011_A549_24H_X3	K13	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:K13	CPC011_A549_24H_X5	K13	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:N14	CPC016_A549_24H_X1	N14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:N14	CPC016_A549_24H_X2	N14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:N14	CPC016_A549_24H_X3	N14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:N14	CPC016_A549_6H_X1	N14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:N14	CPC016_A549_6H_X2	N14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:K13	CPC011_A549_6H_X1	K13	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:K13	CPC011_A549_6H_X2	K13	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:K13	CPC011_A549_6H_X3	K13	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_A549_24H_X1_F1B6_DUO52HI53LO:N08	CPC016_A549_24H_X1	N08	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_A549_24H_X2_F1B6_DUO52HI53LO:N08	CPC016_A549_24H_X2	N08	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_A549_24H_X3_F1B6_DUO52HI53LO:N08	CPC016_A549_24H_X3	N08	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_A549_6H_X1_F1B4_DUO52HI53LO:N08	CPC016_A549_6H_X1	N08	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_A549_6H_X2_F1B4_DUO52HI53LO:N08	CPC016_A549_6H_X2	N08	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:J19	CPC011_A549_24H_X1	J19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:J19	CPC011_A549_24H_X3	J19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:J19	CPC011_A549_24H_X5	J19	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:J19	CPC011_A549_6H_X1	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:J19	CPC011_A549_6H_X2	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:J19	CPC011_A549_6H_X3	J19	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:L07	CPC015_A549_24H_X1	L07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:L07	CPC015_A549_24H_X2	L07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:L07	CPC015_A549_24H_X3	L07	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:L07	CPC015_A549_6H_X1.L2	L07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:L07	CPC015_A549_6H_X2.L2	L07	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:H14	CPC011_A549_24H_X1	H14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:H14	CPC011_A549_24H_X3	H14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:H14	CPC011_A549_24H_X5	H14	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:H14	CPC011_A549_6H_X1	H14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:H14	CPC011_A549_6H_X2	H14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100055480	N06AX17	milnacipran	BRD-K02227374	1	7	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:H14	CPC011_A549_6H_X3	H14	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_A549_24H_X2_F1B6_DUO52HI53LO:G22	CPC010_A549_24H_X2	G22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_A549_24H_X4_F1B6_DUO52HI53LO:G22	CPC010_A549_24H_X4	G22	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_A549_6H_X1_B4_DUO52HI53LO:G22	CPC010_A549_6H_X1	G22	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC010_A549_6H_X3_F1B3_DUO52HI53LO:G22	CPC010_A549_6H_X3	G22	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_A549_24H_X1_F1B6_DUO52HI53LO:I05	CPC011_A549_24H_X1	I05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_A549_24H_X3_F1B6_DUO52HI53LO:I05	CPC011_A549_24H_X3	I05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_A549_24H_X5_F1B6_DUO52HI53LO:I05	CPC011_A549_24H_X5	I05	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_A549_24H_X1_F1B6_DUO52HI53LO:K18	CPC015_A549_24H_X1	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_A549_24H_X2_F1B6_DUO52HI53LO:K18	CPC015_A549_24H_X2	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_A549_24H_X3_F1B6_DUO52HI53LO:K18	CPC015_A549_24H_X3	K18	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_A549_6H_X1.L2_F2B5_DUO52HI53LO:K18	CPC015_A549_6H_X1.L2	K18	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_A549_6H_X2.L2_F2B5_DUO52HI53LO:K18	CPC015_A549_6H_X2.L2	K18	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_A549_6H_X1_F1B3_DUO52HI53LO:I05	CPC011_A549_6H_X1	I05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_A549_6H_X2_F1B3_DUO52HI53LO:I05	CPC011_A549_6H_X2	I05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC011_A549_6H_X3_F1B3_DUO52HI53LO:I05	CPC011_A549_6H_X3	I05	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_A549_24H_X1_F1B6_DUO52HI53LO:F21	CPC017_A549_24H_X1	F21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_A549_24H_X2_F1B6_DUO52HI53LO:F21	CPC017_A549_24H_X2	F21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_A549_24H_X3_F1B6_DUO52HI53LO:F21	CPC017_A549_24H_X3	F21	trt_cp	10.0	um	24	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_A549_6H_X1_F1B4_DUO52HI53LO:F21	CPC017_A549_6H_X1	F21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_A549_6H_X2_F1B4_DUO52HI53LO:F21	CPC017_A549_6H_X2	F21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_A549_6H_X3_F1B4_DUO52HI53LO:F21	CPC017_A549_6H_X3	F21	trt_cp	10.0	um	6	h	A549	cell line	A549	-666	-666	tumor	lung	non small cell lung cancer| carcinoma	adherent	CCL-185	ATCC	58	M	Caucasian
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_ASC_24H_X1_B7_DUO52HI53LO:L09	CPC015_ASC_24H_X1	L09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_ASC_24H_X2_B7_DUO52HI53LO:L09	CPC015_ASC_24H_X2	L09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_ASC_24H_X3_B7_DUO52HI53LO:L09	CPC015_ASC_24H_X3	L09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_ASC_24H_X4_B7_DUO52HI53LO:L09	CPC015_ASC_24H_X4	L09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_ASC_24H_X1_B7_DUO52HI53LO:J10	CPC015_ASC_24H_X1	J10	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_ASC_24H_X2_B7_DUO52HI53LO:J10	CPC015_ASC_24H_X2	J10	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_ASC_24H_X3_B7_DUO52HI53LO:J10	CPC015_ASC_24H_X3	J10	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_ASC_24H_X4_B7_DUO52HI53LO:J10	CPC015_ASC_24H_X4	J10	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_ASC_24H_X1_B7_DUO52HI53LO:K18	CPC017_ASC_24H_X1	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_ASC_24H_X2_B7_DUO52HI53LO:K18	CPC017_ASC_24H_X2	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_ASC_24H_X3_B7_DUO52HI53LO:K18	CPC017_ASC_24H_X3	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_ASC_24H_X4_B7_DUO52HI53LO:K18	CPC017_ASC_24H_X4	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_ASC_24H_X1_B7_DUO52HI53LO:F20	CPC018_ASC_24H_X1	F20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_ASC_24H_X2_B7_DUO52HI53LO:F20	CPC018_ASC_24H_X2	F20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_ASC_24H_X4_B7_DUO52HI53LO:F20	CPC018_ASC_24H_X4	F20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_ASC_24H_X1_B7_DUO52HI53LO:M02	CPC017_ASC_24H_X1	M02	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_ASC_24H_X2_B7_DUO52HI53LO:M02	CPC017_ASC_24H_X2	M02	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_ASC_24H_X3_B7_DUO52HI53LO:M02	CPC017_ASC_24H_X3	M02	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_ASC_24H_X4_B7_DUO52HI53LO:M02	CPC017_ASC_24H_X4	M02	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_ASC_24H_X1_B7_DUO52HI53LO:A20	CPC018_ASC_24H_X1	A20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_ASC_24H_X2_B7_DUO52HI53LO:A20	CPC018_ASC_24H_X2	A20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_ASC_24H_X4_B7_DUO52HI53LO:A20	CPC018_ASC_24H_X4	A20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_ASC_24H_X1_B7_DUO52HI53LO:O16	CPC017_ASC_24H_X1	O16	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_ASC_24H_X2_B7_DUO52HI53LO:O16	CPC017_ASC_24H_X2	O16	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_ASC_24H_X3_B7_DUO52HI53LO:O16	CPC017_ASC_24H_X3	O16	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_ASC_24H_X4_B7_DUO52HI53LO:O16	CPC017_ASC_24H_X4	O16	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_ASC_24H_X1_B7_DUO52HI53LO:I07	CPC017_ASC_24H_X1	I07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_ASC_24H_X2_B7_DUO52HI53LO:I07	CPC017_ASC_24H_X2	I07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_ASC_24H_X3_B7_DUO52HI53LO:I07	CPC017_ASC_24H_X3	I07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_ASC_24H_X4_B7_DUO52HI53LO:I07	CPC017_ASC_24H_X4	I07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_ASC_24H_X1_B7_DUO52HI53LO:M15	CPC016_ASC_24H_X1	M15	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_ASC_24H_X3_B7_DUO52HI53LO:M15	CPC016_ASC_24H_X3	M15	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_ASC_24H_X4_B7_DUO52HI53LO:M15	CPC016_ASC_24H_X4	M15	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_ASC_24H_X1_B7_DUO52HI53LO:M20	CPC016_ASC_24H_X1	M20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_ASC_24H_X3_B7_DUO52HI53LO:M20	CPC016_ASC_24H_X3	M20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_ASC_24H_X4_B7_DUO52HI53LO:M20	CPC016_ASC_24H_X4	M20	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_ASC_24H_X1_B7_DUO52HI53LO:H09	CPC018_ASC_24H_X1	H09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_ASC_24H_X2_B7_DUO52HI53LO:H09	CPC018_ASC_24H_X2	H09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_ASC_24H_X4_B7_DUO52HI53LO:H09	CPC018_ASC_24H_X4	H09	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_ASC_24H_X1_B7_DUO52HI53LO:O06	CPC016_ASC_24H_X1	O06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_ASC_24H_X3_B7_DUO52HI53LO:O06	CPC016_ASC_24H_X3	O06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_ASC_24H_X4_B7_DUO52HI53LO:O06	CPC016_ASC_24H_X4	O06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_ASC_24H_X1_B7_DUO52HI53LO:H06	CPC016_ASC_24H_X1	H06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_ASC_24H_X3_B7_DUO52HI53LO:H06	CPC016_ASC_24H_X3	H06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_ASC_24H_X4_B7_DUO52HI53LO:H06	CPC016_ASC_24H_X4	H06	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_ASC_24H_X1_B7_DUO52HI53LO:K22	CPC016_ASC_24H_X1	K22	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_ASC_24H_X3_B7_DUO52HI53LO:K22	CPC016_ASC_24H_X3	K22	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_ASC_24H_X4_B7_DUO52HI53LO:K22	CPC016_ASC_24H_X4	K22	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_ASC_24H_X1_B7_DUO52HI53LO:J19	CPC018_ASC_24H_X1	J19	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_ASC_24H_X2_B7_DUO52HI53LO:J19	CPC018_ASC_24H_X2	J19	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_ASC_24H_X4_B7_DUO52HI53LO:J19	CPC018_ASC_24H_X4	J19	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_ASC_24H_X1_B7_DUO52HI53LO:L01	CPC015_ASC_24H_X1	L01	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_ASC_24H_X2_B7_DUO52HI53LO:L01	CPC015_ASC_24H_X2	L01	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_ASC_24H_X3_B7_DUO52HI53LO:L01	CPC015_ASC_24H_X3	L01	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_ASC_24H_X4_B7_DUO52HI53LO:L01	CPC015_ASC_24H_X4	L01	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_ASC_24H_X1_B7_DUO52HI53LO:L03	CPC015_ASC_24H_X1	L03	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_ASC_24H_X2_B7_DUO52HI53LO:L03	CPC015_ASC_24H_X2	L03	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_ASC_24H_X3_B7_DUO52HI53LO:L03	CPC015_ASC_24H_X3	L03	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_ASC_24H_X4_B7_DUO52HI53LO:L03	CPC015_ASC_24H_X4	L03	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_ASC_24H_X1_B7_DUO52HI53LO:K04	CPC015_ASC_24H_X1	K04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_ASC_24H_X2_B7_DUO52HI53LO:K04	CPC015_ASC_24H_X2	K04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_ASC_24H_X3_B7_DUO52HI53LO:K04	CPC015_ASC_24H_X3	K04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_ASC_24H_X4_B7_DUO52HI53LO:K04	CPC015_ASC_24H_X4	K04	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_ASC_24H_X1_B7_DUO52HI53LO:N14	CPC016_ASC_24H_X1	N14	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_ASC_24H_X3_B7_DUO52HI53LO:N14	CPC016_ASC_24H_X3	N14	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_ASC_24H_X4_B7_DUO52HI53LO:N14	CPC016_ASC_24H_X4	N14	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_ASC_24H_X1_B7_DUO52HI53LO:N08	CPC016_ASC_24H_X1	N08	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_ASC_24H_X3_B7_DUO52HI53LO:N08	CPC016_ASC_24H_X3	N08	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_ASC_24H_X4_B7_DUO52HI53LO:N08	CPC016_ASC_24H_X4	N08	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_ASC_24H_X1_B7_DUO52HI53LO:L07	CPC015_ASC_24H_X1	L07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_ASC_24H_X2_B7_DUO52HI53LO:L07	CPC015_ASC_24H_X2	L07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_ASC_24H_X3_B7_DUO52HI53LO:L07	CPC015_ASC_24H_X3	L07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_ASC_24H_X4_B7_DUO52HI53LO:L07	CPC015_ASC_24H_X4	L07	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_ASC_24H_X1_B7_DUO52HI53LO:K18	CPC015_ASC_24H_X1	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_ASC_24H_X2_B7_DUO52HI53LO:K18	CPC015_ASC_24H_X2	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_ASC_24H_X3_B7_DUO52HI53LO:K18	CPC015_ASC_24H_X3	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_ASC_24H_X4_B7_DUO52HI53LO:K18	CPC015_ASC_24H_X4	K18	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_ASC_24H_X1_B7_DUO52HI53LO:F21	CPC017_ASC_24H_X1	F21	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_ASC_24H_X2_B7_DUO52HI53LO:F21	CPC017_ASC_24H_X2	F21	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_ASC_24H_X3_B7_DUO52HI53LO:F21	CPC017_ASC_24H_X3	F21	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_ASC_24H_X4_B7_DUO52HI53LO:F21	CPC017_ASC_24H_X4	F21	trt_cp	10.0	um	24	h	ASC	primary	ASC	-666	-666	primary	adipose	normal primary adipocyte stem cells	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_NPC_24H_X1_B7_DUO52HI53LO:L09	CPC015_NPC_24H_X1	L09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_NPC_24H_X2_B7_DUO52HI53LO:L09	CPC015_NPC_24H_X2	L09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_NPC_24H_X3_B7_DUO52HI53LO:L09	CPC015_NPC_24H_X3	L09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_NPC_24H_X4_B7_DUO52HI53LO:L09	CPC015_NPC_24H_X4	L09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_NPC_24H_X1_B7_DUO52HI53LO:J10	CPC015_NPC_24H_X1	J10	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_NPC_24H_X2_B7_DUO52HI53LO:J10	CPC015_NPC_24H_X2	J10	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_NPC_24H_X3_B7_DUO52HI53LO:J10	CPC015_NPC_24H_X3	J10	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_NPC_24H_X4_B7_DUO52HI53LO:J10	CPC015_NPC_24H_X4	J10	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_NPC_24H_X1_B7_DUO52HI53LO:K18	CPC017_NPC_24H_X1	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_NPC_24H_X2_B7_DUO52HI53LO:K18	CPC017_NPC_24H_X2	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_NPC_24H_X3_B7_DUO52HI53LO:K18	CPC017_NPC_24H_X3	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_NPC_24H_X4_B7_DUO52HI53LO:K18	CPC017_NPC_24H_X4	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_NPC_24H_X1_B7_DUO52HI53LO:F20	CPC018_NPC_24H_X1	F20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_NPC_24H_X2_B7_DUO52HI53LO:F20	CPC018_NPC_24H_X2	F20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_NPC_24H_X3_B7_DUO52HI53LO:F20	CPC018_NPC_24H_X3	F20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_NPC_24H_X1_B7_DUO52HI53LO:M02	CPC017_NPC_24H_X1	M02	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_NPC_24H_X2_B7_DUO52HI53LO:M02	CPC017_NPC_24H_X2	M02	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_NPC_24H_X3_B7_DUO52HI53LO:M02	CPC017_NPC_24H_X3	M02	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_NPC_24H_X4_B7_DUO52HI53LO:M02	CPC017_NPC_24H_X4	M02	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_NPC_24H_X1_B7_DUO52HI53LO:A20	CPC018_NPC_24H_X1	A20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_NPC_24H_X2_B7_DUO52HI53LO:A20	CPC018_NPC_24H_X2	A20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_NPC_24H_X3_B7_DUO52HI53LO:A20	CPC018_NPC_24H_X3	A20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_NPC_24H_X1_B7_DUO52HI53LO:O16	CPC017_NPC_24H_X1	O16	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_NPC_24H_X2_B7_DUO52HI53LO:O16	CPC017_NPC_24H_X2	O16	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_NPC_24H_X3_B7_DUO52HI53LO:O16	CPC017_NPC_24H_X3	O16	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_NPC_24H_X4_B7_DUO52HI53LO:O16	CPC017_NPC_24H_X4	O16	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_NPC_24H_X1_B7_DUO52HI53LO:I07	CPC017_NPC_24H_X1	I07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_NPC_24H_X2_B7_DUO52HI53LO:I07	CPC017_NPC_24H_X2	I07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_NPC_24H_X3_B7_DUO52HI53LO:I07	CPC017_NPC_24H_X3	I07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_NPC_24H_X4_B7_DUO52HI53LO:I07	CPC017_NPC_24H_X4	I07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NPC_24H_X1_B6_DUO52HI53LO:G06	NMH001_NPC_24H_X1	G06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NPC_24H_X2.L2_B6_DUO52HI53LO:G06	NMH001_NPC_24H_X2.L2	G06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NPC_24H_X2_B6_DUO52HI53LO:G06	NMH001_NPC_24H_X2	G06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NPC_24H_X3.L2_B6_DUO52HI53LO:G06	NMH001_NPC_24H_X3.L2	G06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NPC_6H_X1_B6_DUO52HI53LO:G06	NMH001_NPC_6H_X1	G06	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NPC_6H_X2.L2_B6_DUO52HI53LO:G06	NMH001_NPC_6H_X2.L2	G06	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NPC_6H_X3_B6_DUO52HI53LO:G06	NMH001_NPC_6H_X3	G06	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_NPC_24H_X1_B7_DUO52HI53LO:M15	CPC016_NPC_24H_X1	M15	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_NPC_24H_X2_B7_DUO52HI53LO:M15	CPC016_NPC_24H_X2	M15	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_NPC_24H_X3_B7_DUO52HI53LO:M15	CPC016_NPC_24H_X3	M15	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_NPC_24H_X4_B7_DUO52HI53LO:M15	CPC016_NPC_24H_X4	M15	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_NPC_24H_X1_B7_DUO52HI53LO:M20	CPC016_NPC_24H_X1	M20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_NPC_24H_X2_B7_DUO52HI53LO:M20	CPC016_NPC_24H_X2	M20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_NPC_24H_X3_B7_DUO52HI53LO:M20	CPC016_NPC_24H_X3	M20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_NPC_24H_X4_B7_DUO52HI53LO:M20	CPC016_NPC_24H_X4	M20	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_NPC_24H_X1_B7_DUO52HI53LO:H09	CPC018_NPC_24H_X1	H09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_NPC_24H_X2_B7_DUO52HI53LO:H09	CPC018_NPC_24H_X2	H09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_NPC_24H_X3_B7_DUO52HI53LO:H09	CPC018_NPC_24H_X3	H09	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_NPC_24H_X1_B7_DUO52HI53LO:O06	CPC016_NPC_24H_X1	O06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_NPC_24H_X2_B7_DUO52HI53LO:O06	CPC016_NPC_24H_X2	O06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_NPC_24H_X3_B7_DUO52HI53LO:O06	CPC016_NPC_24H_X3	O06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_NPC_24H_X4_B7_DUO52HI53LO:O06	CPC016_NPC_24H_X4	O06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_NPC_24H_X1_B7_DUO52HI53LO:H06	CPC016_NPC_24H_X1	H06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_NPC_24H_X2_B7_DUO52HI53LO:H06	CPC016_NPC_24H_X2	H06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_NPC_24H_X4_B7_DUO52HI53LO:H06	CPC016_NPC_24H_X4	H06	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_NPC_24H_X1_B7_DUO52HI53LO:K22	CPC016_NPC_24H_X1	K22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_NPC_24H_X2_B7_DUO52HI53LO:K22	CPC016_NPC_24H_X2	K22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_NPC_24H_X3_B7_DUO52HI53LO:K22	CPC016_NPC_24H_X3	K22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_NPC_24H_X4_B7_DUO52HI53LO:K22	CPC016_NPC_24H_X4	K22	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_NPC_24H_X1_B7_DUO52HI53LO:J19	CPC018_NPC_24H_X1	J19	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_NPC_24H_X2_B7_DUO52HI53LO:J19	CPC018_NPC_24H_X2	J19	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_NPC_24H_X3_B7_DUO52HI53LO:J19	CPC018_NPC_24H_X3	J19	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_NPC_24H_X1_B7_DUO52HI53LO:L01	CPC015_NPC_24H_X1	L01	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_NPC_24H_X1_B7_DUO52HI53LO:L03	CPC015_NPC_24H_X1	L03	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_NPC_24H_X2_B7_DUO52HI53LO:L03	CPC015_NPC_24H_X2	L03	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_NPC_24H_X3_B7_DUO52HI53LO:L03	CPC015_NPC_24H_X3	L03	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_NPC_24H_X4_B7_DUO52HI53LO:L03	CPC015_NPC_24H_X4	L03	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_NPC_24H_X1_B7_DUO52HI53LO:K04	CPC015_NPC_24H_X1	K04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_NPC_24H_X2_B7_DUO52HI53LO:K04	CPC015_NPC_24H_X2	K04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_NPC_24H_X3_B7_DUO52HI53LO:K04	CPC015_NPC_24H_X3	K04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_NPC_24H_X4_B7_DUO52HI53LO:K04	CPC015_NPC_24H_X4	K04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NPC_24H_X2.L2_B6_DUO52HI53LO:P04	NMH001_NPC_24H_X2.L2	P04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NPC_24H_X3.L2_B6_DUO52HI53LO:P04	NMH001_NPC_24H_X3.L2	P04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NPC_24H_X1_B6_DUO52HI53LO:P04	NMH001_NPC_24H_X1	P04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NPC_24H_X2_B6_DUO52HI53LO:P04	NMH001_NPC_24H_X2	P04	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NPC_6H_X1_B6_DUO52HI53LO:P04	NMH001_NPC_6H_X1	P04	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NPC_6H_X2.L2_B6_DUO52HI53LO:P04	NMH001_NPC_6H_X2.L2	P04	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NPC_6H_X3_B6_DUO52HI53LO:P04	NMH001_NPC_6H_X3	P04	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NPC_24H_X1_B6_DUO52HI53LO:H08	NMH002_NPC_24H_X1	H08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NPC_24H_X2_B6_DUO52HI53LO:H08	NMH002_NPC_24H_X2	H08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NPC_24H_X3_B6_DUO52HI53LO:H08	NMH002_NPC_24H_X3	H08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NPC_6H_X1_B6_DUO52HI53LO:H08	NMH002_NPC_6H_X1	H08	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NPC_6H_X2_B6_DUO52HI53LO:H08	NMH002_NPC_6H_X2	H08	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NPC_6H_X3_B6_DUO52HI53LO:H08	NMH002_NPC_6H_X3	H08	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_NPC_24H_X1_B7_DUO52HI53LO:N14	CPC016_NPC_24H_X1	N14	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_NPC_24H_X2_B7_DUO52HI53LO:N14	CPC016_NPC_24H_X2	N14	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_NPC_24H_X3_B7_DUO52HI53LO:N14	CPC016_NPC_24H_X3	N14	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_NPC_24H_X4_B7_DUO52HI53LO:N14	CPC016_NPC_24H_X4	N14	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_NPC_24H_X1_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X1	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_NPC_24H_X2_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X2	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_NPC_24H_X3_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X3	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_NPC_24H_X4_B7_DUO52HI53LO:N08	CPC016_NPC_24H_X4	N08	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_NPC_24H_X1_B7_DUO52HI53LO:L07	CPC015_NPC_24H_X1	L07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_NPC_24H_X2_B7_DUO52HI53LO:L07	CPC015_NPC_24H_X2	L07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_NPC_24H_X3_B7_DUO52HI53LO:L07	CPC015_NPC_24H_X3	L07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_NPC_24H_X4_B7_DUO52HI53LO:L07	CPC015_NPC_24H_X4	L07	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_NPC_24H_X1_B7_DUO52HI53LO:K18	CPC015_NPC_24H_X1	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_NPC_24H_X2_B7_DUO52HI53LO:K18	CPC015_NPC_24H_X2	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_NPC_24H_X3_B7_DUO52HI53LO:K18	CPC015_NPC_24H_X3	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_NPC_24H_X4_B7_DUO52HI53LO:K18	CPC015_NPC_24H_X4	K18	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_NPC_24H_X1_B7_DUO52HI53LO:F21	CPC017_NPC_24H_X1	F21	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_NPC_24H_X2_B7_DUO52HI53LO:F21	CPC017_NPC_24H_X2	F21	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_NPC_24H_X3_B7_DUO52HI53LO:F21	CPC017_NPC_24H_X3	F21	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_NPC_24H_X4_B7_DUO52HI53LO:F21	CPC017_NPC_24H_X4	F21	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NPC_24H_X1_B6_DUO52HI53LO:N11	NMH001_NPC_24H_X1	N11	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NPC_24H_X2.L2_B6_DUO52HI53LO:N11	NMH001_NPC_24H_X2.L2	N11	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NPC_24H_X3.L2_B6_DUO52HI53LO:N11	NMH001_NPC_24H_X3.L2	N11	trt_cp	10.0	um	24	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NPC_6H_X1_B6_DUO52HI53LO:N11	NMH001_NPC_6H_X1	N11	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NPC_6H_X2.L2_B6_DUO52HI53LO:N11	NMH001_NPC_6H_X2.L2	N11	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NPC_6H_X3_B6_DUO52HI53LO:N11	NMH001_NPC_6H_X3	N11	trt_cp	10.0	um	6	h	NPC	differentiated	NPC	-666	differentiated from iPSC, but not terminally differentiated	primary	central nervous system	normal stem fibroblast-derived iPScs	adherent	-666	-666	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_PHH_24H_X2_B7_DUO52HI53LO:L09	CPC015_PHH_24H_X2	L09	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_PHH_24H_X4_B7_DUO52HI53LO:L09	CPC015_PHH_24H_X4	L09	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_PHH_24H_X2_B7_DUO52HI53LO:J10	CPC015_PHH_24H_X2	J10	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_PHH_24H_X4_B7_DUO52HI53LO:J10	CPC015_PHH_24H_X4	J10	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_PHH_24H_X2_B7_DUO52HI53LO:K18	CPC017_PHH_24H_X2	K18	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_PHH_24H_X3_B7_DUO52HI53LO:K18	CPC017_PHH_24H_X3	K18	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_PHH_24H_X4_B7_DUO52HI53LO:K18	CPC017_PHH_24H_X4	K18	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_PHH_24H_X1_B7_DUO52HI53LO:F20	CPC018_PHH_24H_X1	F20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_PHH_24H_X2_B7_DUO52HI53LO:F20	CPC018_PHH_24H_X2	F20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_PHH_24H_X4_B7_DUO52HI53LO:F20	CPC018_PHH_24H_X4	F20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_PHH_24H_X2_B7_DUO52HI53LO:M02	CPC017_PHH_24H_X2	M02	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_PHH_24H_X3_B7_DUO52HI53LO:M02	CPC017_PHH_24H_X3	M02	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_PHH_24H_X4_B7_DUO52HI53LO:M02	CPC017_PHH_24H_X4	M02	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_PHH_24H_X1_B7_DUO52HI53LO:A20	CPC018_PHH_24H_X1	A20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_PHH_24H_X2_B7_DUO52HI53LO:A20	CPC018_PHH_24H_X2	A20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_PHH_24H_X4_B7_DUO52HI53LO:A20	CPC018_PHH_24H_X4	A20	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_PHH_24H_X2_B7_DUO52HI53LO:O16	CPC017_PHH_24H_X2	O16	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_PHH_24H_X3_B7_DUO52HI53LO:O16	CPC017_PHH_24H_X3	O16	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_PHH_24H_X4_B7_DUO52HI53LO:O16	CPC017_PHH_24H_X4	O16	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_PHH_24H_X2_B7_DUO52HI53LO:I07	CPC017_PHH_24H_X2	I07	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_PHH_24H_X3_B7_DUO52HI53LO:I07	CPC017_PHH_24H_X3	I07	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_PHH_24H_X4_B7_DUO52HI53LO:I07	CPC017_PHH_24H_X4	I07	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_PHH_24H_X1_B7_DUO52HI53LO:H09	CPC018_PHH_24H_X1	H09	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_PHH_24H_X2_B7_DUO52HI53LO:H09	CPC018_PHH_24H_X2	H09	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_PHH_24H_X4_B7_DUO52HI53LO:H09	CPC018_PHH_24H_X4	H09	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_PHH_24H_X1_B7_DUO52HI53LO:J19	CPC018_PHH_24H_X1	J19	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_PHH_24H_X2_B7_DUO52HI53LO:J19	CPC018_PHH_24H_X2	J19	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_PHH_24H_X4_B7_DUO52HI53LO:J19	CPC018_PHH_24H_X4	J19	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_PHH_24H_X4_B7_DUO52HI53LO:L01	CPC015_PHH_24H_X4	L01	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_PHH_24H_X2_B7_DUO52HI53LO:L03	CPC015_PHH_24H_X2	L03	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_PHH_24H_X4_B7_DUO52HI53LO:L03	CPC015_PHH_24H_X4	L03	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_PHH_24H_X2_B7_DUO52HI53LO:K04	CPC015_PHH_24H_X2	K04	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_PHH_24H_X4_B7_DUO52HI53LO:K04	CPC015_PHH_24H_X4	K04	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_PHH_24H_X2_B7_DUO52HI53LO:L07	CPC015_PHH_24H_X2	L07	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_PHH_24H_X4_B7_DUO52HI53LO:L07	CPC015_PHH_24H_X4	L07	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_PHH_24H_X2_B7_DUO52HI53LO:K18	CPC015_PHH_24H_X2	K18	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_PHH_24H_X4_B7_DUO52HI53LO:K18	CPC015_PHH_24H_X4	K18	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_PHH_24H_X4_B7_DUO52HI53LO:F21	CPC017_PHH_24H_X4	F21	trt_cp	10.0	um	24	h	PHH	primary	PHH	-666	-666	primary	liver	normal primary liver	-666	-666	CellzDirect	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_SKB_24H_X2_B7_DUO52HI53LO:L09	CPC015_SKB_24H_X2	L09	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100000444	N06AX12	bupropion	BRD-A05186015	1	13	CPC015_SKB_24H_X3_B7_DUO52HI53LO:L09	CPC015_SKB_24H_X3	L09	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_SKB_24H_X2_B7_DUO52HI53LO:J10	CPC015_SKB_24H_X2	J10	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	CPC015_SKB_24H_X3_B7_DUO52HI53LO:J10	CPC015_SKB_24H_X3	J10	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_SKB_24H_X2_B7_DUO52HI53LO:K18	CPC017_SKB_24H_X2	K18	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100002170	N06AA17	amoxapine	BRD-K02265150	1	13	CPC017_SKB_24H_X3_B7_DUO52HI53LO:K18	CPC017_SKB_24H_X3	K18	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_SKB_24H_X1_B7_DUO52HI53LO:F20	CPC018_SKB_24H_X1	F20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_SKB_24H_X2_B7_DUO52HI53LO:F20	CPC018_SKB_24H_X2	F20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100002801	N06AA04	clomipramine	BRD-K52989797	1	13	CPC018_SKB_24H_X3_B7_DUO52HI53LO:F20	CPC018_SKB_24H_X3	F20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_SKB_24H_X2_B7_DUO52HI53LO:M02	CPC017_SKB_24H_X2	M02	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100002995	N06AA01	desipramine	BRD-K60762818	1	13	CPC017_SKB_24H_X3_B7_DUO52HI53LO:M02	CPC017_SKB_24H_X3	M02	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_SKB_24H_X1_B7_DUO52HI53LO:A20	CPC018_SKB_24H_X1	A20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_SKB_24H_X2_B7_DUO52HI53LO:A20	CPC018_SKB_24H_X2	A20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K36616567	3	13	CPC018_SKB_24H_X3_B7_DUO52HI53LO:A20	CPC018_SKB_24H_X3	A20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_SKB_24H_X2_B7_DUO52HI53LO:O16	CPC017_SKB_24H_X2	O16	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K37694030	3	13	CPC017_SKB_24H_X3_B7_DUO52HI53LO:O16	CPC017_SKB_24H_X3	O16	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_SKB_24H_X2_B7_DUO52HI53LO:I07	CPC017_SKB_24H_X2	I07	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003158	N06AA12	doxepin	BRD-K54462405	3	13	CPC017_SKB_24H_X3_B7_DUO52HI53LO:I07	CPC017_SKB_24H_X3	I07	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_SKB_24H_X1_B7_DUO52HI53LO:M15	CPC016_SKB_24H_X1	M15	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_SKB_24H_X2_B7_DUO52HI53LO:M15	CPC016_SKB_24H_X2	M15	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_SKB_24H_X3_B7_DUO52HI53LO:M15	CPC016_SKB_24H_X3	M15	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_SKB_24H_X1_B7_DUO52HI53LO:M20	CPC016_SKB_24H_X1	M20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_SKB_24H_X2_B7_DUO52HI53LO:M20	CPC016_SKB_24H_X2	M20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_SKB_24H_X3_B7_DUO52HI53LO:M20	CPC016_SKB_24H_X3	M20	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_SKB_24H_X1_B7_DUO52HI53LO:H09	CPC018_SKB_24H_X1	H09	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_SKB_24H_X2_B7_DUO52HI53LO:H09	CPC018_SKB_24H_X2	H09	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004011	N06AA21	maprotiline	BRD-K25433859	2	13	CPC018_SKB_24H_X3_B7_DUO52HI53LO:H09	CPC018_SKB_24H_X3	H09	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_SKB_24H_X1_B7_DUO52HI53LO:O06	CPC016_SKB_24H_X1	O06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_SKB_24H_X2_B7_DUO52HI53LO:O06	CPC016_SKB_24H_X2	O06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_SKB_24H_X3_B7_DUO52HI53LO:O06	CPC016_SKB_24H_X3	O06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_SKB_24H_X1_B7_DUO52HI53LO:H06	CPC016_SKB_24H_X1	H06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_SKB_24H_X2_B7_DUO52HI53LO:H06	CPC016_SKB_24H_X2	H06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_SKB_24H_X3_B7_DUO52HI53LO:H06	CPC016_SKB_24H_X3	H06	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_SKB_24H_X1_B7_DUO52HI53LO:K22	CPC016_SKB_24H_X1	K22	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_SKB_24H_X2_B7_DUO52HI53LO:K22	CPC016_SKB_24H_X2	K22	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_SKB_24H_X3_B7_DUO52HI53LO:K22	CPC016_SKB_24H_X3	K22	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_SKB_24H_X1_B7_DUO52HI53LO:J19	CPC018_SKB_24H_X1	J19	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_SKB_24H_X2_B7_DUO52HI53LO:J19	CPC018_SKB_24H_X2	J19	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004543	N06AA10	nortriptyline	BRD-K91263825	1	13	CPC018_SKB_24H_X3_B7_DUO52HI53LO:J19	CPC018_SKB_24H_X3	J19	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_SKB_24H_X2_B7_DUO52HI53LO:L01	CPC015_SKB_24H_X2	L01	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004691	N06AB05	paroxetine	BRD-K37991163	3	13	CPC015_SKB_24H_X3_B7_DUO52HI53LO:L01	CPC015_SKB_24H_X3	L01	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_SKB_24H_X2_B7_DUO52HI53LO:L03	CPC015_SKB_24H_X2	L03	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100004976	N06AA11	protriptyline	BRD-K42098891	1	13	CPC015_SKB_24H_X3_B7_DUO52HI53LO:L03	CPC015_SKB_24H_X3	L03	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_SKB_24H_X2_B7_DUO52HI53LO:K04	CPC015_SKB_24H_X2	K04	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100005203	N06AB06	sertraline	BRD-K82036761	2	13	CPC015_SKB_24H_X3_B7_DUO52HI53LO:K04	CPC015_SKB_24H_X3	K04	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_SKB_24H_X1_B7_DUO52HI53LO:N14	CPC016_SKB_24H_X1	N14	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_SKB_24H_X2_B7_DUO52HI53LO:N14	CPC016_SKB_24H_X2	N14	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_SKB_24H_X3_B7_DUO52HI53LO:N14	CPC016_SKB_24H_X3	N14	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_SKB_24H_X1_B7_DUO52HI53LO:N08	CPC016_SKB_24H_X1	N08	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_SKB_24H_X2_B7_DUO52HI53LO:N08	CPC016_SKB_24H_X2	N08	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_SKB_24H_X2_B7_DUO52HI53LO:L07	CPC015_SKB_24H_X2	L07	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100005656	N06AX16	venlafaxine	BRD-A51714012	1	13	CPC015_SKB_24H_X3_B7_DUO52HI53LO:L07	CPC015_SKB_24H_X3	L07	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_SKB_24H_X2_B7_DUO52HI53LO:K18	CPC015_SKB_24H_X2	K18	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100060834	N06AX21	duloxetine	BRD-K71103788	1	13	CPC015_SKB_24H_X3_B7_DUO52HI53LO:K18	CPC015_SKB_24H_X3	K18	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_SKB_24H_X2_B7_DUO52HI53LO:F21	CPC017_SKB_24H_X2	F21	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-A43974499	3	13	CPC017_SKB_24H_X3_B7_DUO52HI53LO:F21	CPC017_SKB_24H_X3	F21	trt_cp	10.0	um	24	h	SKB	primary	SKB	-666	-666	normal	muscle	myoblast	-666	CC-2580	Lonza	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:O07	BRAF001_HEK293T_6H_X1	O07	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:O08	BRAF001_HEK293T_6H_X1	O08	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:O15	BRAF001_HEK293T_6H_X1	O15	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:O16	BRAF001_HEK293T_6H_X1	O16	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:O23	BRAF001_HEK293T_6H_X1	O23	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:O24	BRAF001_HEK293T_6H_X1	O24	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:P07	BRAF001_HEK293T_6H_X1	P07	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:P08	BRAF001_HEK293T_6H_X1	P08	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:P15	BRAF001_HEK293T_6H_X1	P15	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:P16	BRAF001_HEK293T_6H_X1	P16	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:P23	BRAF001_HEK293T_6H_X1	P23	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X1_B10:P24	BRAF001_HEK293T_6H_X1	P24	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:O07	BRAF001_HEK293T_6H_X2	O07	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:O08	BRAF001_HEK293T_6H_X2	O08	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:O15	BRAF001_HEK293T_6H_X2	O15	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:O16	BRAF001_HEK293T_6H_X2	O16	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:O23	BRAF001_HEK293T_6H_X2	O23	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:O24	BRAF001_HEK293T_6H_X2	O24	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:P07	BRAF001_HEK293T_6H_X2	P07	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:P08	BRAF001_HEK293T_6H_X2	P08	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:P15	BRAF001_HEK293T_6H_X2	P15	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:P16	BRAF001_HEK293T_6H_X2	P16	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:P23	BRAF001_HEK293T_6H_X2	P23	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X2_B10:P24	BRAF001_HEK293T_6H_X2	P24	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:O07	BRAF001_HEK293T_6H_X3	O07	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:O08	BRAF001_HEK293T_6H_X3	O08	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:O15	BRAF001_HEK293T_6H_X3	O15	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:O16	BRAF001_HEK293T_6H_X3	O16	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:O23	BRAF001_HEK293T_6H_X3	O23	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:O24	BRAF001_HEK293T_6H_X3	O24	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:P07	BRAF001_HEK293T_6H_X3	P07	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:P08	BRAF001_HEK293T_6H_X3	P08	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:P15	BRAF001_HEK293T_6H_X3	P15	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:P16	BRAF001_HEK293T_6H_X3	P16	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:P23	BRAF001_HEK293T_6H_X3	P23	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_6H_X3_B10:P24	BRAF001_HEK293T_6H_X3	P24	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:O07	BRAF001_HEK293T_24H_X1	O07	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:O08	BRAF001_HEK293T_24H_X1	O08	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:O15	BRAF001_HEK293T_24H_X1	O15	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:O16	BRAF001_HEK293T_24H_X1	O16	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:O23	BRAF001_HEK293T_24H_X1	O23	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:O24	BRAF001_HEK293T_24H_X1	O24	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:P07	BRAF001_HEK293T_24H_X1	P07	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:P08	BRAF001_HEK293T_24H_X1	P08	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:P15	BRAF001_HEK293T_24H_X1	P15	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:P16	BRAF001_HEK293T_24H_X1	P16	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:P23	BRAF001_HEK293T_24H_X1	P23	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X1_B10:P24	BRAF001_HEK293T_24H_X1	P24	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X2_B10:O07	BRAF001_HEK293T_24H_X2	O07	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X2_B10:O08	BRAF001_HEK293T_24H_X2	O08	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X2_B10:O15	BRAF001_HEK293T_24H_X2	O15	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X2_B10:O16	BRAF001_HEK293T_24H_X2	O16	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X2_B10:P07	BRAF001_HEK293T_24H_X2	P07	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X2_B10:P08	BRAF001_HEK293T_24H_X2	P08	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X2_B10:P15	BRAF001_HEK293T_24H_X2	P15	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X2_B10:P16	BRAF001_HEK293T_24H_X2	P16	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X2_B10:P23	BRAF001_HEK293T_24H_X2	P23	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X2_B10:P24	BRAF001_HEK293T_24H_X2	P24	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X3_B10:O07	BRAF001_HEK293T_24H_X3	O07	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X3_B10:O08	BRAF001_HEK293T_24H_X3	O08	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X3_B10:O15	BRAF001_HEK293T_24H_X3	O15	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X3_B10:O16	BRAF001_HEK293T_24H_X3	O16	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X3_B10:O23	BRAF001_HEK293T_24H_X3	O23	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X3_B10:P07	BRAF001_HEK293T_24H_X3	P07	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X3_B10:P08	BRAF001_HEK293T_24H_X3	P08	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X3_B10:P15	BRAF001_HEK293T_24H_X3	P15	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X3_B10:P16	BRAF001_HEK293T_24H_X3	P16	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X3_B10:P23	BRAF001_HEK293T_24H_X3	P23	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100002160	N06AA09	amitriptyline	BRD-K53737926	1	14	BRAF001_HEK293T_24H_X3_B10:P24	BRAF001_HEK293T_24H_X3	P24	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:O03	BRAF001_HEK293T_6H_X1	O03	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:O04	BRAF001_HEK293T_6H_X1	O04	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:O11	BRAF001_HEK293T_6H_X1	O11	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:O12	BRAF001_HEK293T_6H_X1	O12	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:O19	BRAF001_HEK293T_6H_X1	O19	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:O20	BRAF001_HEK293T_6H_X1	O20	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:P03	BRAF001_HEK293T_6H_X1	P03	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:P04	BRAF001_HEK293T_6H_X1	P04	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:P11	BRAF001_HEK293T_6H_X1	P11	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:P12	BRAF001_HEK293T_6H_X1	P12	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:P19	BRAF001_HEK293T_6H_X1	P19	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X1_B10:P20	BRAF001_HEK293T_6H_X1	P20	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:O03	BRAF001_HEK293T_6H_X2	O03	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:O04	BRAF001_HEK293T_6H_X2	O04	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:O11	BRAF001_HEK293T_6H_X2	O11	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:O12	BRAF001_HEK293T_6H_X2	O12	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:O19	BRAF001_HEK293T_6H_X2	O19	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:O20	BRAF001_HEK293T_6H_X2	O20	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:P03	BRAF001_HEK293T_6H_X2	P03	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:P04	BRAF001_HEK293T_6H_X2	P04	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:P11	BRAF001_HEK293T_6H_X2	P11	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:P12	BRAF001_HEK293T_6H_X2	P12	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:P19	BRAF001_HEK293T_6H_X2	P19	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X2_B10:P20	BRAF001_HEK293T_6H_X2	P20	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:O03	BRAF001_HEK293T_6H_X3	O03	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:O04	BRAF001_HEK293T_6H_X3	O04	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:O11	BRAF001_HEK293T_6H_X3	O11	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:O12	BRAF001_HEK293T_6H_X3	O12	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:O19	BRAF001_HEK293T_6H_X3	O19	trt_cp	10.0	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:O20	BRAF001_HEK293T_6H_X3	O20	trt_cp	2.5	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:P03	BRAF001_HEK293T_6H_X3	P03	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:P04	BRAF001_HEK293T_6H_X3	P04	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:P11	BRAF001_HEK293T_6H_X3	P11	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:P12	BRAF001_HEK293T_6H_X3	P12	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:P19	BRAF001_HEK293T_6H_X3	P19	trt_cp	0.625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_6H_X3_B10:P20	BRAF001_HEK293T_6H_X3	P20	trt_cp	0.15625	um	6	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:O03	BRAF001_HEK293T_24H_X1	O03	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:O04	BRAF001_HEK293T_24H_X1	O04	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:O11	BRAF001_HEK293T_24H_X1	O11	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:O12	BRAF001_HEK293T_24H_X1	O12	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:O19	BRAF001_HEK293T_24H_X1	O19	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:O20	BRAF001_HEK293T_24H_X1	O20	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:P03	BRAF001_HEK293T_24H_X1	P03	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:P04	BRAF001_HEK293T_24H_X1	P04	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:P11	BRAF001_HEK293T_24H_X1	P11	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:P12	BRAF001_HEK293T_24H_X1	P12	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:P19	BRAF001_HEK293T_24H_X1	P19	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X1_B10:P20	BRAF001_HEK293T_24H_X1	P20	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X2_B10:O03	BRAF001_HEK293T_24H_X2	O03	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X2_B10:O04	BRAF001_HEK293T_24H_X2	O04	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X2_B10:O11	BRAF001_HEK293T_24H_X2	O11	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X2_B10:O12	BRAF001_HEK293T_24H_X2	O12	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X2_B10:O19	BRAF001_HEK293T_24H_X2	O19	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X2_B10:O20	BRAF001_HEK293T_24H_X2	O20	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X2_B10:P03	BRAF001_HEK293T_24H_X2	P03	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X2_B10:P04	BRAF001_HEK293T_24H_X2	P04	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X2_B10:P11	BRAF001_HEK293T_24H_X2	P11	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X2_B10:P12	BRAF001_HEK293T_24H_X2	P12	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X2_B10:P20	BRAF001_HEK293T_24H_X2	P20	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X3_B10:O03	BRAF001_HEK293T_24H_X3	O03	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X3_B10:O04	BRAF001_HEK293T_24H_X3	O04	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X3_B10:O11	BRAF001_HEK293T_24H_X3	O11	trt_cp	10.0	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X3_B10:O12	BRAF001_HEK293T_24H_X3	O12	trt_cp	2.5	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X3_B10:P03	BRAF001_HEK293T_24H_X3	P03	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X3_B10:P04	BRAF001_HEK293T_24H_X3	P04	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X3_B10:P11	BRAF001_HEK293T_24H_X3	P11	trt_cp	0.625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003696	N06AA02	imipramine	BRD-K38436528	1	9	BRAF001_HEK293T_24H_X3_B10:P12	BRAF001_HEK293T_24H_X3	P12	trt_cp	0.15625	um	24	h	HEK293T	cell line	HEK293T	-666	immortalized normal	normal	kidney	embryonal kidney	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NEU_24H_X1.L2_B6_DUO52HI53LO:G06	NMH001_NEU_24H_X1.L2	G06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NEU_24H_X2.L2_B6_DUO52HI53LO:G06	NMH001_NEU_24H_X2.L2	G06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NEU_24H_X3.L2_B6_DUO52HI53LO:G06	NMH001_NEU_24H_X3.L2	G06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NEU_6H_X1_B6_DUO52HI53LO:G06	NMH001_NEU_6H_X1	G06	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NEU_6H_X2_B6_DUO52HI53LO:G06	NMH001_NEU_6H_X2	G06	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NEU_6H_X3.L2_B6_DUO52HI53LO:G06	NMH001_NEU_6H_X3.L2	G06	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_NEU_6H_X3_B6_DUO52HI53LO:G06	NMH001_NEU_6H_X3	G06	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_NEU_24H_X2_B7_DUO52HI53LO:M15	CPC016_NEU_24H_X2	M15	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_NEU_24H_X3_B7_DUO52HI53LO:M15	CPC016_NEU_24H_X3	M15	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003404	N06AB08	fluvoxamine	BRD-K72676686	2	13	CPC016_NEU_24H_X4_B7_DUO52HI53LO:M15	CPC016_NEU_24H_X4	M15	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_NEU_24H_X2_B7_DUO52HI53LO:M20	CPC016_NEU_24H_X2	M20	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_NEU_24H_X3_B7_DUO52HI53LO:M20	CPC016_NEU_24H_X3	M20	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003759	N06AF01	isocarboxazid	BRD-K93332168	1	13	CPC016_NEU_24H_X4_B7_DUO52HI53LO:M20	CPC016_NEU_24H_X4	M20	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_NEU_24H_X2_B7_DUO52HI53LO:O06	CPC016_NEU_24H_X2	O06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_NEU_24H_X3_B7_DUO52HI53LO:O06	CPC016_NEU_24H_X3	O06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100004184	N06AX03	mianserin	BRD-A19661776	1	13	CPC016_NEU_24H_X4_B7_DUO52HI53LO:O06	CPC016_NEU_24H_X4	O06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_NEU_24H_X2_B7_DUO52HI53LO:H06	CPC016_NEU_24H_X2	H06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_NEU_24H_X3_B7_DUO52HI53LO:H06	CPC016_NEU_24H_X3	H06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100004205	N06AX11	mirtazapine	BRD-A64977602	2	13	CPC016_NEU_24H_X4_B7_DUO52HI53LO:H06	CPC016_NEU_24H_X4	H06	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_NEU_24H_X2_B7_DUO52HI53LO:K22	CPC016_NEU_24H_X2	K22	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_NEU_24H_X3_B7_DUO52HI53LO:K22	CPC016_NEU_24H_X3	K22	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100004449	N06AX06	nefazodone	BRD-K90789829	1	13	CPC016_NEU_24H_X4_B7_DUO52HI53LO:K22	CPC016_NEU_24H_X4	K22	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NEU_24H_X1.L2_B6_DUO52HI53LO:P04	NMH001_NEU_24H_X1.L2	P04	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NEU_24H_X2.L2_B6_DUO52HI53LO:P04	NMH001_NEU_24H_X2.L2	P04	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NEU_24H_X3.L2_B6_DUO52HI53LO:P04	NMH001_NEU_24H_X3.L2	P04	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NEU_6H_X1_B6_DUO52HI53LO:P04	NMH001_NEU_6H_X1	P04	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NEU_6H_X2_B6_DUO52HI53LO:P04	NMH001_NEU_6H_X2	P04	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NEU_6H_X3.L2_B6_DUO52HI53LO:P04	NMH001_NEU_6H_X3.L2	P04	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_NEU_6H_X3_B6_DUO52HI53LO:P04	NMH001_NEU_6H_X3	P04	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NEU_24H_X1_B6_DUO52HI53LO:H08	NMH002_NEU_24H_X1	H08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NEU_24H_X2_B6_DUO52HI53LO:H08	NMH002_NEU_24H_X2	H08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NEU_24H_X3_B6_DUO52HI53LO:H08	NMH002_NEU_24H_X3	H08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NEU_6H_X1_B6_DUO52HI53LO:H08	NMH002_NEU_6H_X1	H08	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NEU_6H_X2_B6_DUO52HI53LO:H08	NMH002_NEU_6H_X2	H08	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_NEU_6H_X3_B6_DUO52HI53LO:H08	NMH002_NEU_6H_X3	H08	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_NEU_24H_X2_B7_DUO52HI53LO:N14	CPC016_NEU_24H_X2	N14	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_NEU_24H_X3_B7_DUO52HI53LO:N14	CPC016_NEU_24H_X3	N14	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005533	N06AX05	trazodone	BRD-K70778732	1	13	CPC016_NEU_24H_X4_B7_DUO52HI53LO:N14	CPC016_NEU_24H_X4	N14	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_NEU_24H_X2_B7_DUO52HI53LO:N08	CPC016_NEU_24H_X2	N08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100005584	N06AA06	trimipramine	BRD-A19195498	1	13	CPC016_NEU_24H_X3_B7_DUO52HI53LO:N08	CPC016_NEU_24H_X3	N08	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NEU_24H_X1.L2_B6_DUO52HI53LO:N11	NMH001_NEU_24H_X1.L2	N11	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NEU_24H_X2.L2_B6_DUO52HI53LO:N11	NMH001_NEU_24H_X2.L2	N11	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NEU_24H_X3.L2_B6_DUO52HI53LO:N11	NMH001_NEU_24H_X3.L2	N11	trt_cp	10.0	um	24	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NEU_6H_X1_B6_DUO52HI53LO:N11	NMH001_NEU_6H_X1	N11	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NEU_6H_X2_B6_DUO52HI53LO:N11	NMH001_NEU_6H_X2	N11	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NEU_6H_X3.L2_B6_DUO52HI53LO:N11	NMH001_NEU_6H_X3.L2	N11	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_NEU_6H_X3_B6_DUO52HI53LO:N11	NMH001_NEU_6H_X3	N11	trt_cp	10.0	um	6	h	NEU	differentiated	NEU	-666	terminally differentiated to be neurons	normal	-666	-666	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_FIBRNPC_24H_X1_B6_DUO52HI53LO:G06	NMH001_FIBRNPC_24H_X1	G06	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_FIBRNPC_24H_X3_B6_DUO52HI53LO:G06	NMH001_FIBRNPC_24H_X3	G06	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_FIBRNPC_6H_X1_B6_DUO52HI53LO:G06	NMH001_FIBRNPC_6H_X1	G06	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100003386	N06AB03	fluoxetine	BRD-A31159102	1	12	NMH001_FIBRNPC_6H_X2.L2_B6_DUO52HI53LO:G06	NMH001_FIBRNPC_6H_X2.L2	G06	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_FIBRNPC_24H_X1_B6_DUO52HI53LO:P04	NMH001_FIBRNPC_24H_X1	P04	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_FIBRNPC_24H_X3_B6_DUO52HI53LO:P04	NMH001_FIBRNPC_24H_X3	P04	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_FIBRNPC_6H_X1_B6_DUO52HI53LO:P04	NMH001_FIBRNPC_6H_X1	P04	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K47029922	3	3	NMH001_FIBRNPC_6H_X2.L2_B6_DUO52HI53LO:P04	NMH001_FIBRNPC_6H_X2.L2	P04	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_FIBRNPC_24H_X1_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_24H_X1	H08	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_FIBRNPC_24H_X2_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_24H_X2	H08	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_FIBRNPC_24H_X3_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_24H_X3	H08	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_FIBRNPC_6H_X1_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_6H_X1	H08	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_FIBRNPC_6H_X2_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_6H_X2	H08	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100005530	N06AF04	tranylcypromine	BRD-K88809146	3	5	NMH002_FIBRNPC_6H_X3_B6_DUO52HI53LO:H08	NMH002_FIBRNPC_6H_X3	H08	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_FIBRNPC_6H_X1_B6_DUO52HI53LO:N11	NMH001_FIBRNPC_6H_X1	N11	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_FIBRNPC_24H_X1_B6_DUO52HI53LO:N11	NMH001_FIBRNPC_24H_X1	N11	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_FIBRNPC_24H_X3_B6_DUO52HI53LO:N11	NMH001_FIBRNPC_24H_X3	N11	trt_cp	10.0	um	24	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
CID100065856	N06AX18	reboxetine	BRD-K32814891	3	3	NMH001_FIBRNPC_6H_X2.L2_B6_DUO52HI53LO:N11	NMH001_FIBRNPC_6H_X2.L2	N11	trt_cp	10.0	um	6	h	FIBRNPC	iPSC	FIBRNPC	-666	-666	normal	skin	-666	adherent	-666	-666	-666	-666	-666
